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 This thesis focuses on the asymmetric reduction of N-protected derivatives of 
(3S)-3-amino-1-chloro-4-phenyl-2-butanone to their corresponding diastereomeric 
alcohol products, which are key intermediates in the synthesis of HIV protease inhibitors.  
Although the stereoselective synthesis of the (S,S) alcohol product is easily achieved, 
preparing the (R,S) diastereomer is much more challenging.  I investigated three 
diastereoselective reduction processes: 1) Meerwein-Ponndorf-Verley (MPV) reduction, 
2) asymmetric transfer hydrogenation, and 3) boron reducing agents.  The 
diastereoselectivity of the MPV reduction still favored the (S,S) product; however, I 
discovered a significant rate enhancement when the standard catalyst (aluminum 
isopropoxide) was replaced with aluminum tert-butoxide.  Many reaction variables were 
investigated in the asymmetric transfer hydrogenation reaction and the 
diastereoselectivity was improved to give a ratio of the desired (R,S) diastereomer to the 
undesired (S,S) alcohol of 9.5:1.  Using chiral oxazaborolidine catalysts, an 
unprecedented (R,S) to (S,S) ratio of 9.5:1 was achieved.  Finally, I investigated the 
effect of the N-protecting group on the stereoselectivity of the reduction.  When the 
original boc-protecting group was replaced with a phthalimide group, the 










Protease inhibitors are a class of pharmaceutically active compounds that have 
been developed to treat infections caused by viruses.  One type of protease inhibitor 
targets the Human Immunodeficiency Virus (HIV), the cause of Acquired 
Immunodeficiency Syndrome (AIDS).  Researchers have identified and synthesized a 
few HIV protease inhibitors for commercial production, including Amprenavir®, 
Saquinavir®, and Atazanavir®.  Because the structures of these protease inhibitors are 
rather complex, often with multiple chiral centers, their synthesis is difficult and 
expensive.  The optically active N-(tert-butyloxycarbonyl)-(3S)-3-amino-1-chloro-4-
phenyl-(2R)-butan-2-ol [abbreviated (R,S)-CMA] and N-(tert-butyloxycarbonyl)-(3S)-3-
amino-1-chloro-4-phenyl-(2S)-butan-2-ol [abbreviated (S,S)-CMA] are important 
intermediates in the synthesis of HIV protease inhibitors (Figure 1.1). 
 
 
Figure 1.1: Structures of (S,S)- and (R,S)-CMA. 
 
 
Researchers in both academia and industry have investigated the means to 
selectively prepare the diastereomers (S,S)-CMA and (R,S)-CMA from the 
corresponding prochiral ketone, N-(tert-butyloxycarbonyl)-(3S)-3-amino-1-chloro-4-




adjacent to the carbonyl group is chiral (S configuration) and thus can contribute to the 
stereoselectivity of the carbonyl reduction process.  For instance, previous studies 
showed that the Meerwein-Ponndorf-Verley (MPV) reduction of (S)-CMK using 
aluminum isopropoxide in isopropanol proceeded cleanly and stereoselectively to (S,S)-
CMA primarily.  However, establishing an economically competitive method to 
stereoselectively prepare (R,S)-CMA is still a major challenge. 
In this thesis, three cost-effective and diastereoselective processes to prepare 
(R,S)-CMA from (S)-CMK were successfully developed.  The synthetic strategies that 
were investigated are: 1) MPV reduction, 2) asymmetric transfer hydrogenation (ATH), 
and 3) reduction with boron reducing reagents. 
Chapter 2 (Background) overviews the prior research that scientists have 
conducted using a large number of reducing agents to stereoselectively prepare (R,S)-
CMA with varying levels of success.  Although a few techniques producing high yields 
and stereoselective production of (R,S)-CMA have been identified, the transfer of these 
methodologies to an industrial scale is often too intensive and/or costly. 
In Chapter 3 (Meerwein-Ponndorf-Verley Reductions), the reduction of (S)-CMK 
through the MPV reduction is presented.  The classic MPV reduction (aluminum 
isopropoxide in isopropanol) favors the formation of the (S,S) diastereomer.  The 
diastereoselectivity – induced by the α-chiral carbon of (S) configuration – and the 
reaction rates were shown to be dependent on the aluminum alkoxide reagent’s 
capabilities to hydrogen bond with the substrate as well as its state of aggregation.  In 
addition, I discovered a significant rate enhancement when the common MPV catalyst, 
aluminum isopropoxide, was replaced with aluminum tert-butoxide.  Not only was this 
rate enhancement observed in the reduction of (S)-CMK but it was also applied to the 
reduction of acetophenone and benzaldehyde.  This is new intellectual property that can 




ATH reactions often utilize sodium formate or alkylammonium formates as a 
hydrogen source combined with a homogeneous chiral catalyst (e.g., ruthenium, 
rhodium, or iridium).  Chapter 4 (Asymmetric Transfer Hydrogenation Reactions) 
discusses the results of the ATH reactions run on (S)-CMK.  I first focused on achieving 
reproducible results by changing the apparatus and the reaction procedure.  Once I 
established a reliable procedure, I optimized the reaction by varying reaction conditions 
such as solvent, hydrogen source, reagent concentrations, ligand, and metal catalyst 
center.  I achieved significant improvement in diastereoselectivity with the use of a 
rhodium catalyst and chiral ligand, increasing the ratio of (R,S)-CMA to (S,S)-CMA to 
9.5:1. 
The results of the reductions with boron reducing agents are presented in 
Chapter 5 (Boron Reducing Agents).  Oxazaborolidines are useful reducing agents that 
are commercially available or can be synthesized in situ from chiral amino alcohols and 
boranes.  Using chiral oxazaborolidines (R)-(+)-2-methyl-CBS-oxazaborolidine or (S)-(-)-
2-methyl-CBS-oxazaborolidine [abbreviated (R)-(+)-CBS and (S)-(-)-CBS, respectively], 
the ratio of (R,S)-CMA to (S,S)-CMA was improved to 9.5:1.  The reduction of (S)-CMK 
with high diastereoselectivity using (R)-(+)-CBS is new intellectual property.  
Furthermore, oxazaborolidines can be chemically bonded onto solid supports, allowing 
for recycling or continuous processes. 
Chapter 6 [Reduction of (S)-CMK with Various Protecting Groups] summarizes 
the alteration of the amine protecting group from the original tert-butyloxycarbonyl (Boc) 
group.  The diastereoselectivity – induced by the α-chiral carbon of S configuration – is 
dependent on the aluminum alkoxide reagent’s capabilities to hydrogen bond with the 
NH of the Boc-protected (S)-CMK.  By varying the protecting group on the amine, the 
diastereoselectivity could be altered.  First, (S)-CMK was synthesized with the chosen 




protected (S)-CMK was reduced under classic MPV reduction, ATH reaction, or boron 
reagents conditions.  With the phthalimide group, the protected amine cannot hydrogen 
bond with the aluminum isopropoxide and the diastereoselectivity towards (R,S)-CMA 
was improved from a (R,S)-CMA to (S,S)-CMA ratio of 0.06:1 to 1.10:1.  The 
phthalimide- and trifluoroacetamide-protected alcohols and their preparation are new 
intellectual property. 
Finally, Chapter 7 (Recommendations) provides some ideas for future work in the 
stereoselective reduction of (S)-CMK.  Furthermore, a provisional patent has been filed 
and two publications have been written and will be submitted to Journal of Organic 












Applications of (S,S)- and (R,S)-CMA 
  (S,S)- and (R,S)-CMA are pharmaceutically relevant intermediates in the 
synthesis of HIV protease inhibitors.  The virus requires HIV proteases for replication 
within an infected cell and also for release of mature viruses to infect other cells.1  Figure 
2.1 depicts the infection pathways of a cell by HIV and where protease inhibitors can 
alter these pathways and prevent further infection. 
 
 
Figure 2.1: Illustration of HIV infection pathways with the effect of HIV protease 






 A synthetic route to HIV protease inhibitors is well known and Figure 2.2 shows 
the retrosynthetic scheme to derive a few HIV protease inhibitors from (S)-CMK and its 
reduction products, (S,S)- and (R,S)-CMA.  Specifically, Saquinavir®, the first HIV 
protease inhibitor approved by the Food and Drug Administration, and Amprenavir® 
derive from (R,S)-CMA.  Likewise, (S,S)-CMA is a precursor to Atazanavir®.  Figure 2.3 
depicts the structures of these protease inhibitors.  Not only do these drugs prevent the 
spread of HIV, but they also hold much potential for cancer treatments.2,3 
 
 







Figure 2.3: Chemical structures of some HIV protease inhibitors.  Portions of the 




 Researchers have investigated the asymmetric synthesis of (S,S)- and (R,S)-
CMA from the corresponding prochiral ketone (S)-CMK.  Specifically, a reaction pathway 
starting from Boc-phenylalanine has been proposed (Figure 2.4).  Boc-phenylalanine 
first reacts with isobutyl chloroformate (IBCF) to form a mixed anhydride.  In situ addition 
of diazomethane produces a diazoketone intermediate.  The diazoketone is quenched 







Figure 2.4: Synthetic route to (S,S)- and (R,S)-CMA from Boc-phenylalanine. 
 
 
 (S)-CMK (Figure 2.5) is a prochiral ketone with structural characteristics that 
must be carefully considered: (1) the carbonyl group is adjacent to a chiral center (of S 
configuration), (2) the amine is protected with a Boc group, and (3) the chloro group is in 
the α-position relative to the ketone.  The first characteristic, the adjacent chiral center, is 
critical as it can be taken advantage of to induce stereoselective induction through 
specific interactions (steric effects or hydrogen bonding).  Such interactions can 
participate in directing the approach of the reagent.  The Boc group, although identified 
as the protecting group in the original synthesis of (S)-CMK, can be changed if 
necessary.  In addition, as an α-chloroketone, (S)-CMK is highly susceptible to 
dehalogenation and the reaction conditions will have to be chemoselective toward the 
reduction of the carbonyl (Figure 2.6). 
 
 






Figure 2.6: Possible dechlorination products from (S)-CMK reduction. 
 
 
The stereoselective synthesis of the (S,S)- and (R,S)-CMA diastereomers from 
the corresponding prochiral ketone (S)-CMK was extensively investigated by academia 
and industry alike.  The MPV reduction of (S)-CMK using aluminum isopropoxide in 
isopropanol proceeds cleanly to yield (S,S)-CMA in 97% yield and 94% diastereomeric 
excess.5,6  The stereoselective synthesis of (R,S)-CMA is much more challenging.  The 
research presented in this thesis focuses on the diastereoselective reduction of (S)-CMK 
to (R,S)-CMA. 
 
 (S)-CMK Reduction Prior Art 
Aluminohydride Reduction 
 Aluminohydride reducing reagents, such as lithium aluminum hydride (LAH), are 
well known for the reduction of carbonyl groups.  Researchers have investigated these 
reagents for the reduction of (S)-CMK to the corresponding alcohols.  Table 2.1 
summarizes these results.  The highest ratio of (R,S)-CMA to (S,S)-CMA published was 
8:1 with lithium tri-(tert-butoxy) aluminum hydride as the reagent.5,6  Reagents like LAH 
or DIBAL-H (diisobutylaluminum hydride) gave much lower diastereomeric ratios of 0.5:1 




product distribution, aluminohydride reducing reagents are expensive for large-scale 
industrial considerations and are sensitive to atmospheric moisture, making them difficult 
to handle. 
 





 Microorganisms like enzymes make excellent chiral catalysts and have been 
widely studied in the literature for asymmetric transformations.  Bristol-Myers Squibb 
Pharmaceuticals reported extensive studies on microorganism-catalyzed reduction of 
(S)-CMK.  They originally screened 120 microorganisms and obtained yields as high as 
98% with 99% diastereomeric excess of the (R,S) product in their best system.8  The 
researchers also analyzed the microorganisms for the optimal synthesis of (S,S)-
CMA.9,10  From a practical standpoint, however, microorganisms are expensive and their 
handling requires specific conditions (temperature, solvents, pH, etc.) that may limit their 
application to large-scale synthesis. 
 
Borohydride Reduction 
 Borohydride reagents alone or with modifiers represent a powerful group of 
reducing reagents that often offer greater chemoselectivity than their aluminohydride 
analogs.  Borohydride reagents are also much cheaper and not overly sensitive to air or 




borohydride,5-7,11 were investigated for the stereoselective reduction of (S)-CMK.  K-
Selectride provided the best stereoselectivity of all the reagents investigated, yielding a 
diastereomeric ratio [(R,S)-CMA:(S,S)-CMA] of 2:1.  Table 2.2 summarizes the results of 
the borohydride reductions. 
 





 The stereoselective reduction of (S)-CMK can be induced by the adjacent chiral 
center.  However, Pennington and Hodgson12 utilized chiral homogeneous ruthenium, 
rhodium, and iridium catalysts to achieve high diastereoselectivity.  The metal center 
was coordinated to a chiral phosphine and amine group, which have been previously 
shown to increase the catalyst’s activity and stereoselectivity.  The researchers reported 
good conversions and ratios of (R,S)-CMA to (S,S)-CMA as high as 19:1 with moderate 
pressures of hydrogen in various alcohol solvents like methanol and ethanol.  However, 








Asymmetric Transfer Hydrogenation 
 ATH reactions often utilize sodium formate or alkylammonium formate as a 
hydrogen source combined with a homogeneous chiral catalyst.13-15  Metals that have 
been used to catalyze ATH reactions include rhodium, iridium, and ruthenium.  ATH 
reactions have been investigated with (S)-CMK as the starting material in a variety of 
solvents with similar results: ~90% selectivity for either diastereomer (depending on the 
chirality of the catalyst).4  Although these reactions give very high selectivity, the chiral 
ligands are expensive and usually must be synthesized. 
 
Meerwein-Ponndorf-Verley Reduction 
 MPV reductions use aluminum isopropoxide (or another metal alkoxide) with an 
alcohol to perform the hydrogen transfer.16,17  The MPV reduction of (S)-CMK generally 
favors (S,S)-CMA, even when run in various solvents.  Researchers reported 
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 The Meerwein-Ponndorf-Verley (MPV) reduction1-3 of a carbonyl-containing 
substrate to its corresponding alcohol has been used extensively in organic chemistry 
because of its simple and inexpensive reaction procedure.4-6  The MPV reduction is 
straightforward, utilizes mild reagents (aluminum alkoxides), and is chemoselective.  
However, more than catalytic amounts of the metal catalyst may be required to achieve 
high yields in a reasonable amount of time.  Generally, the MPV reduction is catalyzed 
by metal alkoxides and utilizes a secondary alcohol as a hydride source.  Most often, 
this reaction is carried out using aluminum isopropoxide in isopropanol (Figure 3.1), but 
other metal reagents, such as lanthanide metals, have also been reported.7-9 
 
 
Figure 3.1: General MPV reduction scheme. 
 
 
 Stereoselective MPV reductions have been performed by varying the reaction 
conditions.  One approach capitalized on using optically active alcohols as the solvent.  
Although enantioselectivity was successfully observed in a few cases, the enantiomeric 
excess usually remains moderate and mostly unpractical.10  For example, when 
methylcyclohexylketone was reduced in the presence of (S)-3-methyl-2-butanol, the 




approach focused on utilizing chiral and/or bulky groups, such as 1,1’-bi-2-naphthol 
(BINOL), on the aluminum.12-14  When BINOL was added to the reduction of 2-
chloroacetophenone, the product, (R)-chloromethylbenzyl alcohol, was produced in 80% 
enantiomeric excess.15  In addition to the moderate enantiomeric induction, the cost of 
these approaches can be prohibitive to large scale applications.  Therefore, achieving 
sustainable (efficient and cost-effective) stereoselective induction via MPV mediated 
processes remains a major challenge. 
 As discussed in Chapter 2, many scientists have investigated the means to 
selectively prepare (S,S)- and (R,S)-CMA from the corresponding prochiral ketone (S)-
CMK.  The MPV reduction of (S)-CMK using aluminum isopropoxide in isopropanol 
proceeds cleanly to yield (S,S)-CMA in 97% yield and 94% diastereomeric excess.16,17  
The stereoselective synthesis of (R,S)-CMA, however, remains an ongoing challenge. 
Although a wide variety of reagents for the production of (R,S)-CMA were investigated, 
the techniques that produce (R,S)-CMA with high yields and stereoselectivity remain 
expensive or inefficient. 
 This work aims to develop a cost-effective and diastereoselective MPV reduction 
process to produce (R,S)-CMA.  The transition state complex between aluminum 
isopropoxide and (S)-CMK was studied using Spartan® modeling calculations.  Based on 
these models, potential approaches to favor (R,S)-CMA selectively were identified, 
experimentally tested, and analyzed. Additionally, experiments showed that the states of 
aggregation of the aluminum alkoxides are critical to the rates of the reactions.  A 
comparison between aluminum isopropoxide (a tetramer) and aluminum tert-butoxide (a 









MPV Reduction Mechanism 
Figure 3.2 shows the mechanism of the MPV reduction of a ketone.18  The 
reaction is equilibrium limited; in fact, the opposite reaction is known as the Oppenauer 
oxidation,19 which oxidizes an alcohol to a ketone.  In order for the MPV reduction to 
proceed, at least one of the alkoxide groups attached to the metal center must have an 
α-hydrogen.  The α-hydrogen from the alkoxide on the catalyst is transferred to the 
ketone via a six-member ring concerted mechanism.  The chair conformation of this six-
member ring is shown in Figure 3.3.  The alcohol product is released upon substitution 

















Transition State Modeling Studies 
 The chiral center adjacent to the ketone of (S)-CMK is crucial as it can be taken 
advantage of to induce stereoselective induction through specific interactions (steric 
effects and hydrogen bonding).20  For instance, the Boc-protected amine group leaves a 
relatively acidic hydrogen free to engage in hydrogen bonding.  Such interactions can 
participate in directing the approach of the reagent.  Ideally, these effects would favor 
the desired product without the use of chiral catalysts and ligands.  Spartan® modeling 
studies (Hartree Fock level with a basis set of 6-31G*) indicate that the chelation 
between the aluminum species and the Boc-protected amine on (S)-CMK is central to 
the final stereochemistry of the product.  If the aluminum chelates with only the ketone, 
hydrogen transfer on the least hindered face results in the (R,S) diastereomer (Figure 
3.4 A).  On the other hand, if the aluminum isopropoxide coordinates with both the 
ketone and amide groups, hydrogen transfer to the least hindered face results in the 
(S,S) diastereomer (Figure 3.4 B).  Most importantly, the oxygen from the alkoxide and 
the hydrogen on the amide can engage in hydrogen bonding. Because of these 
interactions, the hydrogen transfer preferentially favors the formation of the (S,S)-CMA 






Figure 3.4: MPV reduction intermediate.  A: Mono-chelation between aluminum and 
ketone.  B: Hydrogen bonding and bi-chelation with ketone and nitrogen. 
 
 
 In light of these studies, approaches to disrupt the hydrogen bonding and alter 
the diastereoselectivity were investigated as a function of (1) steric bulkiness of the 
aluminum reagent, (2) solvents, and (3) amine protecting groups on (S)-CMK.  The 
results of the first two effects are discussed below and the effect of the protecting group 








RESULTS AND DISCUSSION 
 
Investigation of Diastereoselectivity 
 I started my investigation of the MPV reduction by looking into the effect of a few 
reaction conditions on the diastereoselectivity of the reaction.  The reactions were first 
run on a batch scale and then repeated in a 12-reaction carousel apparatus to improve 
reproducibility. 
 
Batch Scale Reactions 
 I initially performed the MPV reductions on a 20 mL batch scale in round bottom 
flasks.  The reaction products were isolated and analyzed by proton nuclear magnetic 
resonance (1H NMR) and/or high performance liquid chromatography (HPLC).  Each 
reaction was run once. 
 
Reductions in Various Alcohol Solvents 
 I first ran the MPV reduction in anhydrous isopropanol using aluminum 
isopropoxide as described in the literature for the preparation of the (S,S) diastereomer 
(Figure 3.5).16,17  This reaction allowed me to validate my analytical methods and 
provided a reference point.  The starting material, (S)-CMK, was dissolved in anhydrous 
isopropanol at 50°C followed by the addition of aluminum isopropoxide.  The reaction 
went to near completion after two hours, at which point the product precipitated out of 
solution.  The organic product was collected by filtration and characterized by 1H NMR 
and HPLC.  The HPLC analysis resulted in a diastereomeric ratio of (R,S):(S,S) 
(abbreviated DR) of 0.06:1, comparable to literature results of 0.05:1.16 (R,S)-CMA was 






Figure 3.5: MPV reduction of (S)-CMK. 
 
 
 The MPV reduction was run in other anhydrous alcohol solvents including 2-
butanol, tert-butanol, and a 1:1 mixture of isopropanol and tert-butanol.  I hypothesized 
that increasing the steric bulk around the aluminum center would improve the 
diastereoselectivity of the reaction.  The results are summarized in Table 3.1. Complete 
conversion was observed after one hour when 2-butanol was the solvent, but the 
reaction in tert-butanol was much slower.  After four hours, there was still 90% of the 
starting material remaining.  The mixed isopropanol/tert-butanol solvent showed about 
10% starting material left after four hours.  The tert-butanol partially displaces the 
isopropoxy groups on the aluminum, replacing them with tert-butoxy groups, which do 
not have an available α-hydrogen.  As a consequence, the reaction was expected to be 
slower.  Most interestingly, the increased steric hindrance of the tert-butoxy groups had 
little effect, if any, on the diastereoselectivity.  Although the rate of the reactions 
changed, the distribution of products remained consistently in favor of (S,S)-CMA.  Table 






Table 3.1: MPV reductions in alcohol solvents. 
Al Catalyst Alcohol Time (h) Conversion DR (HPLC) DR (NMR) 
Al(O-i-Pr)3 i-PrOH 2 95% 0.06:1 a 
Al(O-i-Pr)3 2-BuOH 1 95% 0.06:1 0.03:1 
Al(O-i-Pr)3 i-PrOH/t-BuOH (1:1) 4 88% 0.06:1 0.08:1 
Al(O-i-Pr)3 t-BuOH 4 10% b a 
aQuantity of (R,S)-CMA too small to see by 1H NMR. 
bQuantity of (R,S)-CMA too small to see by HPLC. 
 
 
Reduction with Synthesized Aluminum Isopropoxide 
 I synthesized aluminum isopropoxide to compare to the results obtained using 
the commercially available aluminum isopropoxide.  Aluminum isopropoxide was 
synthesized according to a reported literature procedure.21 The reaction between 
aluminum foil and anhydrous isopropanol was catalyzed by carbon tetrachloride.  The 
reaction was run at reflux until all of the foil had been consumed.  Although the reaction 
mixture had black suspended flakes, I used the aluminum isopropoxide solution directly 
in an MPV reduction, assuming complete conversion of the foil to calculate the 
concentration of aluminum isopropoxide. 
 The reaction was run in isopropanol and the product crashed out of solution after 
two hours.  Although the reaction mixture was slightly grey, the product became white 
after washing.  The product was analyzed by HPLC and 1H NMR to give DRs of 0.1:1 
and 0.07:1, respectively.  These results are comparable to the commercial aluminum 
alkoxide DR of 0.06:1. 
 
Reductions with Different Aluminum Alkoxides 
 Aluminum-tri-sec-butoxide and aluminum tert-butoxide, were investigated as 
potential catalysts to evaluate the relationship between the structure of the alkoxide on 




aluminum tert-butoxide are both available for purchase from Aldrich.  Following the 
classic MPV procedure described previously, reactions with aluminum-tri-sec-butoxide 
and aluminum tert-butoxide were carried out in anhydrous 2-butanol.  No visible product 
crashed out after a few hours therefore the reactions were continued at 50°C overnight.  
After running overnight, the product crashed out and analyses showed the complete 
conversion of the starting material to the two product diastereomers.  HPLC analysis 
showed no significant change from the reaction with aluminum isopropoxide, giving DRs 
of 0.04:1 and 0.06:1, respectively.  Since there did not seem to be any improvement in 
diastereoselectivity with the change in aluminum alkoxide catalyst, this strategy was not 
investigated further. 
 
Reductions in Various Organic Solvents 
 In an attempt to alter the potential hydrogen bonding between the oxygen of the 
aluminum alkoxide and the hydrogen of the amine group of (S)-CMK, the reaction was 
run in various solvents with a wide range of polarity and hydrogen bond donor/acceptor 
abilities.  I tested acetonitrile, tetrahydrofuran (THF), ethyl acetate, diethylether, 
benzene, and dimethyl sulfoxide (DMSO).  Although the concentrations of the starting 
material and the aluminum isopropoxide were kept constant, the volume of isopropanol 
was decreased from 20 mL to 0.5 mL and the additional organic solvent (19.5 mL) was 
added.  It should be iterated that isopropanol is the hydrogen source and is actively 
involved in the reaction mechanism.  Because these reactions were slower, all of them 
were run at 50°C overnight. The products were analyzed by HPLC and the results of 





Table 3.2: MPV reductions in various organic solvents. 
Solvent Conversion DR 
MeCN 62% 0.35:1 
THF 56% 0.19:1 
EtOAc 21% 0.17:1 
Et2O 56% 0.11:1 
Benzene 63% 0.09:1 
DMSO 7% a 
aQuantity of (R,S)-CMA too small to see by HPLC. 
 
 
 Although some of the solvents showed improved diastereoselectivity, the overall 
conversion was much lower than in the alcohol solvents, which gave >95% conversion.  
Most notably, acetonitrile, with the strongest hydrogen bond donating and accepting 
properties, gave the highest DR of 0.35:1. 
 
Reductions with Hydrogen Bonding Additives 
 The addition of compounds with hydrogen bonding properties was investigated 
as a means to alter the diastereoselectivity of the MPV reduction.  First, lithium fluoride 
was investigated. It was added to the reaction in a 1:1 molar ratio to (S)-CMK.  The 
reaction was run overnight.  The HPLC results showed no improvement in the DR 
(0.04:1) with respect to the reaction performed without lithium fluoride.   
Tetrabutylammonium fluoride (TBAF) also contains a fluoride anion that can 
engage in hydrogen bonding.  In addition, it is more soluble in organic media than the 
inorganic salt lithium fluoride due to the lipophilic tetraalkylammonium cation.  TBAF is 
commercially available as a solution in THF with about 5 weight% water.  The presence 
of water is a limitation because the aluminum isopropoxide reagent is water sensitive.  
Therefore, the TBAF solution was dried for 24 hours over molecular sieves.  After the 




initially used a 0.1:1 molar ratio of TBAF to (S)-CMK.  HPLC analysis showed a slight 
improvement in the production of (R,S)-CMA, giving a DR of 0.14:1.  Because of this 
slight improvement, I increased the molar ratio of TBAF to (S)-CMK up to 1:1.  The DR 
was identical at 0.14:1. 
 
Carousel Reactions 
 In order to ensure the reproducibility of our results, a 12-reaction carousel from 
Brinkmann was purchased (Figure 3.6).  The apparatus allows for twelve reactions to be 
carried out simultaneously with a controlled temperature, controlled stirring, and options 
of being under inert atmosphere as well as operating under reflux conditions.  The 
workup procedure was also modified.  Rather than isolating the products, the post-
reaction mixtures were diluted with ethyl acetate or methanol, quenched with 
hydrochloric acid, and injected directly in the HPLC for analysis.  The reactions were run 






Figure 3.6: Brinkmann 12-reaction carousel apparatus. 
 
 
Reductions with Aluminum Alkoxides 
One method originally proposed to increase the diastereoselectivity of the MPV 
reduction was to vary the alkoxide group on the aluminum catalyst.  As stated 
previously, we hypothesized that increasing the steric bulk around the aluminum metal 
center would improve the diastereoselectivity.  In addition to using the aluminum 
isopropoxide catalyst, we also tested aluminum tert-butoxide and aluminum ethoxide.  
We heated a solution of (S)-CMK and the aluminum catalyst in anhydrous isopropanol to 
the reaction temperature of 50°C.  At 50°C the solutions were all homogeneous.  
Interestingly, the aluminum tert-butoxide reactions precipitated after about five minutes, 
the aluminum ethoxide reactions precipitated after about an hour, and the aluminum 
isopropoxide reactions precipitated after one and a half hours.  Since the product is less 
soluble in isopropanol than the starting ketone, the rate of precipitation is indicative of 




investigated separately.  The results of these kinetic studies are presented below.  
Although the reactions qualitatively appear complete, they were carried out regardless 
for two hours and then quenched with 2 M hydrochloric acid.  The products were 
extracted into ethyl acetate.  The results of the HPLC analysis are given in Table 3.3.  
Despite slight differences in conversion and yield among the aluminum alkoxides, there 
was no significant improvement in diastereoselectivity. 
 
Table 3.3: MPV reduction with aluminum alkoxides. 
 DR % Conversion % Yield 
Al(OtBu)3 0.05 ± 0.01 99 ± 0.2 86 ± 1.3 
Al(OEt)3 0.06 ± 0.00 90 ± 2.1 76 ± 0.7 
Al(OiPr)3 0.06 ± 0.00 89 ± 5.4 71 ± 5.2 
 
 
Reductions in Various Organic Solvents 
The Spartan® molecular modeling discussed previously suggests that hydrogen 
bonding could occur between the oxygen atoms of aluminum isopropoxide and the NH 
group of (S)-CMK.  As a consequence, preventing this hydrogen bonding from occurring 
might alter the diastereoselectivity.  To validate this hypothesis, MPV reductions were 
run in various organic solvents, some of which might disrupt the hydrogen bonding 
between the aluminum isopropoxide and (S)-CMK.  Isopropanol (10 vol%) was added to 
each solvent for the reaction to proceed in a reasonable time.  The solvents chosen for 
these experiments were ethyl acetate, THF, isopropyl acetate, tert-butanol, 2-butanol, 
dichloromethane (DCM), and toluene.  After loading the reaction tubes with (S)-CMK, 
aluminum isopropoxide, and the anhydrous solvent mixtures, the reactions were run 
overnight at 50°C.  Then each post-reaction mixture was put in an ice bath, diluted with 
methanol, and quenched with 2 M hydrochloric acid before being analyzed by HPLC.  




Table 3.4. MPV reduction of (S)-CMK in various organic solvents. 
Solvent (R,S)/(S,S) % Conversion % Yield 
EtOAc 0.24 ± 0.01 73 ± 1.1 58 ± 1.0 
THF 0.13 ± 0.01 92 ± 5.2 85 ± 5.2 
iPrOAc 0.09 ± 0.00 100 ± 0.0 91 ± 0.6 
t-BuOH 0.08 ± 0.00 98 ± 0.6 85 ± 1.3 
2-BuOH 0.05 ± 0.00 98 ± 0.2 91 ± 0.6 
DCM 0.05 ± 0.00 100 ± 0.0 95 ± 1.5 
Toluene 0.05 ± 0.01 100 ± 0.0 90 ± 1.4 
 
 
 The DR increased when the reaction was run in aprotic polar solvents like ethyl 
acetate and THF.  However, these solvents also generally produce lower yields and 
conversions.  The hydrogen bonding between (S)-CMK and aluminum isopropoxide 
most likely contributes to increasing the rate of reaction by keeping (S)-CMK coordinated 
with the aluminum center, bringing to close proximity the two reactive centers.  I 
hypothesized that the MPV reduction in ethyl acetate may lead to more byproducts 
because the solvent and isopropanol can undergo trans-esterification, decreasing the 
amount of isopropanol that is available for proton transfer.  This was confirmed by 
running the MPV reduction in isopropyl acetate.  The product yield dramatically 
increased from 58% in ethyl acetate to 91% in isopropyl acetate.  Unfortunately, the DR 
decreased from 0.24:1 in ethyl acetate to 0.09:1 in isopropyl acetate. 
 
Investigation of Reaction Kinetics 
It was observed that the rate of the reaction was drastically increased by 
switching the catalyst from aluminum isopropoxide to aluminum tert-butoxide.  This is a 
critical observation because utilizing aluminum tert-butoxide instead of aluminum 
isopropoxide for MPV reductions could save both time and money in industrial 
processes. The MPV reductions of (S)-CMK, acetophenone, and benzaldehyde were 




Reduction of (S)-CMK 
 The MPV reduction of (S)-CMK was initially performed in isopropanol at 50°C 
using aluminum isopropoxide.  A set of twelve identical reactions were run 
simultaneously and quenched at ten-minute intervals over the course of two hours.  The 
same experiment was run using aluminum tert-butoxide as the catalyst with the 
reactions quenched every five minutes for one hour.  These kinetic experiments were 
run in triplicate and the results are shown in Figure 3.7.  The reactions with aluminum 
tert-butoxide achieve 90% yield in fifteen minutes, while the aluminum isopropoxide 
reactions reach less than 10% yield in the same time period.  These reactions were 
repeated in a 9:1 toluene/isopropanol solvent mixture (Figure 3.8).  Again, aluminum 
tert-butoxide showed higher activity than aluminum isopropoxide.  Because of a dilution 
effect, the MPV reduction in toluene required about twice as long to achieve the same 






Figure 3.7. Reaction conversion and yield as a function of time for the MPV reduction of 







Figure 3.8. Reaction conversion and yield as a function of time for the MPV reduction of 
(S)-CMK in 9:1 toluene/isopropanol catalyzed by Al(OtBu)3 or Al(OiPr)3. 
 
 
Reduction of Acetophenone 
 The kinetics of the MPV reduction of acetophenone and benzaldehyde were also 
investigated.  For the reduction of acetophenone to sec-phenylethanol, the reactions 
with aluminum tert-butoxide and aluminum isopropoxide were conducted at 50°C in 
anhydrous isopropanol.  The reactions with aluminum tert-butoxide were stopped every 
fifteen minutes for three hours and the reactions with aluminum isopropoxide ran for 
seven hours with reactions stopped every 35 minutes.  Figure 3.9 shows the results of 
these reactions run in triplicate with the percent yield of sec-phenylethanol plotted over 
time.  The reduction with aluminum tert-butoxide yields about 75% product after three 




level of completion.  A similar trend was observed when the same reactions were run in 
a 9:1 toluene/isopropanol solvent mixture (Figure 3.10). 
 
 
Figure 3.9. Reaction conversion and yield as a function of time for the MPV reduction of 







Figure 3.10. Reaction conversion and yield as a function of time for the MPV reduction 
of acetophenone in 9:1 toluene/isopropanol catalyzed by Al(OtBu)3 and Al(OiPr)3. 
 
 
Reduction of Benzaldehyde 
 The MPV reduction of benzaldehyde to benzylalcohol was conducted using both 
aluminum isopropoxide and aluminum tert-butoxide following the same procedure as 
with acetophenone.  Because of the increased reactivity of the aldehyde, the reaction 
was carried out at 40°C instead of 50°C.  Each reaction was run three times.  The results 
of the MPV reductions of benzaldehyde are shown in Figure 3.11.  Again, the rate 
increase using aluminum tert-butoxide compared to aluminum isopropoxide is evident 
from this data.  The reduction using aluminum tert-butoxide reaches over 80% yield in 
less than ten minutes, whereas the aluminum isopropoxide reaction requires 90 minutes 
to achieve the same yield.  In addition, the reaction in 9:1 toluene/isopropanol takes 




tert-butoxide (Figure 3.12).  These experiments show that the rate enhancement of 
aluminum tert-butoxide over aluminum isopropoxide applies to aldehyde as well as 
ketone starting materials. 
 
 
Figure 3.11. Reaction conversion and yield as a function of time for the MPV reduction 







Figure 3.12. Reaction conversion and yield as a function of time for the MPV reduction 
of benzaldehyde in 9:1 toluene/isopropanol catalyzed by Al(OtBu)3 and Al(OiPr)3. 
 
 
Aluminum Alkoxide States of Aggregation 
The relative rates of reaction between aluminum tert-butoxide and aluminum 
isopropoxide were attributed to their respective states of aggregation.  Based on 
molecular weight studies and 1H NMR experiments, Shiner and coworkers proposed that 
aluminum tert-butoxide exists as a cyclic dimer while aluminum isopropoxide forms the 
tetrameric complex shown in Figure 3.13.22  1H NMR studies that I conducted on 
aluminum tert-butoxide and aluminum isopropoxide in d6-benzene support the tetrameric 
nature of aluminum tert-butoxide and the dimeric nature of aluminum isopropoxide.  This 
provides a 1:2 ratio of methyl protons in aluminum tert-butoxide and a 1:1:2 ratio of 
methyl groups in aluminum isopropoxide.  As Figure 3.13 shows, the dimeric structure 




1:2 ratio: those on the bridging oxygens and those nonbridging groups highlighted in red.  
The tetrameric structure of aluminum isopropoxide results in two different types of 
bridging alkoxide groups, giving a 1:1:2 ratio of the two bridging alkoxide groups to the 
nonbridging groups.  Additionally, increasing equivalents of anhydrous isopropanol were 
added to a solution of aluminum tert-butoxide in d6-benzene.  As each successive 
equivalent of isopropanol is added, the 1H NMR spectrum became more complex and 
peaks corresponding to the isopropyl CH group emerged.  The NMR spectra are in 
agreement with the alkoxy groups exchanging only at the nonbridging tert-butoxy groups 
and the aluminum complex overall maintaining its dimeric structure. 
 
 
Figure 3.13. States of aggregation of Al(OtBu)3 and Al(OiPr)3.  Nonbridging alkoxide 
groups are highlighted in red. 
 
 
 Furthermore, it has been previously suggested that only the nonbridging alkoxy 
groups of aluminum alkoxides can perform the hydrogen transfer required in the MPV 




aluminum tert-butoxide and aluminum isopropoxide structures shows a decrease in this 
ratio between the dimeric and tetrameric complexes (2:1 to 1:1).  As a result, the cyclic 
dimer is expected to be more reactive than the tetramer, which is consistent with the 
experimental results.  The increased steric hindrance of the aluminum isopropoxide 
complex would also contribute to slowing the MPV reduction rate.  Other researchers 
have also attributed a faster MPV reaction rate to a lower state of aggregation of the 
aluminum catalyst.14,24 
 Overall, this improvement in the MPV reduction can be easily applied to industrial 
processes.  The procedure for running the reaction, product purification method, and 
product yield and selectivity do not change from the common reaction using aluminum 
isopropoxide.  However, at least a two-fold decrease in reaction time was observed for 
each of the starting materials investigated when the MPV catalyst was changed from 
aluminum isopropoxide to aluminum tert-butoxide.  Increasing the rate of the reaction not 
only decreases the time it takes to produce a desired compound but also lowers the 
energy costs associated with heating a large vessel over a longer period of time.  
Currently, reducing the amount of aluminum tert-butoxide to take advantage of its higher 
catalyst potency, is being investigated.  By reducing the amount of the aluminum 
species, costs can be reduced (both of the materials as well as disposal of aluminum-




 In conclusion, techniques have been developed to improve the stereoselectivity 
and reaction kinetics of the classic MPV reduction.  The reaction procedure was 
modified from batch conditions to improve the reproducibility of the results and an 




the reaction was run in different solvents.  In addition, a significant rate increase was 
observed when aluminum isopropoxide was replaced with aluminum tert-butoxide as an 
MPV catalyst for (S)-CMK, acetophenone, and benzaldehyde.  The kinetic effect was 







Materials and Equipment 
 All chemicals were ordered from Aldrich or VWR and used as received, unless 
otherwise noted.  The (S)-CMK starting material and samples of (S,S)- and (R,S)-CMA 
were obtained from Ampac Fine Chemicals (Sacramento, CA).  Acetophenone and 
benzaldehyde were distilled prior to use. 
All solvents used in the batch MPV reductions were dried before being used.  
Isopropanol was dried over calcium chloride then distilled onto molecular sieves.  2-
Butanol and tert-butanol were dried over powdered molecular sieves and distilled before 
use.  Acetonitrile was similarly dried over calcium hydride then distilled onto molecular 
sieves.  I dried DMSO by distillation from sodium hydroxide.  Anhydrous THF was 
purchased from Aldrich and used as received.  Ethyl acetate, diethylether, and benzene 
were dried over molecular sieves before use.  All solvents used in the carousel MPV 
reductions were purchased as anhydrous from Aldrich and used as received except for 
isopropyl acetate, which was obtained at 99% purity and dried over molecular sieves 
before use. 
1H and 13C NMR spectra were obtained from a Varian-Mercury VX400 MHz 
spectrometer using CDCl3 as an internal reference, unless otherwise noted.  HPLC 
analysis was run on an Agilent 1100 series LC with a UV detector and an electron spray 
ionization mass spectrometer (ESI-MS). 
 
Product Analysis 
1H NMR Analytical Method 
 The DR and percent conversion were determined in some reactions from the 1H 




CMK starting material as well as the (R,S) and (S,S) products.  One easily identifiable 
difference between the spectra is the shift in the NH peak (labeled as “a” in the figure).  
The peak shows up at about 5.08 ppm in the starting material and shifts downfield to 
4.87 and 4.58 ppm in the (R,S)-CMA and (S,S)-CMA products, respectively.  By 
integrating the area of these peaks, we were able to determine the relative concentration 
of each component in our product samples, giving us the DR and percent conversion. 
 
 




HPLC Analytical Method 
 All samples were run in the HPLC to determine the DR, conversion, and product 
yield.  A Phenomenex Luna 5µ C18(2) reverse phase column was used in conjunction 
with a guard column to prevent clogging.  The solvent system consisted of HPLC grade 




and column temperature were set to 1.5 mL/min and 40°C, respectively.  We ran our 
samples using the solvent gradient shown in Table 3.5.  The method ran for fifteen 
minutes then had a post-run time of four minutes.  The UV detector was set to 210 nm. 
 
Table 3.5: HPLC solvent gradient. 







 The (S)-CMK reduction samples were dissolved in solvents compatible with the 
HPLC method (methanol and DMSO).  We observed a retention time of about 7.8 
minutes for the (S)-CMK starting material and 4.6 and 5.6 minutes for the (S,S)- and 
(R,S)-CMA products, respectively (Figure 3.15).  The relative amount of each compound 
was determined by integrating their respective peaks. 
 
 









 In order to determine the percent conversion and yield for the MPV reactions run 
in the carousel reactor, we made calibration curves for (S)-CMK, (S,S)-CMA, and (R,S)-
CMA on the HPLC.  Samples of each compound in methanol were made in duplicate at 
each concentration and the curve was made using the average area between the two 
samples.  The calibration curves are shown in Figure 3.16, Figure 3.17, and Figure 3.18.  
These calibration curves were used to determine the product yield in the MPV reductions 
from the HPLC spectra. 
 
 














Figure 3.18: HPLC calibration curve of (R,S)-CMA in methanol. 
 
 
Batch Scale MPV Reductions 
General Reaction Procedure 
 (S)-CMK was reduced following the MPV reduction procedure used in literature.16  
(S)-CMK (1.9 g, 6.4 mmol) was dissolved in anhydrous isopropanol (20 mL) and heated 
to 50°C.  Aluminum isopropoxide (0.68 g, 3.4 mmol) was added and allowed to react for 
two hours.  The product precipitated out of solution to form a white slurry.  The reaction 
mixture was cooled to room temperature.  Then, the aluminum isopropoxide was 
quenched with water (~50 mL) and acetic acid (~5 mL).  The organics were extracted 
into ethyl acetate.  The organic phase was washed with a saturated sodium bicarbonate 
solution then brine.  The organics were dried over magnesium sulfate and the solvent 




 The same reaction procedure described above was used with other alcohol 
solvents (2-butanol, tert-butanol, and 1:1 isopropanol/tert-butanol) and different 
aluminum alkoxides (aluminum-tri-sec-butoxide and aluminum tert-butoxide), keeping 
the molar ratios constant.  The reaction time varied with the alcohols used. 
 
Synthesis of Aluminum Isopropoxide 
 Aluminum isopropoxide was synthesized according to a standard procedure.21  
Aluminum foil (2.7 g, 0.1 mol), anhydrous isopropanol (30 mL, 0.39 mol) and mercury (II) 
chloride (0.05 g, 0.1 mmol) were stirred together.  This mixture was heated to reflux at 
90°C.  Once at reflux, carbon tetrachloride (0.2 mL, 2 mmol) was added to initiate the 
reaction.  Bubbles formed on the aluminum and the mixture started to turn grey.  More 
isopropanol (30 mL, 0.39 mol) was added to wash the carbon tetrachloride off the sides 
of the flask.  The reaction was allowed to react under reflux.  After all the foil had reacted 
(3-4 hours), the reaction was removed from heat and cooled to room temperature.  The 
reaction mixture had black suspended particles in it.  This mixture was used in the MPV 
reaction without further purification or characterization.  The concentration was 
calculated assuming 100% yield of aluminum isopropoxide from the aluminum foil. 
 
Reductions in Various Organic Solvents 
 The MPV reductions in various organic solvents were done in a similar manner to 
the general reaction procedure above.  All the organic solvents used in the MPV 
reductions were dried before being used according to literature procedure.  (S)-CMK (1.9 
g, 6.4 mmol) and anhydrous isopropanol (0.5 mL, 6.5 mmol) were stirred in the 
anhydrous organic solvent (19.5 mL) and heated to 50°C.  Aluminum isopropoxide (0.68 
g, 3.4 mmol) was added and allowed to react overnight.  The reaction mixture was 




water (~50 mL) and acetic acid (~5 mL).  Any organic precipitate was extracted into ethyl 
acetate.  The organic phase was washed with a saturated sodium bicarbonate solution 
then brine.  The organics were dried over magnesium sulfate and the solvent was 
removed under vacuum.  This yielded a white powdery product, which was analyzed by 
HPLC. 
 
Reduction with Hydrogen Bonding Additives 
 The reaction was run following the same general reaction procedure above.  The 
additives (either TBAF or lithium fluoride) were added to the (S)-CMK solution at the 
beginning of the reaction.  A solution of TBAF in THF (0.75 mL of 1 M solution, 0.75 
mmol) was used while the lithium fluoride (0.17 g, 6.5 mmol) was added as a solid.  The 
starting solution was yellow in both cases.  The reactions were run in anhydrous 
isopropanol overnight at 50°C.  When TBAF was used, the organics could not be easily 
extracted following the above procedure because the aqueous and organics were one 
phase.  However, when brine was added to the reaction mixture, the phases split and 
the product could be isolated.  The lithium fluoride reaction product was obtained by the 
standard workup. 
 
Carousel MPV Reductions 
General Reaction Workup 
 Depending on the amount of conversion of (S)-CMK in each reaction, the various 
post-reaction mixtures required different dilution volumes to make the solutions 
homogeneous.  When the reactions proceeded past about 80% conversion to the 
desired products, the resulting heterogeneous reaction mixtures required more ethyl 
acetate or methanol to dissolve the products and create a homogeneous solution.  The 




concentrations for HPLC analysis and they were all diluted with methanol to a total 
sample volume of 1 mL. 
 
Reduction with Aluminum Alkoxides 
(S)-CMK (0.475 g, 1.59 mmol) was stirred together with aluminum isopropoxide 
(0.170 g, 0.83 mmol), aluminum tert-butoxide (0.205 g, 0.83 mmol), or aluminum 
ethoxide (0.135 g, 0.83 mmol) in anhydrous isopropanol (5 mL).  The reaction mixtures 
were heated to 50°C under argon atmosphere for two hours.  The reactions were 
removed from heat and diluted with ethyl acetate.  Hydrochloric acid (5 mL of a 2 M 
solution) was added to quench the reactions and the organics were extracted into ethyl 
acetate.  Each solution was sampled twice and diluted with methanol before being 
analyzed by HPLC.  Table 3.6 shows the volume dilutions used in the different reactions. 
 
Table 3.6: Reaction workup with aluminum alkoxides. 
 Ethyl Acetate Added Sample Volume 
Al(OiPr)3 10 mL 0.150 mL 
Al(OtBu)3 20 mL 0.300 mL 
Al(OEt)3 10 mL 0.150 mL 
 
 
Reduction in Various Organic Solvents 
 (S)-CMK (0.475 g, 1.59 mmol) and aluminum isopropoxide (0.170 g, 0.83 mmol) 
were dissolved in a mixture of an anhydrous organic solvent (4.5 mL) and anhydrous 
isopropanol (0.5 mL).  The organic solvents used were ethyl acetate, THF, isopropyl 
acetate, 2-butanol, tert-butanol, DCM, and toluene.  The solutions were heated to 50°C 
and the reactions were run overnight (18 hours).  The reaction mixtures were then 




acid (2 mL of a 2 M solution).  Each solution was sampled twice and analyzed by HPLC.  
Table 3.7 shows the volume dilutions used in the different reactions. 
 
Table 3.7: Reaction workup for various organic solvent solutions. 
 Methanol Added Sample Volume 
EtOAc 20 mL 0.250 mL 
THF 20 mL 0.250 mL 
iPrOAc 30 mL 0.350 mL 
2-BuOH 30 mL 0.350 mL 
t-BuOH 30 mL 0.350 mL 
DCM 30 mL 0.350 mL 
Toluene 30 mL 0.350 mL 
 
 
Kinetics of (S)-CMK Reduction 
 (S)-CMK (0.475 g, 1.59 mmol) was dissolved in anhydrous isopropanol (5 mL) at 
50°C under argon.  Aluminum isopropoxide (0.170 g, 0.83 mmol) or aluminum tert-
butoxide (0.205 g, 0.83 mmol) was added to start the reaction.  The solutions were 
homogeneous at the start of the reaction but as the reaction progressed, the product 
precipitated out of solution.  When aluminum tert-butoxide was used as the catalyst, the 
products precipitated in less than ten minutes.  When aluminum isopropoxide was used, 
the products precipitated after an hour.  After the specified reaction time, the reactions 
were removed from heat and placed in an ice bath.  The reactions were quenched cold 
with hydrochloric acid (2 mL of a 2 M solution) and diluted with methanol (20 mL or 30 
mL).  Each reaction mixture was sampled (0.250 mL or 0.350 mL) twice and further 
diluted with methanol (0.750 mL or 0.650 mL).  These crude solutions were run directly 
on the HPLC without further purification. 
 The same kinetics experiment was run in a 9:1 toluene/isopropanol solvent 




and anhydrous isopropanol (0.5 mL) at 50°C under argon.  Aluminum isopropoxide 
(0.170 g, 0.83 mmol) or aluminum tert-butoxide (0.205 g, 0.83 mmol) was added to start 
the reaction.  The solutions were all homogeneous at the start of the reaction and 
became heterogeneous as the reaction progressed.  The aluminum tert-butoxide 
reactions were run for two hours with reactions quenched every ten minutes; the 
aluminum isopropoxide reactions ran for four hours and the reactions were quenched 
every twenty minutes.  After the allotted reaction times, the reaction tubes were placed in 
an ice bath to stop the reaction.  The post-reaction mixtures were diluted with methanol 
(20 mL or 30 mL) and quenched cold with hydrochloric acid (2 mL of a 2 M solution).  
Each solution was sampled (0.250 mL or 0.350 mL) twice, diluted with methanol, and 
analyzed by HPLC. 
 
Kinetics of Acetophenone Reduction 
 Aluminum isopropoxide (0.170 g, 0.83 mmol) or aluminum tert-butoxide (0.205 g, 
0.83 mmol) was stirred under argon in anhydrous isopropanol (5 mL) at 50°C.  
Acetophenone (190 µL, 1.59 mmol) was added to start the reaction.  The solutions were 
homogeneous throughout the reaction.  After the allotted reaction time, each reaction 
was quenched with hydrochloric acid (2 mL of a 2 M solution) and diluted with methanol 
(10 mL).  The reactions were cooled in an ice bath and sampled twice to run on the 
HPLC. 
 
Kinetics of Benzaldehyde Reduction 
 Aluminum isopropoxide (0.170 g, 0.83 mmol) or aluminum tert-butoxide (0.205 g, 
0.83 mmol) was stirred under argon in anhydrous isopropanol (5 mL) at 50°C to dissolve 
the aluminum alkoxide.  The temperature was lowered to 40°C before benzaldehyde 




throughout the reaction time.  After the allotted reaction time, each reaction was 
quenched with hydrochloric acid (2 mL of a 2 M solution) and diluted with methanol (10 
mL).  The reactions were cooled in an ice bath and sampled twice to run on the HPLC. 
 
Al(OiPr)3 State of Aggregation 
 1H NMR (C6D6) δ 1.32 (d, 36H), 1.38 (d, 18H), 1.68 (d, 18H), 4.41 (m, 6H), 4.67 
(m, 6H).  13C NMR (C6D6) δ 25.4, 26.7, 28.0, 28.2, 63.6, 66.4. 
 
Al(OtBu)3 State of Aggregation 
 1H NMR (C6D6) δ 1.38 (s, 12H), 1.48 (s, 6H).  13C NMR (C6D6) δ 31.2, 31.4, 33.8, 
94.5. 
 
Al(OtBu)3 and Isopropanol State of Aggregation 
Four separate solutions were made containing Al(OtBu)3 (0.034 g, 0.140 mmol) 
dissolved in C6D6 (1.5 mL).  Anhydrous isopropanol was added to each solution in the 
following amounts: 0 µL, 10 µL, 20 µL, and 30 µL.  The solutions were all heated to 50°C 
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 The reduction of prochiral ketones by a hydrogen donor, such as isopropanol or 
sodium formate, in the presence of a homogeneous catalyst and a chiral ligand is known 
as asymmetric transfer hydrogenation (ATH).1-3  Metals which have been used to 
catalyze transfer hydrogenation reactions include rhodium, iridium, and ruthenium.  
Historically, catalytic hydrogenation with molecular hydrogen was used to reduce 
carbonyl compounds to the corresponding alcohols.  The use of chiral ligands in 
coordination with the transition metal catalysts can result in very high 
enantioselectivity.4,5  The field of ATH reactions is relatively new, with the first discovery 
being the cyclopentadienyl ruthenium (II) catalyst system for the reduction of ketones by 
Shvo and co-workers just over twenty years ago.6,7  Instead of using reagents like 
molecular hydrogen or boranes, this method uses air-stable transition metal catalysts in 
conjunction with a benign hydrogen source like isopropanol (Figure 4.1).  Much of the 
progress in ATH reactions has been done by Noyori and co-workers,8,9 which, in addition 
to his work with heterogeneous catalytic hydrogenation, led to his Nobel Prize in 2001.10 
 
 






 Although the ATH reaction is a powerful technique in organic chemistry, there are 
a few drawbacks to the system.  First, the hydrogen transfer is reversible and the 
reaction efficiency is determined by the relative structures of the ketone starting material 
and the hydrogen donor.  Not only can this limit the conversion of the reaction, but it may 
also decrease the enantioselectivity towards the desired product.  Formic acid was 
proposed as an alternative inexpensive hydrogen source that would improve the reaction 
conversion through the irreversible evolution of carbon dioxide.  Using a 5:2 formic 
acid/triethylamine azeotropic mixture led to improved product yields in the ATH 
reaction.11  Another potential downside to the ATH reaction is the high cost of the 
transition metal catalysts and chiral ligands.  To decrease the process cost as well as 
the environmental impact, researchers have investigated recyclable ATH catalyst 
systems.  The first attempt at a recyclable catalyst involved its immobilization on silica,12-
14 polymers,15 or dendrimers.16  Catalyst recycling was also achieved by modifying the 
catalyst and running the reaction in an ionic liquid17,18 or aqueous solvent system.19,20 
 ATH has been investigated previously as a method to prepare both (S,S)- and 
(R,S)-CMA from the corresponding ketone (S)-CMK.  Combining a rhodium catalyst with 
the chiral ligands (1R,2R)-N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine [(1R,2R)-
TsDPEN] or (1S,2S)-N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine [(1S,2S)-
TsDPEN], researchers produced the (R,S) and (S,S) diastereomeric products, 
respectively, in up to 80% diastereomeric excess each.21  Unfortunately, as mentioned 
above, both the rhodium catalyst and the chiral ligands are expensive and not viable for 
industrial scale application of this process. 
 I proposed to explore cost-effective methods of reduction to produce (R,S)-CMA.  
The reduction of (S)-CMK was carried out under heterogeneous catalytic hydrogenation 
conditions where molecular hydrogen was used as the hydrogen source.  Then I 




results is paramount to research; therefore, my efforts were first devoted to controlling all 
variables.  Once I established a reliable procedure, the reaction was optimized by 
varying reaction conditions such as solvent, hydrogen source, reagent concentrations, 




Heterogeneous Catalytic Hydrogenation 
 Heterogeneous catalytic hydrogenation (Figure 4.2) of double bonds is efficient 
and allows for easy product purification with low cost reagents.4,5,22,23  Molecular 
hydrogen is used as the hydrogen source and the reaction is run in the presence of a 
heterogeneous transition metal catalyst.  The reaction occurs through a four step 
mechanism: (1) the dihydrogen is adsorbed onto the metal surface, (2) the dihydrogen is 
cleaved by the metal into two metal-hydrogen bonds, (3) the ketone approaches the 
hydrogen-metal on the surface, and (4) the carbonyl reacts with the hydrogen atoms to 
yield the product.  Noyori and coworkers developed several novel hydrogenation 
systems that involved various chiral ligands complexed with transition metal catalysts to 
reduce aromatic ketones.24-27 
 
 
Figure 4.2: General heterogeneous catalytic hydrogenation reaction scheme. 
 
 
 The reduction of (S)-CMK is presented with the following heterogeneous 
catalysts: platinum oxide, palladium on carbon, and nickel nanoparticles.  In addition to 




and time on the product yield and diastereoselectivity were also explored.  These results 
were used as a basis of comparison for the ATH reactions. 
Asymmetric Transfer Hydrogenation 
 (S)-CMK was previously reduced via ATH to its diastereomeric products.21  My 
aim was mainly to utilize an achiral catalyst, taking full advantage of the adjacent chiral 
center in the (S)-CMK as the sole source for chiral induction.  As the reaction scheme in 
Figure 4.3 shows, the catalyst is made of a dichloro(p-cymene)ruthenium(II) dimer 
{[Ru(p-cymene)Cl2]2} complexed with a diamine ligand like (1R,2R)-TsDPEN28 or the 
achiral version, N-tolylsulfonylethylenediamine (TsEN)29,30.  The structures of the ligands 
are shown in Figure 4.4. 
 
 







Figure 4.4: ATH reaction ligands.  A: (1R,2R)-N-(p-Toluenesulfonyl)-1,2-




 The in situ synthetic scheme of catalyst formation is shown in Figure 4.5 and the 
catalytic cycle for the reduction is depicted in Figure 4.6.  The catalyst and diamine 
ligand are first combined to form the pre-catalyst.  The active catalyst is formed in situ 
from the reaction of the hydrogen source (such as sodium formate) with the pre-catalyst.  
The active catalyst can then coordinate with the starting material and transfer a proton to 
the ketone, forming the alcohol product.  Reaction of the oxidized catalyst with another 







Figure 4.5: ATH catalyst formation mechanism.  A: Pre-catalyst formation.  B: In situ 














RESULTS AND DISCUSSION 
 
Heterogeneous Catalytic Hydrogenation 
 Adams’ catalyst (platinum oxide) was tested as a heterogeneous catalyst for the 
reduction of (S)-CMK with 30 psi pressure of hydrogen gas.  After three hours at room 
temperature, the pressure was vented.  The reaction mixture was filtered through a 
Celite pad, and the organics were extracted into diethylether.  The crude products were 
analyzed by HPLC.  The hydrogenation was run in a variety of solvents including 
methanol, ethanol, ethyl acetate, acetonitrile, THF, dimethylformamide (DMF), and 
water.  The best results were found in acetonitrile, which gave 54% conversion and a DR 
of about 0.9:1 in three repeated reactions. 
 
Table 4.1: Catalytic hydrogenation of (S)-CMK with platinum oxide. 
Solvent Conversion DR 
MeCN 54% 0.9:1 
THF 2% 0.8:1 
EtOAc 3% 0.7:1 
MeOH 35% 0.5:1 
EtOH 29% 0.5:1 
DMF 6% 0.3:1 
H2O 0% a 
a No products were detectable by HPLC  
 
 
 Although the induced diastereoselectivity was encouraging, the high conversions 
shown in Table 4.1 can be misleading.  Most of the conversion was due to the formation 
of byproducts, mostly due to hydrogenolysis of the chlorine group.  The hydrogenolysis 
results in a mixture of the dechlorinated ketone (referred to as MK) and both 




MA, respectively] (Figure 4.7 and Figure 4.8).  In an attempt to favor the desired 
reaction, the reaction vessel was pressurized to 50 psi of hydrogen and vented three 
times.  Then, the vessel was pressurized to 100 psi and left to react overnight.  The 








Figure 4.8: Sample HPLC spectrum of hydrogenation of (S)-CMK showing starting 





 The results from other heterogeneous catalysts were similar to the reductions 
with Adam’s catalyst.  Another catalyst investigated was 5 weight% palladium on carbon.  
After reaction with 30 psi of hydrogen in ethanol, the HPLC analysis showed very little 
conversion of (S)-CMK and no sign of the desired products, (R,S)- and (S,S)-CMA.  The 
only conversion of (S)-CMK resulted in dehalogenation.  When the reaction was run 
using nickel nanoparticles as the catalyst, the analysis showed only 1% conversion of 
the starting material. 
 
Asymmetric Transfer Hydrogenation 
 The ATH reaction was carried out with the achiral ligand TsEN in a wide range of 
solvents, including mixed aqueous and organic solvent systems.  Sodium formate and 
triethylammonium formate were both explored as hydrogen sources.  Getting 
reproducible results is paramount to research; therefore, my efforts were first devoted to 
controlling all variables. 
 
Original Reaction Apparatus 
 I originally began running the ATH reactions in a homemade apparatus 
consisting of an oil bath with an incoming nitrogen line split into eight outlets, which were 
connected to reaction tubes.  The homemade apparatus was designed to run eight 
reactions at one time with similar conditions, making it an ideal tool to screen a wide 
variety of conditions.  The reactions were run on a 1 mL scale overnight at 40°C.  The 
catalyst precursor and ligand were stirred in the solvent for one hour to form the pre-
catalyst before the sodium formate was added.  Finally, (S)-CMK was added to start the 
reaction.  The reactions were quenched with saturated ammonium chloride, extracted 
with diethylether, and filtered through a silica plug.  The solvent was removed under a 




ATH in “Wet” Organic Solvents with the Achiral Catalyst (TsEN) 
 The first ATH reactions used a small amount of water in an organic solvent (THF, 
DMSO, DMF, and ethanol) to increase solubility of the sodium formate and thereby 
maintain a practical reaction rate.  I added water (0.1 mL) to the original volume of 
organic solvent (1 mL) but otherwise used the same reaction conditions described 
above.  The HPLC and 1H NMR results are shown in Table 4.2.  In all cases, the 
reactions proceeded to almost complete conversion.  Analyses were done by HPLC or 
1H NMR.  These reactions were shown to favor the desired (R,S) diastereomer with a 
DR as high as 2.5:1. 
 
Table 4.2: ATH in "wet" organic solvents with achiral catalyst. 
Solvent Conversion DR (HPLC) DR (NMR) 
THF 95% 1.3:1 0.8:1 
DMSO 92% 1.0:1a 1.7:1a 
DMF 92% 2.5:1 2.4:1 
EtOH 95% 1.2:1 1.1:1 
aEstimated DR (overlapping peaks in HPLC or 1H NMR) 
 
 
ATH in Pure Organic Solvents with the Achiral Catalyst (TsEN) 
 ATH reactions were carried out in the same solvents used above (THF, DMSO, 
DMF, and ethanol) without the addition of water.  The reactions were all heterogeneous 
and ran overnight.  The HPLC and 1H NMR results (Table 4.3) showed a decrease in the 
DR compared to the “wet” solvents.  In the case of THF, the conversion was also 
significantly decreased from 95% to 22%, which is believed to result from the 
heterogeneous nature of the reactions (due to very low sodium formate solubility in 
organic solvents).  In all cases, it seems that the addition of a small amount of water to 




Table 4.3: ATH reaction in pure organic solvents with achiral catalyst. 
Solvent Conversion DR (HPLC) DR (NMR) 
THF 22% 0.8:1 0.8:1 
DMSO 100% 0.2:1a 0.4:1 
DMF 94% 0.1:1a 0.4:1a 
EtOH 93% 0.9:1 0.8:1 
aEstimated DR (overlapping peaks in HPLC or 1H NMR) 
 
 
ATH in Water with the Achiral Catalyst (TsEN) 
 I next investigated the ATH reaction in pure water using the same achiral catalyst 
(TsEN).  The reaction mixture was heterogeneous as the (S)-CMK starting material’s 
solubility in water is negligible.  The reaction was run under the same conditions as in 
the case of the organic solvents.  Although 50% of the starting material was recovered, 
the DR was promising at 2.1:1 and 1.8:1 by HPLC and 1H NMR, respectively.   
Encouraged by this favorable DR, the reaction was repeated in water for two days to 
increase the conversion.  Although the conversion was much higher at 89%, the DR 
dropped to 0.9:1 and 0.8:1. 
 
ATH in 1:1 Water/Organic Solvent Mixtures with the Achiral Catalyst (TsEN) 
 ATH reactions in a 1:1 mixture of water and organic solvents were investigated.  
Again, the reactions were heterogeneous as the (S)-CMK starting material did not 
completely dissolve in any of the solvent systems. The results of these reactions are 
listed in Table 4.4.  In all cases except the reaction run in DMSO and water, the DR was 






Table 4.4: ATH reaction in 1:1 organic solvent/water mixture with achiral catalyst. 
Solvent Conversion DR (HPLC) DR (NMR) 
THF/H2O 93% 1.7:1 1.3:1 
DMSO/H2O 83% 0.7:1 0.9:1 
DMF/H2O 79% 3.2:1 3.9:1 
EtOH/H2O 81% 2.4:1 2.4:1 
 
 
ATH in “Wet” Organic Solvents with the Chiral Catalyst [(1R,2R)-TsDPEN] 
 The ATH reaction on (S)-CMK was carried out under conditions identical to the 
reactions described above with the exception of the ligand being replaced with chiral 
(1R,2R)-TsDPEN.  The reactions were run in the “wet” solvent systems (10% water) 
investigated previously.  The chiral catalyst gave significantly better diastereoselectivities 
than the catalyst utilizing the achiral ligand, TsEN.  Table 4.5 shows an increase in DR of 
up to four times, in the case of THF.  The conversions in these reactions were above 
90%, except for the reaction in DMSO, which resulted in a conversion of 77%.  I also ran 
the reaction with (1R,2R)-TsDPEN in water for two days.  This reaction again shows an 
increase in diastereoselectivity from the reaction with TsEN. 
 
Table 4.5: ATH reaction in "wet" organic solvents and water with chiral catalyst. 
Solvent Conversion DR (HPLC) DR (NMR) 
H2O (2 days) 92% 2.5:1 2.9:1a 
THF 98% 5.5:1 5.1:1 
DMSO 77% b 5.1:1 
DMF 97% 4.4:1 4.0:1a 
EtOH 96% 3.6:1 4.7:1 
aEstimated DR (overlapping peaks in HPLC or 1H NMR) 






 (1R,2R)-TsDPEN has been used in the reduction of (S)-CMK previously in 
literature.  However, the reaction has not been run in these solvent systems.  Instead, 
the literature reports the ATH reaction on (S)-CMK in pure ethyl acetate, toluene, DCM, 
or isopropanol with triethylammonium formate as the hydrogen source.21  These novel 
ATH reaction systems give good conversions and high diastereoselectivities (DR ~9:1).  
However, the downside to using the chiral catalyst is a much greater expense.  
 
Reproducibility of ATH Reactions 
 After a couple of reactions in “wet” organic solvents (THF and DMSO) and in 1:1 
water/organic solvent mixtures (THF, DMSO, DMF, and ethanol) were repeated, it 
became evident that reproducibility was poor.  The DRs of the repeated reactions as well 
as the reactions reported above are given in Table 4.6 and Table 4.7 below, as analyzed 
by HPLC.  
 
Table 4.6: Repeated ATH reactions in "wet" organic solvents with achiral catalyst. 
Solvent DR, Run 1 DR, Run 2 
THF 1.3:1 2.3:1 
DMSO 1.0:1 0.7:1 
 
 
Table 4.7: Repeated ATH reactions in 1:1 water/organic solvent mixtures with achiral 
catalyst. 
Solvent DR, Run 1 DR, Run 2 
THF/H2O 1.7:1 2.6:1 
DMSO/H2O 0.7:1 1.9:1 
DMF/H2O 3.2:1 1.2:1 






 The repeated reactions gave very different results and the data were scattered, 
showing improvements in some cases and decreased ratios in others.  Clearly, my 
reaction conditions and apparatus were not providing satisfactory reproducibility.  The 
setup does not have a temperature controller or consistent stirring in all reaction tubes, 
which could make it very difficult to achieve identical reaction conditions. 
 
New Reaction Apparatus 
 A twelve-reaction carousel apparatus designed specifically for running 
simultaneous identical reactions was purchased from Brinkmann (see Chapter 3).  The 
apparatus consists of a temperature controller with a stir plate, a water-cooled 
condenser, and a nitrogen source for each of the twelve reactions. 
 I repeated some of the reactions run previously in my homemade apparatus.  
The same reaction procedure was followed.  The reactions were run in DMSO, DMF, 
and THF with no water, 10% water, 20% water, or 50% water (except for THF).  The 
reactions with no water and 10% water were repeated and sampled twice to give a total 
of four data points for each solvent system.  The reactions run with 20% or 50% water 
were run twice but only sampled once each.  These results are plotted in Figure 4.9.  
The data were relatively consistent in the pure organic solvents but variations still 
occurred in the systems with water added, especially in DMF with 10% water.  Although 






Figure 4.9: ATH results in new apparatus. 
 
 
Optimization of Workup Procedures 
 The inconsistency of my results may have risen from a partial and/or preferential 
extraction of the products [(R,S)- and (S,S)-CMA] in the diethylether phase.  To directly 
determine if the workup procedures were or were not altering the data, aliquots of the 
same reaction mixture were taken at three different stages: crude product mixture, 
diethylether extraction, and DCM extraction.  Twelve identical reactions were all run in 
DMF with 10% water.  I first took an aliquot from each reaction, centrifuged, and diluted 
the supernatant in methanol to make HPLC samples.  Next, the reaction mixtures were 
subjected to the same diethylether extraction technique used previously.  The organic 
phase was not completely homogeneous so I also tried extracting the organics into 
another solvent, DCM.  The DCM workup resulted in two homogeneous phases: an 




solvent removed under reduced pressure.  The product residue was dissolved in 
methanol and analyzed by HPLC.  All of these results are compared in Table 4.8. 
 
Table 4.8: Comparison of workup procedures in ATH reaction. 
 DR % Conversion 
Crude 0.45 ± 0.04 91 ± 9.3 
Ether Extract 1.21 ± 0.44 91 ± 9.4 
DCM Extract 0.33 ± 0.11 96 ± 7.7 
 
 
 As I expected, the crude sampling gave the most consistent results.  The DR was 
much lower than the results measured in the old apparatus.  The diethylether workup 
again gave high DRs with a significant amount of error.  The (S,S) diastereomer is 
probably much less soluble in diethylether than the (R,S) product, leading to preferential 
extraction.  This explains the previously misleading results.  The DCM seemed to extract 
more of both products and results in DRs more comparable to the crude samples.  I 
concluded that the reaction procedure must be improved to enable me to gather 
accurate and reproducible data. 
 
Optimized Reaction Apparatus with Product Sampling 
 Rather than quenching the reaction and extracting the products, I switched my 
reaction procedure to dissolving the crude product mixture in a solvent (DMSO or 
methanol) and injecting these samples directly into the HPLC.  DMSO and methanol 
were chosen because the starting material as well as both products had high solubility in 
these solvents.  Each experiment was consistently sampled twice.  The concentrations 
of the starting material and product diastereomers were calculated from calibration 




by dividing the concentration of (R,S)-CMA by that of (S,S)-CMA.  The percent 
conversion was determined based on the disappearance of the starting material (utilizing 
the HPLC calibration curve).  Finally, the yield was calculated based on the appearance 
of the products, also utilizing HPLC calibration curves. 
 
Test of Reproducibility 
 In addition to changing the sampling procedure, I also increased the scale of my 
reactions to 5 mL to reduce the effect of experimental errors.  Half of the reactions (six) 
were run in DMF and the other half (six) were run in DMF with 10% water (“wet” DMF).  
The ruthenium catalyst precursor and TsEN were stirred for one hour at 40°C before the 
sodium formate and (S)-CMK were added.  After running overnight, half of the reaction 
mixtures were dissolved in DMSO and the other half in methanol.  The data from these 
reactions are shown in Table 4.9. 
 
Table 4.9: Reproducibility of ATH reaction in pure and "wet" DMF. 
  DR % Conversion % Yield 











Water 0.21 ± 0.05 100 ± 0.0 87 ± 3.7 










Water 0.39 ± 0.01 100 ± 0.0 85 ± 2.2 
 
 
 The new sampling technique greatly reduced the amount of error in my data.  
The most notable feature of this data set is the precision; the DRs vary by less than 0.05 
and the yields by less than 4% in all cases.  Another important trend is the increase in 




trends occur when the reactions are sampled in DMSO or methanol.  The methanol 
results were slightly more consistent than those results in DMSO. 
 
Reproducibility with Triethylammonium Formate 
 The ATH reactions with formic acid and triethylamine, which form 
triethylammonium formate in situ, were run in ethyl acetate at room temperature.  The 
previous literature reported experimental procedures utilizing a higher concentration of 
(S)-CMK and a lower concentration of catalyst, leading to a substrate-to-catalyst ratio 
(S/C) of 1000:1.21  This ratio is ten times higher than the procedure I used in the 
reactions discussed above, which had a S/C of 100:1.  Twelve reactions were run with 
triethylammonium formate; six reactions used a S/C of 100:1 and six used a S/C of 
1000:1.  The reactions were all run on a 5 mL scale.  The ruthenium catalyst percursor 
and TsEN ligand were stirred together in the solvent for thirty minutes then triethylamine 
and formic acid were added before the (S)-CMK was added to start the reaction.  The 
reaction mixtures were all homogeneous at the beginning of the reaction.  After the 
reactions were run overnight, they were diluted in DMSO or methanol and the samples 
were analyzed by HPLC. 
 The results were very consistent with respect to the DRs, which ranged between 
0.26:1 and 0.29:1.  The results of the reactions, worked up in either DMSO or methanol, 
are summarized in Table 4.10.  The rows in the tables refer to a S/C of 1000:1 and a S/C 
of 100:1.  These reactions showed an increase in DR as well as product yield from the 
previously run reactions using sodium formate.  This improvement in reaction results is 
most likely due to the increased solubility of the triethylammonium formate in the solvent 




Table 4.10: Reproducibility of ATH reactions with triethylammonium formate in ethyl 
acetate. 
  DR % Conversion % Yield 










S/C = 100:1 0.26 ± 0.01 100 ± 0.0 89 ± 2.3 









S/C = 100:1 0.27 ± 0.01 100 ± 0.0 74 ± 1.2 
 
 
 Although the DR did not significantly change with the different substrate-to-
catalyst ratios, the higher catalyst loading improved the product yields.  A higher catalyst 
concentration most certainly favors the desired reaction and minimizes the generation of 
side products.  The starting material was not present in any of the samples.  At a lower 
catalyst loading (S/C = 1000:1), many side products were formed, explaining the 
relatively low yield.  The HPLC-MS spectra showed peaks consistent with the 
dechlorinated analogues of (S)-CMK, (R,S)-CMA, and (S,S)-CMA.  In all cases, the 
results were very reproducible with very small experimental errors. 
 
Effect of Different Reaction Conditions on ATH Reaction 
 Once a reliable and reproducible procedure was established, I moved on to 
improving my reaction results.  The effect of each variable investigated is summarized in 








Table 4.11: Effect of different reaction conditions on ATH reaction. 








High yields (~80%) for all 
Highest DR in methanol (0.45:1) 
Substrate-to-
Catalyst Ratio 
From 25:1 to 





From 0.5:1 to 5:1 
< 2:1 ratio: decreased yields and conversions 
> 2:1 ratio: conversion and yield high 
No effect on DR 
Ratio of Formic 
Acid to 
Triethylamine 
From 0.4:1 to 
2.5:1 
< 1:1 ratio: many side products and low yields 
> 1:1 ratio: no side products and high yields 
No effect on DR 
Substrate 
Concentration 
From 0.05 M to 









Increase in DR (as compared to pure solvents) 
Highest DR in DMF (from 0.34:1 to 0.55:1) 
Slight increase in yields 
Time 
Reaction 
quenched at 10, 
20, 30, 40, 50, 
and 60 minute 
intervals 






     Improved DR to 1.89:1 
     No effect on yield (78%) 
(-)-Ephedrine 
     DR of 1.32:1 (methanol) and 0.95:1  
     (THF/water) 
     Many side products 
     Low yields (57%) 
Metal Catalyst Ru(II), Rh(III), and Ir(III) 
TsEN Ligand 
     DR – 0.45:1 (Ru), 0.73:1 (Rh), and 0.80:1 (Ir) 
(1R,2R)-TsDPEN 






ATH Reaction with Triethylammonium Formate in Various Organic Solvents 
 The ATH reaction, using triethylammonium formate, was run in a variety of 
organic solvents: THF, ethyl acetate, DMF, ethanol, methanol, and DMSO.  One set of 
reactions was run with a S/C of 100:1 and a lower concentration of (S)-CMK and one set 
with a S/C of 1000:1 and a higher starting material concentration.  Not all of the reaction 
mixtures were completely homogeneous prior to reaction.  At a S/C of 1000:1, the 
methanol and ethanol mixtures were heterogeneous.  With a S/C of 100:1, only the 
ethanol reaction mixture was heterogeneous.  All of the reactions were run at room 
temperature overnight.   
 The DRs, conversions, and product yields of the reactions in various solvents are 
shown in Figure 4.10 and Figure 4.11.  Figure 4.10 shows the results of the reactions 
run with a S/C of 1000:1 and Figure 4.11 represents the reactions run with a S/C of 
100:1.  The solvents are listed by increasing DR with methanol and DMSO giving the 
highest DR.  Interestingly, although these two solvents gave the highest DR, the overall 
product yields when run with a S/C of 1000:1 were low, indicative of a large amount of 
side products.  The DR was not affected much by the change in catalyst loading, but the 
yields increased significantly with the addition of larger amounts of catalyst.  Again, this 
was attributed to the catalyst favoring the desired reaction.  The catalyst loading 
corresponding to a S/C of 100:1 was utilized in subsequent reactions as it minimized the 






Figure 4.10: ATH with triethylammonium formate in various organic solvents using a 
S/C of 1000:1. 
 
 
Figure 4.11: ATH with triethylammonium formate in various organic solvents using a 




Effect of Temperature and Water on ATH Reaction with Triethylammonium Formate 
 The reactions carried out with triethylammonium formate were run in the same 
organic solvents (THF, ethyl acetate, DMF, ethanol, methanol, and DMSO) and 
temperature (40°C) as described above with sodium formate.  In addition, one set of 
reactions was run in the same solvents with the addition of 10% water.  The reaction 
conditions and workup procedure were otherwise kept identical.  The results are shown 
in Figure 4.12 and Figure 4.13.  The most significant effects of increasing the 
temperature can be seen in the reactions run in THF and DMF.  The yield of the reaction 
in THF decreases dramatically from that of about 80% at room temperature to 45% at 
40°C.  However, the reaction in DMF shows an improvement in DR, going from about 
0.35:1 at room temperature to 0.40:1 at 40°C.  Figure 4.13 shows that water had the 
effect of evening out the results in different solvents.  Overall, the best results still occur 







Figure 4.12: ATH with triethylammonium formate in various organic solvents at 40°C. 
 
 
Figure 4.13: ATH reaction with triethylammonium formate in various solvents with 10% 





Effect of Substrate-to-Catalyst Ratio 
 The effect of the ratio of (S)-CMK substrate to ruthenium catalyst was 
investigated.  Keeping the amounts of (S)-CMK, triethylamine, and formic acid constant, 
the amounts of catalyst precursor and ligand were varied from 0.04 equivalents (S/C = 
25:1) to 0.0025 equivalents (S/C = 400:1).  The ratio of ligand to catalyst precursor was 
kept constant.  The reactions were all run in duplicate in methanol at room temperature.  
Table 4.12 summarizes the results of these experiments.  The small amount of deviation 
in the DR and yield between the various catalyst loadings falls within experimental error.  
Overall, the substrate-to-catalyst ratio appears to have no effect on either DR or yield.  
This means that low catalyst and ligand loadings (S/C = 400:1) can be used to decrease 
the cost of the reaction without any impact on the product yield. 
 
Table 4.12: Effect of substrate-to-catalyst ratio on ATH reaction. 
 DR % Conversion % Yield 
25:1 0.45 ± 0.01 100 ± 0.0 82 ± 3.1 
50:1 0.43 ± 0.00 100 ± 0.0 83 ± 0.5 
100:1 0.45 ± 0.01 100 ± 0.0 83 ± 1.4 
150:1 0.45 ± 0.01 100 ± 0.0 83 ± 1.6 
200:1 0.44 ± 0.00 100 ± 0.0 79 ± 1.5 
400:1 0.45 ± 0.02 100 ± 0.0 78 ± 1.1 
 
 
Effect of Formate-to-Substrate Ratio 
 The ratio of triethylammonium formate to substrate was investigated.  All the 
reaction vessels were loaded with the same amounts of catalyst, ligand, and starting 
material in methanol.  While maintaining the same ratio of triethylamine to formic acid, I 
decreased the amount of triethylammonium formate from five equivalents down to 0.5 
equivalents.  A decline in yield as the amount of formate decreased was expected since 




decreased for a formate-to-substrate ratio less than 2:1 (Table 4.13).  The DRs, 
however, remained unchanged. 
 
Table 4.13: Effect of formate-to-substrate ratio on ATH reaction. 
 DR % Conversion % Yield 
5:1 0.43 ± 0.02 100 ± 0.0 86 ± 3.4 
4:1 0.43 ± 0.01 100 ± 0.0 86 ± 1.8 
3:1 0.43 ± 0.01 100 ± 0.0 84 ± 4.0 
2:1 0.44 ± 0.01 100 ± 0.0 86 ± 2.1 
1:1 0.45 ± 0.01 93 ± 3.5 63 ± 8.6 
0.5:1 0.46 ± 0.03 53 ± 10.1 27 ± 6.8 
 
 
Effect of Triethylamine-to-Formic Acid Ratio 
 I explored the effects of the triethylamine-to-formic acid ratio by keeping the 
catalyst, ligand, (S)-CMK, and formic acid loadings constant while decreasing the 
amount of triethylamine used from 2.5 equivalents relative to formic acid to 0.4 
equivalents.  These reactions were again run in methanol at room temperature.  As 
Table 4.14 shows, the DR was unaffected by the changes in triethylamine-to-formic acid 
ratio.  However, the yields significantly decreased from 98% down to 20% in the 
presence of an excess of triethylamine.  I attribute this decrease in yield to a number of 
side reactions that occur in the basic solution, further evidenced by the large number of 
extra peaks detected in the HPLC spectrum.  In order to maintain high yields, an excess 








Table 4.14: Effect of triethylamine-to-formic acid ratio on ATH reaction. 
 DR % Conversion % Yield 
2.5:1 0.43 ± 0.01 100 ± 0.0 20 ± 8.0 
2:1 0.42 ± 0.01 100 ± 0.0 53 ± 22 
1.5:1 0.43 ± 0.03 100 ± 0.0 46 ± 28 
0.67:1 0.45 ± 0.01 100 ± 0.0 91 ± 3.5 
0.5:1 0.46 ± 0.01 100 ± 0.0 88 ± 3.9 
0.4:1 0.48 ± 0.01 100 ± 0.0 98 ± 4.5 
 
 
Effect of Substrate Concentration 
 The effect of (S)-CMK concentration on the diastereoselectivity and yield of the 
ATH reaction was investigated.  The catalyst was prepared on a batch scale by stirring 
the ruthenium precatalyst and TsEN ligand in methanol for one hour at room 
temperature.  Each reaction tube was then loaded with a set volume of the catalyst 
solution.  Triethylamine, formic acid, and increasing amounts of (S)-CMK were added to 
start the reactions.  All reactions were initially homogeneous except for the experiment 
using an initial (S)-CMK concentration of 0.8 M.  The results of these experiments are 
given in Table 4.15.  The DR did not vary as a function of the (S)-CMK concentration.  
The yield did decrease slightly (about 10%) at higher substrate concentrations.  This 
could be due to a decrease in formate-to-substrate ratio at higher concentrations or the 
heterogeneous nature of the 0.8 M reaction. 
 
Table 4.15: Effect of varying (S)-CMK concentration on ATH reaction. 
 DR 
% 
Conversion % Yield 
0.05 M 0.48 ± 0.02 100 ± 0.0 89 ± 1.4 
0.1 M 0.45 ± 0.03 100 ± 0.0 85 ± 3.3 
0.2 M 0.45 ± 0.01 100 ± 0.0 86 ± 2.1 
0.4 M 0.44 ± 0.01 100 ± 0.0 82 ± 1.7 
0.6 M 0.45 ± 0.01 100 ± 0.0 83 ± 7.1 




Effect of Time on ATH Reaction 
 In order to determine how the diastereoselectivity changes as a function of time, 
two sets of six identical reactions were prepared and quenched at ten minute intervals 
for one hour.  First, the catalyst was prepared by mixing the ruthenium precatalyst and 
TsEN in methanol for one hour.  Then, triethylamine and formic acid were added.  
Finally, a solution of (S)-CMK in methanol was added, triggering the beginning of the 
reaction.  After 10, 20, 30, 40, 50, or 60 minutes, the reactions were quenched with a 
saturated ammonium chloride solution.  The organics were extracted into DCM.  The 
solvent was removed from each solution and the residue dissolved in methanol and 
analyzed by HPLC.  Throughout the time interval investigated, the DR remained 
constant at 0.42:1.  After one hour, the reaction yield was about 60% (Figure 4.14), 
indicating that running these reactions overnight is unnecessary.  The reaction is likely 






Figure 4.14: Effect of time on ATH reaction. 
 
 
Investigation of Various ATH Ligands 
 One of the most influential variables to the ATH reaction is the ligand surrounding 
the transition metal catalyst.  In the reactions described above, TsEN was used with a 
ruthenium metal center.  The reactions were carried out with other ligands 
[ethylenediamine, ethanolamine, and (-)-ephedrine] or without any ligand.  The same 
general reaction procedure was used.  All of the reactions were run in methanol at room 
temperature overnight.  The results of these reactions are given in Table 4.16.  In all 
cases the yields were significantly lower than that with TsEN (80%).  In the case of 
ethylenediamine, the HPLC spectrum showed no peaks corresponding to the desired 




in DR (0.56:1) but yielded very little product (5%).  The reaction using (-)-ephedrine also 
increased the DR but a large number of side reactions led to a decrease in yield (23%).  
(-)-Ephedrine was also used as a ligand in a 1:1 water/THF solvent system, which 
resulted in a DR of 0.95:1 with a higher yield of 57%.  However, there were still a large 
number of side products present. 
 
Table 4.16: Effect of ligand on ATH reaction. 
 DR % Conversion % Yield 
No ligand 0.44 ± 0.01 56 ± 3.4 23 ± 3.0 
Ethylenediamine   34 ± 1.3 0 
Ethanolamine 0.56 ± 0.02 39 ± 1.9 5.4 ± 0.9 
(-)-Ephedrine   40 ± 5.0 0 
 
 
 In addition to using the reference ligands in the ATH reaction, the commonly 
used chiral ligand (1R,2R)-TsDPEN was tested for the ATH reduction of (S)-CMK.  
Researchers found that the use of (1R,2R)-TsDPEN in conjunction with ruthenium, 
rhodium, or iridium catalyst precursors gave high yields and diastereoselectivity in the 
reduction of various ketones.8,9  When the chiral ligand (1R,2R)-TsDPEN was used in 
place of TsEN, it was found that the DR increased to 1.89:1 from 0.45:1.  The yield 
remained around 80%, comparable to my previous reactions.  Although I improved the 
diastereoselectivity of the ATH reaction, the chiral ligand is ten times more expensive 
than the achiral version. 
 
Effect of Various Metal Catalysts 
 I finally chose to focus on the use of different transition metal catalyst precursors.  
The most commonly used compounds in the literature ATH reactions are [Ru(p-




previously, stirring the different catalyst precursors together with either TsEN or (1R,2R)-
TsDPEN in methanol for one hour and then adding the remaining reagents to start the 
reaction.  Table 4.17 summarizes the results of these experiments.  Both the rhodium 
and iridium catalyst precursors improved the diastereoselectivity of the reaction with 
either of the ligands.  The use of the rhodium catalyst in conjunction with the chiral ligand 
resulted in the highest DR of 9.5:1.  Unfortunately, the rhodium catalyst precursor is ten 
times more expensive than the ruthenium precursor so the increase in selectivity would 
have to be weighed against the increased cost of the reaction. 
 
Table 4.17: ATH reaction with Ru, Rh, and Ir catalyst precursors. 
 
 
 Because of the significant improvements in diastereoselectivity observed with the 
rhodium catalyst, this catalyst was studied in different solvents.  Figure 4.15 shows the 
results of the ATH reaction with rhodium and TsEN in ten pure organic solvents.  As with 
the ruthenium catalyst, it was found that methanol gave the best results in terms of both 
DR and yield.  Again, mixed water/organic solvent systems were investigated.  Choosing 
six organic solvents (methanol, ethanol, isopropanol, DMF, DMSO, and acetonitrile), the 
experiments were conducted with rhodium and TsEN in a mixed 10% water/organic 
solvent mixture.  These results are illustrated in Figure 4.16.  Interestingly, the DR 




solvents (DMF, DMSO, and acetonitrile) all showed an increase in diastereoselectivity 
with the increase in water content.  In addition, a significant increase in yield occurred 
when 10% water was added to DMSO.  I speculate that the reaction proceeds faster in a 
water/DMSO system, reducing the number of side reactions. 
 
 







Figure 4.16: ATH reaction with Rh catalyst in pure organic solvents and in organic 





 In conclusion, I have investigated many aspects of the ATH reaction to optimize 
the reaction conditions for diastereoselective production of (R,S)-CMA.  I first focused on 
obtaining reproducible and reliable results.  Then, by varying the reaction conditions, I 
was able to increase the DR from 0.06:1 in the standard MPV reduction to as high as 
9.5:1 using a chiral rhodium catalyst.  The transition metal used as the catalyst and the 









Materials and Equipment 
 All chemicals were ordered from Sigma-Aldrich or VWR and used as received, 
unless otherwise noted.  The (S)-CMK starting material and samples of (S,S)- and (R,S)-
CMA were obtained from Ampac Fine Chemicals (Sacramento, CA).  1H and 13C NMR 
spectra were obtained from a Varian-Mercury VX400 MHz spectrometer using CDCl3 as 
an internal reference, unless otherwise noted.  HPLC analysis was run on an Agilent 
1100 series LC with a UV detector and an ESI-MS. 
 
Product Analysis 
 The products were analyzed using the same 1H NMR techniques as in the MPV 
reductions.  The same HPLC method was also used to analyze the ATH product 
samples but new calibration curves were made. 
 
HPLC Analysis: DMSO Calibration Curves 
 Samples of (S)-CMK, (S,S)-CMA, and (R,S)-CMA were used to make calibration 
curves on the HPLC.  A stock solution at the highest concentration (~5 mg/mL) was 
made for each compound and diluted to make the remainder of the samples.  The peak 
areas from the HPLC spectra were plotted against the sample concentrations and fitted 
to a straight line going through the origin.  The resulting calibration curves all gave high 
correlation values (R2 > 0.99).  These curves are given in Figure 4.17, Figure 4.18, and 
Figure 4.19.  The (R,S)-CMA sample was only 90% pure, with 10% of (S,S)-CMA as the 
impurity.  The sample concentrations were corrected by subtracting the concentration of 




calibration curve based on the corresponding peak areas in the (R,S)-CMA calibration 
samples.  These curves were used to obtain the product yield from the ATH reactions 
based on the HPLC spectra peak areas. 
 
 
















HPLC Analysis: Methanol Calibration Curves 
 The calibration curves for (S)-CMK, (S,S)-CMA, and (R,S)-CMA in methanol 
were obtained in a manner identical to that for the same curves in DMSO.  The samples 
for the methanol calibration curves were made in duplicate and the curve was made 
using the average area between the two samples.  Error bars are shown in the (S)-CMK 
and (S,S)-CMA curves but they were generally smaller than the representative points.  
The concentrations in the (R,S)-CMA samples were again corrected using the (S,S)-
CMA calibration curve.  The calibration curves are shown in Figure 4.20, Figure 4.21, 
and Figure 4.22.  These calibration curves were used to determine the product yield in 
the AHT reactions from the HPLC spectra. 
 
 















Heterogeneous Catalytic Hydrogenation 
 The catalytic hydrogenation reactions were run in a Bucchi shaker hydrogenation 
apparatus as shown in Figure 4.23.  This setup allows for good mixing while running 
reactions under pressure. 
 
 
Figure 4.23: Shaker type hydrogenation apparatus. 
 
 
Hydrogenation with Platinum Oxide 
 (S)-CMK (2.5 g, 8.4 mmol) was added to a suspension of platinum oxide (0.1 g, 
0.4 mmol) in a solvent (25 mL).  The organic solvents used include acetonitrile, THF, 
ethyl acetate, methanol, ethanol, DMF, and water.  The reaction vessel was flushed with 
nitrogen then 50 psi of hydrogen was added and vented.  This cycle was repeated three 
times.  The reaction vessel was then filled with 30 psi of hydrogen and left to run at room 
temperature for three hours.  The reaction vessel was vented to stop the reaction and 
the solution was filtered on a Celite pad to remove the catalyst.  The solution was diluted 
with water and extracted into diethylether.  The ethyl acetate was removed under 




Hydrogenation with Palladium on Carbon 
 The same procedure was used for the palladium on carbon catalyst as was 
described above for the platinum oxide.  The only difference was the amount of 
palladium on carbon (0.045 g of 5 weight% loading, 0.02 mmol). 
 
Hydrogenation with Nickel Nanoparticles 
 The same procedure was used for the nickel nanoparticle catalyst as was 
described above for the platinum oxide.  The nickel nanoparticles were previously 
synthesized by Hillary Huttenhower. 
 
Asymmetric Transfer Hydrogenation 
Synthesis of (1R,2R)-TsDPEN 
 (1R,2R)-N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine was synthesized 
according to literature procedure.31  (1R,2R)-1,2-diphenylethylenediamine (0.81 g, 3.8 
mmol) was stirred in anhydrous THF (32 mL) at 0°C.  Anhydrous triethylamine (1.6 mL) 
was added to this solution.  Then a solution of 4-methylbenzene-1-sulfonyl chloride (0.73 
g, 3.8 mmol) in anhydrous THF (8 mL) was added over thirty minutes.  The reaction 
mixture was stirred overnight at 0°C.  The solvent was removed under vacuum to afford 
a white solid.  This solid was treated with a sodium bicarbonate solution (60 mL) and 
extracted with DCM (4 x 15 mL).  The combined organic layers were washed with brine 
(20 mL), dried over magnesium sulfate and concentrated under vacuum.  The crude 
product was purified by flash chromatography in ethyl acetate on a silica column.  This 
afforded the pure product as a white solid.  This compound is also commercially 
available from Aldrich. 
 1H (CDCl3): 2.30 (s, 3H), 4.11 (d, 2H), 4.26 (m, 1H), 6.94 (d, 2H), 7.14 (m, 10H), 




Synthesis of TsEN 
 The achiral ligand (N-tolylsulfonylethylenediamine) was synthesized following the 
same procedure as above for the chiral ligand.  The only modification was to change the 
starting diamine material to 1,2-ethylenediamine.  The product was a white powdery 
solid.  This compound is also commercially available from Aldrich. 
 1H (CDCl3): 2.40 (s, 3H), 2.76 (m, 2H), 2.93 (m, 2H), 7.29 (d, 2H), 7.72 (d, 2H).  
 
Original Reaction Apparatus 
 The original reaction apparatus used for the ATH reactions consisted of an oil 
bath on a hot plate with a nitrogen line split into eight outlets, which could be connected 
to reaction tubes.  A cold water line was wrapped around the top of each tube to act as a 
makeshift condenser.  The temperature was monitored by a thermometer placed in the 
oil bath and maintained using the hot plate controls.  Each reaction tube was equipped 
with a magnetic stir bar to enhance mixing of the contents. 
 
Original Reaction Procedure 
 The ATH reaction was originally performed as follows.  The catalyst precursor, 
dichloro(p-cymene)ruthenium (II) dimer (3 mg, 0.005 mmol), and the chiral or achiral 
ligand (0.018 mmol) were stirred in the organic solvent or water (1 mL) for one hour at 
40°C.  In the case of the “wet” organic solvents, an additional amount of water (0.1 mL) 
was used.  I also tried 1:1 mixtures of water and organic solvents, in which case 0.5 mL 
of both water and organic solvent were added to the reaction mixture in place of the 1 
mL of organic solvent.  Sodium formate (0.26 g, 3.9 mmol) was then added to the 
reaction mixture, followed by the (S)-CMK (0.15 g, 0.50 mmol).  The reaction was 
allowed to run overnight at 40°C.  The reaction was removed from heat and quenched 




ether and filtered through a Celite pad.  The ether solvent was removed by drying under 
nitrogen and this crude product was analyzed by HPLC and 1H NMR. 
 
New Reaction Apparatus 
 A 12-reaction carousel apparatus from Brinkmann with built-in temperature 
controller and stir plate (see Chapter 3) was purchased.  This apparatus has 
connections for all twelve reactions to be run under an inert gas with consistent stirring 
and heating.  The set up also includes a condenser, which was hooked up to a cold 
water line.  The temperature controller kept the temperature of each reaction to ±1°C of 
the set point. 
 
Comparison of Workup Methods 
 Twelve identical reactions in DMF with 10% water were set up and run according 
to the standard procedure above.  After reacting overnight, the reactions were removed 
from heat and a small sample (~0.2 mL) was removed from each reaction.  These 
samples were centrifuged and the supernatant decanted and diluted in methanol.  The 
crude samples were run directly in the HPLC.  Using the same reaction mixtures, I next 
repeated my ether extract procedures as before.  The reactions were quenched using 
saturated ammonium chloride, extracted into ether, and filtered through a Celite pad.  
The ether was removed under inert gas and the solid residue was dissolved in methanol 
to make HPLC samples.  The reaction mixtures were extracted again using DCM.  This 
extraction resulted in two clear phases with no precipitates.  The DCM extraction was 
repeated and the organic phase decanted and dried.  HPLC samples of the residue were 






Product Sampling Test of Reproducibility 
 The reproducibility of my crude sampling method was tested using the ATH 
reactions run in DMF, with six reactions in pure DMF and six reactions in “wet” DMF.  
The scale of the reactions was increased to 5 mL to also improve the reproducibility.  
The ruthenium catalyst precursor (15 mg, 0.025 mmol) and TsEN (21 mg, 0.085 mmol) 
were stirred in the solvent (either 5 mL DMF, or 4.5 mL DMF and 0.5 mL water) for one 
hour at 40°C.  Sodium formate (1.3 g, 19 mmol) and then (S)-CMK (0.75 g, 2.5 mmol) 
was added to start the reaction.  The reactions were run overnight at 40°C.  At the 
conclusion of the reaction, the reaction mixtures were removed from heat and half of 
them dissolved in methanol (15 mL) while the other half were dissolved in DMSO (15 
mL).  Small samples (0.125 mL) were taken from each flask and diluted to 1 mL with 
their respective solvents.  These samples were analyzed by HPLC. 
 
Reproducibility with Triethylammonium Formate 
 I ran one set of six reactions using the literature conditions and one set of six 
reactions using the reagent concentrations used in the previous ATH reactions.  In the 
case of the literature reactions, smaller amounts of the ruthenium catalyst precursor (2.6 
mg, 0.0042 mmol) and TsEN (3.7 mg, 0.015 mmol) were used while larger amounts of 
(S)-CMK (1.2 g, 4.0 mmol) were added.  Under our reactions conditions, the ruthenium 
catalyst (16 mg, 0.026 mmol) and TsEN (21 mg, 0.083 mmol) to substrate (0.74 g, 2.5 
mmol) ratio was much higher.  In all cases, the catalyst and ligand were stirred in ethyl 
acetate for thirty minutes at room temperature.  Then, the triethylamine (0.56 mL, 4.0 
mmol) and formic acid (0.18 mL, 4.9 mmol) were added.  Condensation was formed on 
the walls of the reaction tubes after addition of the acid but they cooled after a few 
minutes.  After waiting for ten minutes, the (S)-CMK starting material was added.  The 




left to run overnight at room temperature.  Half of the reactions were dissolved in 
methanol (25 mL) and half in DMSO (25 mL).  Two samples (0.25 mL) were taken from 
each reaction and diluted to 1 mL with their respective solvents.  These samples were 
analyzed by HPLC. 
 
ATH General Reaction Procedure 
 ATH reactions were run according to the following general reaction procedure.  
[Ru(p-cymene)Cl2]2 (2.6 mg, 0.0042 mmol) and the TsEN ligand (3.7 mg, 0.015 mmol) 
were first loaded into the reaction tubes, dissolved in the reaction solvent (5 mL) and 
stirred at room temperature for one hour to form the precatalyst.  Next, the triethylamine 
(0.56 mL, 4.0 mmol) and formic acid (0.18 mL, 4.9 mmol) were added.  The (S)-CMK 
(0.75 g, 2.5 mmol) was added last to start the reaction.  After running overnight, the 
reaction mixtures were all dissolved in methanol (25 mL) and stirred for approximately 
thirty minutes until the solutions were homogeneous.  Two samples (0.25 mL) were 
taken from each solution and diluted with methanol to a total volume of 1 mL.  The 
samples were analyzed by HPLC using the procedure described above. 
 
Reaction in Various Organic Solvents 
 ATH reactions were run in six organic solvents: ethyl acetate, DMSO, THF, DMF, 
methanol, and ethanol.  One set was run using literature conditions with a substrate-to-
catalyst ratio of 1000:1; the other set of reactions was run using my previous conditions 
with a substrate-to-catalyst ratio of 100:1.  In the first case, the ruthenium catalyst 
precursor (2.6 mg, 0.0042 mmol) and TsEN (3.7 mg, 0.015 mmol) loadings were much 
lower and the amount of (S)-CMK substrate (1.19 g, 4.00 mmol) was high.  With a 
substrate-to-catalyst loading of 100:1, we used larger amounts of catalyst (16 mg, 0.025 




mmol).  In both cases, the catalyst and ligand were first loaded in the reaction tubes and 
stirred in the reaction solvent (5 mL) for one hour.  Next, the triethylamine (0.56 mL, 4.0 
mmol) and formic acid (0.18 mL, 4.9 mmol) were added.  The (S)-CMK was added last 
to start the reaction.  Not all of the reactions were homogeneous, the worst being the 
alcohol solvents.  The reactions were all run at room temperature overnight and 
analyzed following the general procedure above. 
 
Effect of Temperature and Water 
 The effect of temperature and water concentration was evaluated by running the 
ATH reaction at 40°C with one set of reactions in pure organic solvents and one with a 
1:9 water/organic solvent mixture.  The organic solvents tested were the same as above: 
ethyl acetate, DMSO, THF, DMF, methanol, and ethanol.  The ruthenium catalyst 
precursor (16 mg, 0.025 mmol) and TsEN ligand (21 mg, 0.085 mmol) were stirred 
together in the reaction solvent for thirty minutes at 40°C.  Triethylamine (0.56 mL, 4.0 
mmol) and formic acid (0.18 mL, 4.9 mmol) were added to the mixtures.  Finally, (S)-
CMK (0.75 g, 2.5 mmol) was added to start the reaction.  The reactions were run at 40°C 
overnight.  Following the same workup procedure as above, the reactions were 
dissolved in methanol (25 mL) and sampled twice before being run on the HPLC. 
 
Effect of Substrate-to-Catalyst Ratio 
 Following the same general reaction procedure described above, the effect of the 
substrate-to-catalyst ratio was investigated by varying the amount of catalyst and ligand 
while everything else remained the same.  The reactions were all run in methanol (5 
mL).  The amount of ruthenium catalyst precursor was decreased from a S/C of 25:1 (62 
mg, 0.10 mmol) to a S/C of 400:1 (3.7 mg, 0.006 mmol).  The ratio of TsEN ligand to the 




mmol) to 5.3 mg (0.02 mmol).  The reactions were run at room temperature overnight 
and analyzed as described above. 
 
Effect of Formate-to-Substrate Ratio 
 Following the same general reaction procedure described above, the effect of the 
formate-to-substrate ratio was investigated by varying the amount of triethylamine and 
formic acid while everything else remained the same.  The reactions were all run in 
methanol (5 mL).  The amount of formic acid was decreased from a formate-to-substrate 
ratio of 5:1 (0.47 mL, 13 mmol) to a formate-to-substrate ratio of 0.5:1 (0.05 mL, 1.2 
mmol).  The ratio of triethylamine to formic acid remained the same so it also decreased 
from 1.4 mL (10 mmol) to 0.14 mg (1.0 mmol).  The reactions were run at room 
temperature overnight and analyzed as described above. 
 
Effect of Triethylamine-to-Formic Acid Ratio 
 Following the same general reaction procedure described above, the effect of the 
triethylamine-to-formic acid ratio was investigated by varying the amount of triethylamine 
while everything else remained the same, including the amount of formic acid.  The 
reactions were all run in methanol (5 mL).  The amount of triethylamine was decreased 
from a triethylamine-to-formic acid ratio of 2.5:1 (1.7 mL, 12 mmol) to a triethylamine-to-
formic acid ratio of 0.4:1 (0.27 mL, 2.0 mmol).  The reactions were run at room 
temperature overnight and analyzed as described above. 
 
Effect of Substrate Concentration 
 Following the same general reaction procedure described above, the effect of the 
(S)-CMK substrate concentration was investigated by varying the amount of (S)-CMK 




mL).  The concentration of (S)-CMK was decreased from 0.8 M (1.2 g, 4.0 mmol) to 0.05 
M (0.074 g, 0.25 mmol).  The reactions with 0.8 M (S)-CMK were not homogeneous at 
the start of the reaction.  The reactions were run at room temperature overnight and 
analyzed as described above. 
 
Effect of Time on ATH Reaction 
 The ruthenium catalyst precursor and TsEN ligand were stirred in methanol (2 
mL) at room temperature for one hour.  Triethylamine and formic acid were added.  (S)-
CMK (10 g, 34 mmol) was dissolved in methanol (36 mL) at 50°C.  The (S)-CMK solution 
(3 mL) was added to each reaction tube to start the reaction.  The reactions were run for 
10, 20, 30, 40, 50, and 60 minutes at room temperature.  At the end of the allotted time 
interval, the reactions were quenched with saturated ammonium chloride (3 mL) and 
extracted into DCM (3 mL).  The DCM solutions were dried overnight and analyzed by 
HPLC. 
 
Investigation of Various ATH Ligands 
 Following the same general reaction procedure described above, the effect of the 
ligand was investigated by substituting other compounds [ethylenediamine, 
ethanolamine, (-)-ephedrine, or (1R,2R)-TsDPEN] for TsEN or running the reaction 
without a ligand.  The ruthenium catalyst precursor was stirred with either no ligand, 
ethylenediamine (6.0 µL, 0.090 mmol), ethanolamine (6.0 µL, 0.099 mmol), (-)-ephedrine 
(15 mg, 0.088 mmol), or (1R,2R)-TsDPEN (31 mg, 0.085 mmol) in methanol (5 mL) for 
one hour at room temperature.  Triethylamine, formic acid, and then (S)-CMK were 
added to start the reactions.  The reactions were all run at room temperature overnight 





Effect of Catalyst Metal Center 
 Following the same general reaction procedure described above, the effect of the 
catalyst metal center was investigated by switching the catalyst precursor from [Ru(p-
cymene)Cl2]2 to [Rh(C5Me5)Cl2]2 or [Ir(C5Me5)Cl2]2.  The rhodium (16 mg, 0.026 mmol) or 
iridium (20 mg, 0.025 mmol) catalyst precursors were stirred with TsEN (18 mg, 0.083 
mmol) or (1R,2R)-TsDPEN (31 mg, 0.083 mmol) in methanol (5 mL) at room 
temperature for one hour.  The reactions were started by adding triethylamine, formic 
acid, and (S)-CMK.  Although the rhodium reactions were run in duplicate, the iridium 
reactions were only run once with each ligand.  The reactions were run at room 
temperature overnight and analyzed as described above.  The rhodium reactions were 
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 Asymmetric reduction of carbonyl compounds is of fundamental importance in 
the synthesis of chiral secondary alcohols, such as (S,S)-CMA and (R,S)-CMA, which 
are central to biologically-active substances.  As a result, reducing agents used to 
perform such a chemical transformation are numerous; however, obtaining both a high 
yield and high selectivity remains a challenge.  The use of a boron reducing agent and/or 
a boron catalyst is one of the approaches used to achieve stereo- and chemo-selective 
reduction of carbonyls to alcohols. 
 The use of boron or boron based compounds as a catalyst for reduction 
reactions started in 1936 with the use of triethylborane to reduce benzaldehyde to its 
corresponding boronic ester (Figure 5.1).1,2  The subsequent discovery of sodium 
borohydride as a reducing agent in 1952 changed how chemists performed reductions of 
aldehydes and ketones because of its high chemoselectivity and increased stability 
compared to its lithium counterparts.3  This discovery led to the development of other 
boron reducing agents, including 9-borabicyclo[3.3.1]-nonane (9-BBN),4,5 
diisopinocampheylboranes,6 and the Selectride reagents.  Unfortunately, although these 
reagents are mild and highly selective for the reduction of carbonyls, they are not 






Figure 5.1: Reduction of benzaldehyde with triethylborane.2 
 
 
 The asymmetric reduction of carbonyls using oxazaborolidine catalysts is an 
effective tool for the stereoselective synthesis of chiral alcohols.7  These reactions are 
run under mild conditions, are operationally simple, and result in high selectivity and 
yield, making them well-suited for industrial applications.  The oxazaborolidine catalyst is 
formed from the reaction of an amino alcohol (chiral or achiral) and a borane complex, 
boronic acid, or boroxine.  Oxazaborolidines with a B-H moiety are usually formed in situ 
and used immediately.  Due to the moisture and air sensitivity of the B-H 
oxazaborolidines,8-10 methods to produce the more chemically stable B-alkyl11-13 and B-
aryl14 catalysts have been developed.  For example, the commercially available (R)-(+)-
CBS and (S)-(-)-CBS have proven to be effective catalysts in the reduction of many 
different carbonyl compounds.8,15-20 
  Previous work using boron reducing agents in the reduction of (S)-CMK has been 
reported (Table 5.1).21,22  The highest DR (5:1) was achieved using the chiral reagent 
(+)-Dip chloride.  While an excellent DR was achieved, this reagent is expensive for use 









Table 5.1: Summary of boron reagents used in the reduction of (S)-CMK.21,22 
Reagent(s) Solvent Temp (ºC) Time (h) DR 
(+)-Dip Chloride (1.4 eq.) THF 5 → 25 12 5:1 
K-Selectride®/MgBr2*OEt2 THF 25 0.5 2.6:1 
K-Selectride® THF reflux 2 2:1 
K-Selectride®/Ti(OiPr)4  THF 25 0.5 2:1 
KS-Selectride® THF 25 2 2:1 
R-Alpine borane (conc.) THF reflux 216 1:1 
L-Selectride® THF 25 1 0.9:1 
NaBH4/CeCl3 (anhydrous) THF 25 2 0.8:1 
N-Selectride® EtOH/THF 25 2 0.7:1 
NaBH4/CeCl3·7H2O THF 25 18 0.7:1 
NaBH4/EDTA (Na2·2H2O) THF 25 0.5 0.7:1 
NaCNBH3 THF 25 36 0.7:1 
(+)-2-Butanol/NaBH4 THF 25 1 0.6:1 
Cp2TiBH4 Glyme 25 0.5 0.6:1 
NaBH4 THF 25 2 0.6:1 
(-)-2-Butanol/NaBH4 THF 25 0.5 0.6:1 
NaBH4/Al(OiPr)4 THF reflux 2 0.6:1 
NaBH4/Diacetone-D-glucose THF 25 12 0.6:1 
NaBH4/EDTA   THF 25 12 0.6:1 
NaBH4/L-Tartaric Acid THF 5 1 0.6:1 
NaBH4/MgBr2·OEt2 THF 25 1 0.6:1 
BH3-t-butylamine THF 25 1 0.5:1 
LS-Selectride® THF 25 1 0.5:1 
NaBH4/D-Tartaric Acid THF 25 0.5 0.5:1 
(+)-2-Butanol·BH3 THF 25 1 0.4:1 
NaBH4/CaCl2 MeOH 25 1 0.4:1 
AminoAlcohol Borane THF 25 12 0.3:1 
Na(PEG)2BH2 THF 25 0.5 0.3:1 
BH3·THF EtOH/THF 25 2 0.2:1 
 
 
 The goal of this work was to explore boron reducing agents in the reduction of 
(S)-CMK to optimize the yield and DR while minimizing the reaction cost.  The research 




extended to chiral oxazaborolidines, which proved to yield the best results.  The 
objective of this investigation was to identify boron reducing agents that stereoselectively 




Boron Triisopropoxide Reduction Mechanism 
 As Figure 5.2 shows, the mechanism of the boron triisopropoxide reduction of 
ketones is analogous to that of the MPV reduction with aluminum isopropoxide.  First, 
the carbonyl compound coordinates with the boron of the boron triisopropoxide.  The 
reaction proceeds through a six member ring transition state by hydride transfer to the 
carbonyl from the α-carbon of the isopropoxide group.  Acetone is released and the 












Oxazaborolidine Reduction Mechanism 
 The mechanism of the oxazaborolidine-catalyzed reduction of ketones is known 
in the literature (Figure 5.3).23  The oxazaborolidine first complexes with a borohydride 
molecule to form a charged species, which then coordinates with the ketone to mediate 
the hydride transfer from the borohydride to the ketone.  Upon addition of another 
borohydride molecule, the alcohol product is released.  The resulting catalyst can 
undergo another catalytic cycle.  This mechanism has been used extensively to help 
researchers understand the high stereoselectivity of the reduction.24-31 
 
 
Figure 5.3: Mechanism of the reduction of ketones by 2-methyl-CBS-oxazaborolidine.23 
 
 
RESULTS AND DISCUSSION 
 
Reduction with Sodium Borohydride 
 The reduction of (S)-CMK was investigated with sodium borohydride.  Sodium 
borohydride was previously used for the reduction of (S)-CMK to give a DR of 0.6:1.21,22  




and 100% conversion.  Sodium borohydride does not appear to be a promising reducing 
agent for the selective production of (R,S)-CMA. 
 
Reduction with Boron Triisopropoxide 
 The diastereoselective reduction of (S)-CMK was carried out with boron 
triisopropoxide.  The reagent was purchased from Aldrich and was also prepared and 
used in situ following literature procedures.32-34  The reduction of (S)-CMK was 
performed using both the purchased reagent and the reagent prepared in situ.  When 
the reduction was run with the purchased reagent for 48 hours in refluxing THF, no 
reaction was consistently observed.  The solvent was changed to toluene so that a 
higher reaction temperature could be achieved but again, no reaction occurred.  In 
contrast, when the reaction was run with the reagent synthesized in situ, after reacting 
overnight in THF at room temperature, 38% conversion of (S)-CMK was observed with a 
DR of 0.38:1. 
 The two boron triisopropoxide reagents (bought or prepared) were characterized 
by 11B NMR to explain the results of the reduction reactions.  The coupling of protons 
with the boron nuclei can complicate the spectrum by increasing the multiplicity of the 
peaks, but they give important information regarding the number of protons attached to 
each boron atom.35  Analysis of the purchased boron reagent showed a single peak (δ 
17.2 ppm) which remained a singlet when run without proton decoupling, indicative of no 
hydrogen atoms present on the boron nucleus. 
 Three different samples of boron triisopropoxide prepared in situ were made: (1) 
BH3•THF with one equivalent of isopropanol in an NMR tube, (2) BH3•THF with 3.2 
equivalent of isopropanol (as used above) in an NMR tube, and (3) BH3•THF with 3.2 
equivalent of isopropanol on a batch scale (sampled directly from the round-bottom 




before the NMR spectra were recorded.  The batch scale preparation was stirred for 24 
hours before a sample was analyzed by 11B NMR.  As a comparison, the 11B NMR 
spectrum of BH3•THF was obtained, which showed a single peak (δ -0.47 ppm) as a 
singlet with proton decoupling and a quartet without the decoupling.  When one 
equivalent of isopropanol was used, four boron species (δ 26.79, 18.93, 17.60, -0.34 
ppm) were observed.  In contrast, when 3.2 equivalents of isopropanol were used, there 
were three different boron peaks in the 11B NMR spectrum (δ 26.79, 18.47, 17.54, -0.34 
ppm).  The batch mixture with 3.2 equivalents of isopropanol was analyzed after 24 
hours and showed two boron species (δ 18.48, 17.54 ppm). 
 Although the desired boron triisopropoxide is formed in each of the above 
samples, there are other boron species present that may also perform the reduction.  
Also, the formation of the desired boron triisopropoxide reducing agent takes longer than 
the time reported in the literature, as evidenced by the BH3•THF peak present in the 
samples after two hours.  Overall, boron triisopropoxide does not seem to be a 
promising reducing agent for the synthesis of (R,S)-CMA. 
 
Reduction with Borane Catalyzed by Oxazaborolidines 
 Four different oxazaborolidines were investigated: (1) (4R,5S)-4,5-diphenyl-1,3,2-
oxazaborolidine [abbreviated (R,S)-DPO] made and used in situ, (2) 1,3,2-
oxazaborolidine made and used in situ, and (3) two commercially available catalysts 
[(R)-(+)-CBS and (S)-(-)-CBS] (Figure 5.4).  The first two catalysts were synthesized and 






Figure 5.4: Structures of oxazaborolidine catalysts.  A: (4R,5S)-4,5-Diphenyl-1,3,2-
oxazaborolidine [(R,S)-DPO].  B: 1,3,2-Oxazaborolidine.  C: (R)-(+)-CBS or (S)-(-)-CBS. 
 
 
 The reduction reactions were originally run under “batch” conditions in a standard 
round-bottom flask apparatus as a screening tool to identify promising reaction 
conditions.  The reactions were repeated on the same scale as the batch conditions in 
the carousel apparatus used extensively in Chapters 3 and 4.  One difficulty that arose in 
the carousel setup was the challenge of drying the reaction tubes and keeping them 
under an inert atmosphere.  The seals of the carousel reactor are made with Teflon, 
which melts at elevated temperatures.  Although the glass reaction tubes were dried in 
the oven, the remaining parts of the apparatus were not dried, which may have allowed 
moisture into the reaction tubes.  Since the borane reducing agent is water sensitive, 
even small amounts of water could affect the reproducibility of the reaction. 
 As this work was an initial screening of reagents for future application to an 
industrial process, the main focus was to identify the best performing catalysts in terms 
of high yields and diastereoselectivity.  Reaction variables, such as temperature and 
concentration, were investigated briefly without optimization of the reaction conditions. 
 
Synthesis and Characterization of Oxazaborolidines 
  (R,S)-DPO was prepared from (1R,2S)-1,2-diphenyl-2-aminoethanol and borane 
according to a literature procedure (Figure 5.5).36-38  Attempts to characterize the in situ 




instability of the oxazaborolidine catalyst when isolated from the solvent.  However, 
proton decoupled 11B NMR showed a singlet at δ -19.6 ppm consistent with the 
formation of one boron containing specie.  Without proton decoupling, the peak 
appeared as a doublet, indicating that one proton was attached to the boron, supporting 
the formation of the desired catalyst. 
 
 
Figure 5.5: Synthesis of (R,S)-DPO. 
 
 
 The achiral catalyst, 1,3,2-oxazaborolidine, was synthesized in the same manner 
as the chiral (R,S)-DPO above.  2-Aminoethanol and borane were reacted in THF to 
form the achiral catalyst (Figure 5.6).  The 1H and 13C NMR spectra were again difficult 
to interpret because of the catalyst instability when isolated.  The proton decoupled 11B 
NMR spectrum showed a single peak as a singlet at δ -19.4 ppm.  Without proton 
decoupling, the peak appeared as a doublet, evidencing the presence of one hydrogen 
atom on the boron nucleus, consistent with the formation of the desired catalyst. 
 
 








 The reduction of (S)-CMK using borane alone in a mixture of THF and ethanol 
has been reported with a DR of 0.2:1.21,22  The reaction was investigated as a function of 
temperature, with the reaction temperature varying from -20°C to 25°C.  This reaction 
was carried out as a control experiment under batch conditions at 0°C in THF (Figure 
5.7).  Then the reaction was carried out once each at 10°C and -20°C under batch 
conditions and three times at 25°C in the carousel reactor.  The HPLC analyses of these 
reactions are given in Table 5.2.  All of the reactions went to completion after eight 
hours.  The DR was slightly higher in all cases (between 0.30:1 and 0.45:1) than the 
previously reported value (0.2:1).  However, since the DR is within experimental error, 
the temperature does not seem to have a significant influence on the diastereoselectivity 
of the reaction. 
 
 
Figure 5.7: Reduction of (S)-CMK with borane without catalyst. 
 
 
Table 5.2: Reduction of (S)-CMK with borane. 
Reagent Batch/Carousel Temp (ºC) % Yield DR 
BH3-THF Batch 0 98 ± 3 0.45 ± 0.04 
BH3-THF Batch 10 100a 0.40 
BH3-THF Batch -20 100a 0.40 
BH3-THF Carousel 25 98 ± 3 0.30 ± 0.05 








 (R,S)-DPO and 1,3,2-oxazaborolidine were formed as described above and used 
as in situ catalysts for the reduction of (S)-CMK.  The reducing agent in these reactions 
was borane.  One equivalent of either catalyst was formed in situ with BH3•THF.  A 
solution of (S)-CMK in THF was added to start the reaction.  These reactions were 
analyzed by HPLC and the results are given in Table 5.3.  The in situ catalysts were 
originally used on a batch scale with six equivalents of borane to give DRs of 1.2:1 with 
(R,S)-DPO and 0.86:1 with 1,3,2-oxazaborolidine.  However, when these reactions were 
repeated in the carousel setup, the DR decreased by half and the yield also decreased.  
This decrease has been attributed to possible water contamination in the carousel 
reactor that caused the degradation of the oxazaborolidine compounds.  To investigate 
the effect of the excess of borane, carousel reactions were run using 1.1 equivalents of 
borane to form each of the oxazaborolidines, which results in only 0.1 excess 
equivalents of borane assuming complete yield of the oxazaborolidine catalysts.  
Interestingly, these reactions resulted in DRs of 0.34:1 with (R,S)-DPO and 0.59:1 with 
1,3,2-oxazaborolidine, similar to that of pure borane.  An excess of borane is probably 
necessary to achieve complete conversion of the aminoalcohols to the oxazaborolidine 
catalysts. 
 
Table 5.3: Reduction of (S)-CMK with (R,S)-DPO or 1,3,2-oxazaborolidine. 
Catalyst Batch/Carousel Time (h) % Yield DR 
(R,S)-DPO Batch 18 97a 1.2 ± 0.1 
(R,S)-DPO Carousel 18 85 ± 4 0.59 ± 0.05 
(R,S)-DPO (1.1 eq BH3) Carousel 18 97 ± 13 0.34 ± 0.01 
1,3,2-Oxazaborolidine Batch 24 90a 0.86 ± 0.02 
1,3,2-Oxazaborolidine Carousel 18 85 ± 8 0.48 ± 0.05 
1,3,2-Oxazaborolidine 
(1.1 eq BH3) 
Carousel 18 75 ± 9 0.59 ± 0.08 
aYields estimated from total peak area in HPLC 
 




 The reduction of (S)-CMK was attempted using the commercially available 
oxazaborolidine compounds originally synthesized by Corey [(R)-(+)-CBS and (S)-(-)-
CBS].7  The reactions were all run three times using a 2 M solution of either catalyst in 
THF at room temperature either on a batch scale or in the carousel reactor.  The results 
of these reactions are summarized in Table 5.4.  Significant changes in DR occurred 
upon going from a batch scale to the carousel reactor.  With (S)-(-)-CBS, the DR 
dropped from 0.49:1 on a batch scale to 0.17:1 in the carousel.  Similarly, the DR 
increased from 3.8:1 in the batch reaction to 6.3:1 in the carousel.  One possible 
explanation for this difference is the solubility of the oxazaborolidine catalysts in THF.  
The catalysts were purchased from Aldrich as a 2 M solution but the catalyst was 
observed to precipitate around the rim of the bottle, especially in the case of (R)-(+)-
CBS.  A different bottle of the reagents were used for the batch reactions as for the 
carousel reactions, which may have caused the discrepancy. 
 
Table 5.4: Reduction of (S)-CMK with commercially available (R)-(+)-CBS and (S)-(-)-
CBS. 
Catalyst Batch/Carousel Time (h) % Yield DR 
(S)-(-)-CBS Batch 24 90* 0.49 ± 0.06 
(S)-(-)-CBS Carousel 18 91 ± 2 0.17 ± 0.01 
(S)-(-)-CBS (no BH3) Carousel 18 0 ± 3 --- 
(R)-(+)-CBS Batch 24 85* 3.8 ± 0.3 
(R)-(+)-CBS Carousel 18 72 ± 8 6.3 ± 0.2 
(R)-(+)-CBS (no BH3) Carousel 18 0 ± 3 --- 
aYields estimated from total peak area in HPLC 
 
 
 Since the reproducibility was poor when the reactions were run with the (R)-(+)-
CBS and (S)-(-)-CBS solutions in THF, (R)-(+)-CBS and (S)-(-)-CBS were purchased as 
solids so the amount of catalyst in each reaction could be accurately controlled.  The 




with the catalyst as a solution in THF.  The DR (5.2:1) is closer to that of the batch 
reactions (3.8:1). 
 
Table 5.5: Comparison of (R)-(+)-CBS as a solution or as a solid. 
Catalyst Time (h) % Yield DR 
(R)-(+)-CBS (2 M soln.) 18 72 ± 8 6.3 ± 0.2 
(R)-(+)-CBS (solid) 18 89 ± 5 5.2 ± 0.4 
 
 
Reproducibility of Oxazaborolidine-Catalyzed Reactions 
 In an effort to improve the reproducibility of the oxazaborolidine reactions, a stock 
solution of each oxazaborolidine catalyst [(R,S)-DPO, 1,3,2-oxazaborolidine, (R)-(+)-
CBA, and (S)-(-)-CBS] was prepared with BH3•THF and loaded directly into each 
carousel reaction tube.  Each reaction was run six times at room temperature and the 
results of these reactions are given in Table 5.6.  Each reaction showed slightly 
improved yields compared to the previous results.  In addition, the diastereoselectivity 
improved for (R,S)-DPO and 1,3,2-oxazaborolidine (DR of 0.80:1 and 0.61:1, 
respectively).  The reaction with (S)-(-)-CBS also became more stereoselective with a 
DR of 0.07:1, although in this case the reaction is selective for the (S,S)-CMA product.  
The most significant result is a DR of 9.5:1 using (R)-(+)-CBS.  (R)-(+)-CBS is the most 
effective catalyst for the diastereoselective production of (R,S)-CMA. 
 
Table 5.6: Reduction of (S)-CMK using stock solutions of oxazaborolidine catalysts. 
Catalyst Time (h) % Yield DR DR (previous) 
(R,S)-DPO 8 90 ± 2 0.80 ± 0.01 0.59 ± 0.05 
1,3,2-Oxazaborolidine 8 88 ± 2 0.61 ± 0.02 0.48 ± 0.05 
(S)-(-)-CBS 8 94 ± 2 0.07 ± 0.01 0.17 ± 0.01 






 In conclusion, several boron reducing agents were screened for the 
diastereoselective reduction of (S)-CMK to (R,S)-CMA.  The most promising reagents 
investigated are the chiral oxazaborolidine catalysts in conjunction with borane.  (S)-(-)-
CBS stereoselectively produced the (S,S) product while (R)-(+)-CBS yielded the desired 







Materials and Equipment 
 All chemicals were ordered from Aldrich and used as received, unless otherwise 
noted.  The (S)-CMK starting material and samples of (S,S)-CMA and (R,S)-CMA were 
obtained from Ampac Fine Chemicals (Sacramento, CA).  All solvents used were 
purchased as anhydrous from Aldrich and used as received.  The glassware and 
apparatus were dried before use in the reactions. 
 1H and 13C NMR spectra were obtained from a Varian-Mercury VX 400 MHz 
spectrometer using DMSO-d6 as an internal reference.  11B NMR spectra were obtained 
from a Bruker DRX 500 MHz spectrometer using THF- d6 as an internal reference.   
Elemental analyses were performed by Atlantic Microlab (Norcross, GA).  HRMS 
experiments were performed by Georgia Institute of Technology Bioanalytical Mass 
Spectrometry Facility (Atlanta, GA).  HPLC analysis was run on an Agilent 1100 series 
LC with a UV detector and an ESI-MS.  The product analysis was performed following 
the analytical procedure described in Chapters 3 and 4. 
 
Batch Reactions 
Reduction with Boron Triisopropoxide Prepared in situ 
 A BH3•THF solution (5 mL of a 1 M solution, 5 mmol) was charged to a round-
bottom flask under argon in an ice bath and allowed to cool for 30 minutes.  Anhydrous 
isopropanol (1.3 mL, 17 mmol) was added dropwise to the borane solution over 30 
minutes.  After hydrogen evolution ceased (~ two hours) the solution was stirred 
overnight and allowed to warm to room temperature.  (S)-CMK (2.0 g, 6.7 mmol) was 
dissolved in anhydrous THF and added to the reaction mixture.  The mixture was 




aqueous layer was saturated with potassium carbonate.  The organic layer was isolated, 
dried over magnesium sulfate, diluted with THF, and analyzed by HPLC.     
 
Reduction with Commercially Available Boron Triisopropoxide 
 (S)-CMK (2.0 g, 6.7 mmol) was dissolved in anhydrous THF.  After one hour, 
boron triisopropoxide (1.9 mL, 8.1 mmol) was added to the reaction flask.  The mixture 
was heated to reflux and allowed to stir for three days.  At 24 hour intervals, samples 
were taken, diluted with THF, and analyzed by HPLC. 
 
Reduction with Borane 
 (S)-CMK (1.5 g, 5.0 mmol) was dissolved in anhydrous THF (10 ml) and cooled 
to 0°C in an ice bath.  A solution of BH3•THF (5 mL of a 1 M solution, 5 mmol) was 
added to the (S)-CMK solution. The solution was stirred for two hours, quenched with 
methanol, diluted with THF, and analyzed by HPLC. 
 
Reduction with 4,5-Diphenyl-1,3,2-oxazaborolidine  
  (1S,2R)-(+)-2-Amino-1,2-diphenylethanol (0.13 g, 0.60 mmol) was placed in a 
round bottom flask in an ice bath.  BH3•THF (3.6 mL of a 1 M solution, 3.6 mmol) was 
slowly added to the flask. The solution was allowed to stir overnight and slowly warm to 
room temperature. (S)-CMK (0.18 g, 0.60 mmol) was dissolved in anhydrous THF (~20 
mL) and added to the reaction mixture. After 18 hours, the reaction solution was diluted 
with THF and analyzed by HPLC.  
 
Reduction with 1,3,2-Oxazaborolidine.  
 Ethanolamine (0.10 mL, 1.7 mmol) was placed in a round bottom flask in an ice 




solution was allowed to stir overnight and to slowly warm to room temperature.  (S)-CMK 
(0.5 g, 1.7 mmol) was dissolved in anhydrous THF (~20 mL) and added to the reaction 
mixture.  After 18 hours, the reaction solution was diluted with THF and analyzed by 
HPLC. 
 
Reduction with (S)-(-)-CBS 
 (S)-(-)-CBS (2.0 mL of a 1 M solution in THF, 2.0 mmol) was placed in an ice 
bath.  BH3•THF (1.7 mL of a 1 M solution, 1.7 mmol) was slowly added to the flask.  The 
solution was allowed to stir for one hour before a solution of (S)-CMK (0.5 g, 1.7 mmol) 
dissolved in anhydrous THF (~20 mL) was added to the reaction mixture.  After 18 
hours, the reaction solution was diluted with THF and analyzed by HPLC. 
 
Reduction with (R)-(+)-CBS 
 (R)-(+)-CBS (2.0 mL of a 1 M solution, 2.0 mmol) was placed in an ice bath.  
BH3•THF (1.7 mL of a 1 M solution, 1.7 mmol) was slowly added to the flask.  The 
solution was allowed to stir for one hour before a solution of (S)-CMK (0.5 g, 1.7 mmol) 
dissolved in anhydrous THF (~20 mL) was added to the reaction mixture.  After 18 
hours, the reaction solution was diluted with THF and analyzed by HPLC. 
 
Carousel Reactions 
Reduction with Borane 
 (S)-CMK (0.6 g, 3.0 mmol) was placed in three of the reactor tubes.  The tubes 
were then placed in the carousel and put under an argon atmosphere.  Anhydrous THF 
(2 mL) was added to each reactor tube to dissolve the (S)-CMK.  After one hour, the 




solution was stirred for two hours, quenched with methanol, diluted with THF, and 
analyzed by HPLC.     
 
Preparation of 1,3,2-Oxazaborolidine Stock Solution 
 Ethanolamine (1.0 mL, 18 mmol) was placed under an argon atmosphere and 
cooled to 0ºC in an ice bath.  A solution of BH3•THF (108 mL of a 1 M solution, 108 
mmol) was slowly added to the flask. The solution was allowed to stir for 24 hours and 
slowly warm up to room temperature. 
 
Reduction with 1,3,2-Oxazaborolidine Stock Solution  
 (S)-CMK (0.77 g, 2.6 mmol) was placed in six of the reactor tubes in the carousel 
reactor.  The tubes were then placed in the carousel reactor and put under an argon 
atmosphere.  Anhydrous THF (2 mL) was added to each reactor tube to dissolve the (S)-
CMK.  After one hour, the stock solution of 1,3,2-oxazaborolidine (16 mL) was added to 
each of the reactor tubes.  The solution was allowed to stir for eight hours.  At this time 
the reaction was quenched with methanol (6 mL).  The quenched reaction mixture was 
diluted with THF and analyzed by HPLC.      
 
Preparation of 4,5-Diphenyl-1,3,2-oxazaborolidine Stock Solution  
 (1S,2R)-(+)-2-Amino-1,2-diphenylethanol (3.8 g, 18 mmol) was placed under an 
argon atmosphere and cooled to 0ºC in an ice bath.  A solution of BH3•THF (54 mL of a 
1 M solution, 54 mmol) was slowly added to the flask.  The solution was allowed to stir 







Reduction with 4,5-Diphenyl-1,3,2-oxazaborolidine Stock Solution 
 (S)-CMK (0.77 g, 2.6 mmol) was placed in six of the reactor tubes in the carousel 
reactor.  The tubes were then placed in the carousel reactor and put under an argon 
atmosphere.  Anhydrous THF (2 mL) was added to each reactor tube to dissolve the (S)-
CMK.  After one hour, the stock solution of 4,5-diphenyl-1,3,2-oxazaborolidine (8 mL) 
was added to each of the reactor tubes.  The solution was allowed to stir for eight hours.  
At this time the reaction was quenched with methanol (6 mL).  The quenched reaction 
mixture was diluted with THF and analyzed by HPLC. 
 
Preparation of 2-Methyl-CBS-oxazaborolidine Stock Solutions  
 (S)-(-)-CBS or (R)-(+)-CBS (3.9 g, 14 mmol) was placed under an argon 
atmosphere.  A solution of BH3•THF (28 mL of a 1 M solution, 28 mmol) was slowly 
added to the flask.  The solution was allowed to stir overnight. 
 
Reduction with (S)-(-)-CBS or (R)-(+)-CBS  
 (S)-CMK (0.60 g, 2.0 mmol) was placed in six of the reactor tubes in the carousel 
reactor.  The tubes were then placed in the carousel reactor and put under an argon 
atmosphere.  Anhydrous THF (2 mL) was added to each reactor tube to dissolve the (S)-
CMK. After one hour, the stock solution of 2-methyl-CBS-oxazaborolidine (4 mL) was 
added to each of the reactor tubes. The solution was allowed to stir for eight hours. At 
this time the reaction was quenched with methanol (4 mL). The quenched reaction 
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 The diastereoselectivity of the MPV reduction of (S)-CMK – induced by the α-
chiral carbon of S configuration – is influenced by the aluminum alkoxide reagent’s 
capabilities to hydrogen bond with the amide of the Boc-protected (S)-CMK.  The 
possible transition state complexes between aluminum isopropoxide and (S)-CMK were 
studied using Spartan® modeling calculations.  Based on these models, potential 
approaches to favor (R,S)-CMA selectively were identified, including the replacement of 
the Boc protecting group.  By replacing the Boc protecting group with a phthalimide 
group, which cannot hydrogen bond with the aluminum isopropoxide, it was 
hypothesized that the diastereoselectivity toward (R,S)-CMA could be improved. 
 The effect of the amine protecting group on the diastereoselectivity of the (S)-
CMK reduction was investigated by altering the protecting group.  First, (S)-CMK was 
synthesized with two different N-protecting groups: phthalimide or trifluoroacetamide 
(Figure 6.1).  In the MPV reduction, the protected amine of the phthalimide-protected 
(S)-CMK cannot hydrogen bond with the aluminum isopropoxide and the 
diastereoselectivity towards (R,S)-CMA was improved.  The phthalimide-protected (S)-
CMK was also reduced under the same ATH reaction or boron reagents conditions used 






Figure 6.1: Structures of phthalimide-protected (S)-CMK (A) and trifluoroacetamide-





 Spartan® modeling studies (Hartree-Fock level with basis set of 6-31G*) showed 
that hydrogen bonding between the aluminum isopropoxide and (S)-CMK plays an 
essential role in determining the stereoselectivity of the products (see Chapter 3).  
Preventing this hydrogen bonding from occurring could favor our desired (R,S)-CMA 
product.  One method proposed to prevent this hydrogen bonding is to replace the Boc 
protecting group with a phthalimide group that does not contain an acidic hydrogen 
capable of hydrogen bonding.  This approach has been shown to improve the 
stereoselectivity of the MPV reduction of a similar α-aminoketone.1 
 (S)-CMK with phthalimide and trifluoroacetamide protecting groups have been 
previously synthesized2,3 but the reduction of the ketones to their respective alcohols has 










RESULTS AND DISCUSSION 
 
Synthesis of (S)-CMK with Different Amine Protecting Groups 
 The phthalimide protecting group yields a tertiary amine, precluding possible 
hydrogen bonding with the alkoxide groups on the aluminum.  The trifluoroacetamide 
protecting group yields a secondary amine with a hydrogen still available for hydrogen 
bonding.  However, the trifluoroacetamide group was investigated to evaluate the 
electronic effect of the protecting group on the reaction selectivity. 
 
Synthesis of (S)-CMK Ammonium Hydrochloride Salt 
 The Boc protecting group was removed by treating (S)-CMK with hydrochloric 
acid to form the corresponding ammonium hydrochloride salt [(S)-4-chloro-3-oxo-1-
phenylbutan-2-aminium chloride] (Figure 6.2).4  1H and 13C NMR, elemental analysis, 
and melting point support the formation of the ammonium hydrochloride salt.5  The free 
amine analog of (S)-CMK could be obtained upon neutralization of the ammonium 
hydrochloride salt but I observed early on that the free amine was unstable.  I 
hypothesize that this can be due to substitution reactions between the free amine of one 
molecule and the chlorine group of another molecule. 
 
 
Figure 6.2: Formation of (S)-4- chloro-3-oxo-1-phenylbutan-2-aminium chloride through 







Synthesis of Phthalimide-Protected (S)-CMK 
 The synthesis of a phthalimide-protected version of (S)-CMK was initially 
attempted using the synthetic strategy of the Boc-protected (S)-CMK.6,7  This method 
involves the reaction of N-phthaloyl-L-phenylalanine with IBCF at 0°C to form a mixed 
anhydride intermediate.  The mixed anhydride is reacted in situ at 0°C with 
diazomethane and quenched with hydrochloric acid to form the chloromethyl ketone 
product.  Unfortunately, after several attempts, the desired product could not be isolated.  
Instead of going through the unstable mixed anhydride intermediate, the synthetic 
procedure was modified to use the acid chloride intermediate (Figure 6.3).8  N-Phthaloyl-
L-phenylalanine was reacted with oxalyl chloride to form the corresponding acid chloride, 
which was then reacted with trimethylsilyldiazomethane.  After quenching with 
hydrochloric acid, the final product, N-phthaloyl-(3S)-3-amino-1-chloro-4-phenyl-2-
butanone (Phth-CMK) was obtained.  Phth-CMK was successfully isolated in 73% yield 










Synthesis of Trifluoroacetamide-Protected (S)-CMK 
 Following the same synthetic scheme used to synthesize Phth-CMK, the desired 
trifluoroacetamide-protected product, N-trifluoroacetyl-(3S)-3-amino-1-chloro-4-phenyl-2-
butanone (TFA-CMK), was isolated in 30% yield.  An alternative synthetic route, in which 
the free amine derivative of (S)-CMK was directly reacted with trifluoroacetic anhydride 
to form TFA-CMK, was investigated (Figure 6.4).  The previously isolated ammonium 
hydrochloride salt of (S)-CMK was first neutralized to form the free amine analog.  
Careful attention was paid to keep the free amine dilute and cold to prevent its 
decomposition.  Trifluoroacetic acid was then added to successfully form TFA-CMK in 
85% yield.  The product was characterized by 1H and 13C NMR, melting point, elemental 
analysis, and mass spectrometry. 
 
 




Reduction of (S)-CMK with Different Protecting Groups 
Asymmetric Transfer Hydrogenation 
 The reduction of Phth-CMK via ATH was investigated (Figure 6.5).  The 




in methanol for one hour at room temperature followed by the addition of triethylamine 
and formic acid.  The reaction started upon the addition of the Phth-CMK starting 
material.  The Phth-CMK did not dissolve immediately but as the reaction progressed a 
homogeneous brown solution was formed.  The reaction was run overnight then 
quenched with ammonium chloride and extracted in DCM.  HPLC and 1H NMR analysis 
showed complete conversion of the starting material with a DR of 2.1:1. 
 
 
Figure 6.5: ATH reduction of Phth-CMK. 
 
 
Reduction with Boron Reducing Agents 
 The reduction of an ammonium hydrochloride salt similar to the deprotected (S)-
CMK with sodium borohydride was previously reported with a DR of 1.5:1 (Figure 6.6).9  
This approach was repeated in our laboratory.  The reduction of the (S)-CMK 
hydrochloride salt was performed under the same conditions as in the literature with the 
exception of the solvent being pure methanol.  Analysis of the post-reaction mixture by 
1H NMR showed that all of the ammonium hydrochloride salt had reacted and only the 
alcohol products were present.  The DR was not determined as the HPLC method failed 
to separate the alcohol products.  The alcohols were reacted with di-tert-butyl 
dicarbonate to reform the original (S,S)-CMA and (R,S)-CMA (Figure 6.7),9 for which the 
HPLC method was well established.  After the Boc protection, the DR was found to be 




step of the salt with a Boc group should not have changed the original DR; however, a 
direct measurement of the DR on the salt would be unequivocal. 
 
 




Figure 6.7: Boc protection of (S)-CMK ammonium hydrochloride salt. 
 
 
 Phth-CMK was also reduced with sodium borohydride using the same procedure 
as with the ammonium hydrochloride salt, except that the methanol was replaced with 
acetonitrile for homogeneity.  The post-reaction analysis by HPLC indicated the 
formation of many unidentified compounds and some unreacted Phth-CMK.  Sodium 
borohydride is prone to reducing the ketone but can also reduce the carbonyl groups of 
the protecting phthalimide group10,11 and possibly cleave the phthalimide group 
altogether12 (Figure 6.8).  The lack of peaks corresponding to the products suggests that 











 The reduction of the (S)-CMK ammonium hydrochloride salt through the MPV 
reduction was attempted (Figure 6.9).  The (S)-CMK salt was stirred in anhydrous 
isopropanol at 50°C and aluminum isopropoxide was added to start the reaction.  
Unfortunately, no reaction occurred with the MPV reduction of the ammonium 
hydrochloride salt.  This is probably due to the low solubility of the salt in the organic 
solvent.  Since the free amine of (S)-CMK was found to be unstable, I did not pursue 
reduction of this compound. 
 
 
Figure 6.9: MPV reduction of (S)-CMK ammonium hydrochloride salt. 
 
 
 The previously synthesized Phth-CMK and TFA-CMK were next reduced using 
the MPV reduction.  However, due to its low solubility in isopropanol, Phth-CMK did not 
react with aluminum isopropoxide in a pure isopropanol solution overnight at 50°C.  
Even when acetonitrile was added as a cosolvent, the starting material had a very low 




place.  To circumvent this limitation, the reduction was attempted in refluxing isopropanol 
overnight.  Even at this temperature, the solution was heterogeneous; however, the 
reaction did proceed.  About 25% conversion of our starting material with a DR of about 
1:1 was observed by HPLC analysis.  Since the starting material readily dissolves in 
toluene, toluene was chosen as our reaction solvent with 10% isopropanol to speed up 
the reaction.  Phth-CMK (Figure 6.10) and TFA-CMK (Figure 6.11) were both reduced in 
a 9:1 toluene/isopropanol solvent mixture.  Each reduction was catalyzed by aluminum 
isopropoxide and the experiments were carried out in triplicate overnight at 50°C.  These 
reactions were analyzed by HPLC and the results are summarized in Table 6.1.  The 
products of the reductions of Phth-CMK and TFA-CMK were isolated and characterized 
by X-ray crystallography. 
 
 











Table 6.1. MPV reduction of (S)-CMK, Phth-CMK, and TFA-CMK. 
Reactant DR % Conversion % Yield 
(S)-CMK 0.05 ± 0.01 100 ± 0.0 90 ± 1.4 
Phth-CMK 1.10 ± 0.00 99 ± 0.0 92 ± 0.1 
TFA-CMK 0.03 ± 0.00 99 ± 0.0 99 ± 0.0 
 
 
 As Table 6.1 shows, the data supports the hypothesis that preventing hydrogen 
bonding will affect the diastereoselectivity of the reaction.  By removing both hydrogens 
on the nitrogen in Phth-CMK, the diastereoselective preference for the (S,S) 
diastereomeric product was eliminated, giving an even product distribution.  The reaction 
does not seem to be affected by the type of protecting group on the amine (Boc vs. 
trifluoroacetamide), only by the presence or absence of a hydrogen on the nitrogen that 




 In conclusion, the stereoselectivity of the reduction of (S)-CMK has been 
improved through the use of different protecting groups.  The greatest improvement in 
selectivity was observed when the Boc protecting group of (S)-CMK was replaced with a 
phthalimide group.  Specifically, preventing the hydrogen bonding between the amide 
proton of (S)-CMK and the alkoxy group of the aluminum isopropoxide in the MPV 
reduction reversed the diastereoselectivity in favor of (R,S)-CMA.  In addition, the ATH 







Materials and Equipment 
 All chemicals were ordered from Aldrich or VWR and used as received, unless 
otherwise noted.  The (S)-CMK starting material was obtained from Ampac Fine 
Chemicals (Sacramento, CA).  All solvents used in the MPV reduction were purchased 
as anhydrous from Aldrich and used as received. 
 1H, 13C, and 17F NMR spectra were obtained from a Varian-Mercury VX400 MHz 
spectrometer using CDCl3 as an internal reference, unless otherwise noted.  Elemental 
analyses were performed by Atlantic Microlab (Norcross, GA).  High resolution mass 
spectrometry (HRMS) experiments [either ESI or fast atom bombardment (FAB)] were 
performed by Georgia Institute of Technology Bioanalytical Mass Spectrometry Facility 
(Atlanta, GA).  X-ray crystallography was performed by the X-ray Crystallography Lab at 
Emory University (Atlanta, GA).  HPLC analysis was run on an Agilent 1100 series LC 
with a UV detector set to 210 nm. 
 
Synthesis of (S)-CMK with Different Protecting Groups 
Synthesis of (S)-4-Chloro-3-oxo-1-phenylbutan-2-aminiumchloride   
 (S)-CMK (5.00 g, 16.8 mmol) was dissolved in ethyl acetate (50 mL) and cooled 
to 0°C in an ice bath.  Concentrated hydrochloric acid (15.3 mL, 503 mmol) was added 
dropwise to the solution.  Upon complete addition of the acid, the ice bath was removed 
and the solution was stirred at room temperature for one hour.  The white solid was 
filtered and washed with ethyl acetate and diethylether to give pure the pure ammonium 
hydrochloride salt (3.85 g, 16.4 mmol, 98%). 
 mp 170-172°C (literature mp 170°C5).  1H NMR δ 3.17 (m, 2H), 4.51 (s, 1H), 4.62 




198.3.  MS (ESI+) calculated for C10H13NOCl2: 234.12.  Found: 198.2 (C10H13NOCl).  
Elemental analysis calculated for C10H13NOCl2: C, 51.30; H, 5.60; N, 5.98.  Found: C, 
54.41; H, 5.62; N, 6.01. 
 
General Procedure for the Preparation of N-Protected α-Chloroketones (Phth-CMK and 
TFA-CMK) 
 N-Protected-L-phenylalanine (5.0 mmol) was placed under an argon atmosphere 
and anhydrous DCM (25 mL) and DMF (2 drops) were added to dissolve the solid.  The 
solution was cooled to 0°C and oxalyl chloride (0.48 mL, 5.5 mmol) was slowly added to 
the solution over fifteen minutes.  The solution was allowed to stir at 0°C overnight.  
Trimethylsilyldiazomethane (5.0 mL of a 2 M solution in hexanes, 10 mmol) was slowly 
added to the reaction mixture over one hour.  The solution was allowed to stir at 0°C 
under argon for 24 hours.  At this time hydrochloric acid (5.0 mL of a 2 M solution in 
diethylether, 10 mmol) was added at 0°C.  After one hour, the solution was allowed to 
warm to room temperature and the reaction was opened to the atmosphere.  After three 
hours, the organic layer was washed with saturated sodium bicarbonate and then with 
brine.  The solvent was removed via rotary evaporation resulting in a yellow solid.  The 
crude material was decolorized with charcoal in acetonitrile. 
 
Synthesis of Phth-CMK 
 Phth-CMK was synthesized following the general procedure above.  The 
decolorized material was recrystallized in a 9:1 mixture of hexanes/ethyl acetate.  Phth-
CMK was isolated as a white solid (1.2 g, 3.7 mmol, 73%). 
 mp 117–118°C (lit mp 119–120°C2).  1H NMR δ 3.30 (br m, 2H), 4.80 (br q, 2H), 
5.33 (q, 1H), 7.10 (m, 5H), 7.81 (s, 4H).  13C NMR δ 32.9, 47.7, 57.9, 123.4, 126.7, 




C18H14NO3Cl: 327.0662.  Found: 328.0731 (M+H).  Elemental analysis calculated for 
C18H14NO3Cl: C, 65.96; H, 4.31; N, 4.27.  Found: C, 65.90; H, 4.20; N, 4.21. 
 
Synthesis of TFA-CMK 
 TFA-CMK was synthesized following the general procedure above.  The 1H NMR 
of the crude product showed the presence of TFA-CMK (~30% yield). 
 1H NMR δ 2.84 (m, 1H), 3.24 (m, 1H), 4.74 (q, 2H), 4.85 (m, 1H), 7.23 (m, 5H), 
9.83 (d, 1H). 
 
Alternative Synthesis of TFA-CMK   
 The ammonium hydrochloride salt of (S)-CMK (20 mmol) was neutralized using 
saturated sodium bicarbonate in ethyl acetate.  The organic layer was dried over 
magnesium sulfate and filtered over an ice bath.  The dilute solution of the free amine 
was placed under an argon atmosphere and allowed to cool to 0°C.  Trifluoroacetic 
anhydride (5.6 mL, 40 mmol) was added dropwise.  The reaction mixture was poured 
into water (30 mL) after one hour and extracted with ethyl acetate (2 x 75 mL).  The 
organic layer was washed with brine (2 x 30 mL), dried over magnesium sulfate, and 
concentrated under reduced pressure.  Crystallization from toluene afforded the pure 
TFA-CMK, which was isolated as a white solid (5.1 g, 17 mmol, 85%). 
 mp 114–115°C (lit mp 112°C13).  1H NMR δ 2.85 (m, 1H), 3.25 (m, 1H), 4.72 (q, 
2H), 4.83 (m, 1H), 7.25 (m, 5H), 9.81 (d, 1H).  13C NMR δ 34.4, 47.7, 58.3, 114.2, 117.1, 
126.7, 128.3, 129.1, 136.8, 156.2, 156.5, 198.8.  17F NMR δ -75.  HRMS (FAB+) 
calculated for C12H11ClF3NO2: 293.0430.  Found: 294.0517 (M+H).  Elemental analysis 






Asymmetric Transfer Hydrogenation 
 The ATH reaction on Phth-CMK was performed following the same reaction 
procedure used with (S)-CMK as in Chapter 4.  [Ru(p-cymene)Cl2]2 (15 mg, 0.025 mmol) 
and TsEN (21 mg, 0.085 mmol) were stirred in methanol (5 mL) at room temperature for 
one hour.  Triethylamine (0.560 mL, 4.02 mmol) and formic acid (0.184 mL, 4.88 mmol) 
were added to the reaction mixture.  Phth-CMK (0.67 g, 2.1 mmol) was added to start 
the reaction.  The Phth-CMK initially did not dissolve and formed a slurry.  As the 
reaction progressed, the reaction mixture became a brown solution.  The reaction was 
run overnight at room temperature.  The reaction was quenched with ammonium 
chloride.  The organics were extracted into DCM and washed with brine.  The solution 
was dried over magnesium sulfate and the solvent was removed under vacuum.  The 
product residue was analyzed by 1H NMR and HPLC. 
 
Reduction with Boron Reducing Agents 
Sodium Borohydride Reduction of (S)-CMK Ammonium Hydrochloride Salt 
 Sodium borohydride (0.34 g, 5.6 mmol) and sodium hydroxide (0.17 g, 4.3 mmol) 
were dissolved in methanol (15 mL) and cooled to 0°C in an ice bath.  The previously 
synthesized (S)-CMK ammonium hydrochloride salt (1.0 g, 4.3 mmol) was dissolved in 
methanol (10 mL) and added to the reaction mixture.  After the reaction ran for one hour 
at 0°C, the reaction was quenched with an excess of hydrochloric acid in methanol (10 
mL of a 2 M solution, 20 mmol).  The solvent was removed under vacuum.  The product 
mixture was analyzed by 1H NMR and HPLC. 
 




 The (S)-CMK ammonium hydrochloride salt reduction products were protected 
following a known method.9  Sodium carbonate (0.34 g, 3.2 mmol) was dissolved in 
distilled water (10 mL).  Di-tert-butyl dicarbonate (0.51 g, 2.3 mmol) was dissolved in 
DCM (10 mL) and this solution was added to the sodium carbonate.  The products from 
the above mentioned sodium borohydride reduction were slowly added to the reaction 
mixture at room temperature.  The reaction was heated to 35°C and run for one hour.  
The organic phase was diluted with DCM (20 mL) and washed with water and brine.  
The solvent was removed under vacuum.  The resulting solid was analyzed by HPLC. 
 
Sodium Borohydride Reduction of Phth-CMK 
 A solution of sodium borohydride (0.085 g, 3.1 mmol) and sodium hydroxide 
(0.18 g, 3.8 mmol) in acetonitrile (25 mL) was cooled to 0°C in an ice bath.  Phth-CMK 
(0.5 g, 1.5 mmol) was added and the reaction was run overnight.  The reaction was 
slowly warmed to room temperature and the solvent was removed under vacuum.  The 
resulting solid residue was dissolved in ethyl acetate and washed with dilute acid, water, 
and brine.  The organic phase was dried over magnesium sulfate and the solvent was 
removed under vacuum.  The product was analyzed by HPLC. 
 
Meerwein-Ponndorf-Verley Reduction 
 The MPV reduction of Phth-CMK and TFA-CMK was performed on a smaller 
scale compared to the MPV reductions described in Chapter 3.  Phth-CMK or TFA-CMK 
and aluminum isopropoxide was dissolved in 9:1 toluene/isopropanol (anhydrous).  This 
solution was heated to 50°C and run overnight.  The reactions were run in triplicate.  The 
amounts of the reagents used in each reaction are listed in Table 6.2.  The reactions 




acid (1 mL of a 2 M solution) to quench the reactions.  Samples (0.300 mL) of each 
solution were taken and analyzed on the HPLC.  
 
Table 6.2: Reagent loadings in MPV reduction of Phth-CMK and TFA-CMK. 
 Phth-CMK TFA-CMK 
Mass CMK (g) 0.262 0.156 
Amount CMK (mmol) 0.801 0.532 
Mass Al(OiPr)3 (g) 0.085 0.057 
Amount Al(OiPr)3 (mmol) 0.416 0.279 
Volume Solvent (mL) 2.5 1.67 
 
 
Analysis of Reduction Products 
Purification of Phth-CMK Reduction Products 
 Starting from the crude product mixture from the MPV reduction of Phth-CMK 
described above, the product compounds were separated by column chromatography.  
The solvent was removed under vacuum from the MPV reduction solution and the 
residue loaded on a silica column.  The products were separated using an 8:2 
hexane/ethyl acetate mobile phase.  One of the diastereomeric products was isolated 
and recrystallized in a 7:3 hexane/ethyl acetate solvent mixture.  The product crystallized 
as fine white needles. 
 
Analysis of (R,S)-Phth-CMA 
 1H NMR δ 3.22 (ddd, 2H), 3.46 (dd, 1H). 3.63 (dd, 1H), 4.18 (bs, 1H), 4.22 (m, 
1H), 4.95 (ddd, 1H), 7.20 (m, 5H), 7.69 (m, 2H), 7.82 (bs, 2H).  13C NMR δ 35.1, 45.9, 
55.0, 71.0, 123.5, 126.8, 128.6, 129.0, 131.3, 134.3, 136.6, 172.2.  Elemental analysis 
calculated for C10H15NO3Cl: C, 65.36; H, 5.14; N, 4.23; Cl, 10.74.  Found: C, 65.47; H, 





Figure 6.12: X-ray crystal structure of (R,S)-Phth-CMA. 
 
 
Purification of TFA-CMK Reduction Products 
 Starting from the crude product mixture from the MPV reduction of TFA-CMK 
described above, the product compounds were separated by column chromatography.  
The solvent was removed under vacuum from the MPV reduction solution and the 
residue loaded on a silica column.  The products were separated using a 9:1 
hexane/ethyl acetate mobile phase.  The main diastereomeric product was isolated and 
recrystallized in a 7:3 hexane/ethyl acetate solvent mixture to yield white needles. 
 
Analysis of (S,S)-TFA-CMA 
 1H NMR δ 2.75 (dd, 1H), 3.20 (dd, 1H), 3.53 (dd, 1H), 3.64 (dd, 1H), 3.82 (ddd, 
1H), 4.20 (ddd, 1H), 7.20 (m, 5H).  13C NMR δ 36.3, 47.6, 55.5, 73.6, 88.0, 127.5, 129.3, 
130.3, 139.0, 159.2.  Elemental analysis calculated for C12H13NO2ClF3: C, 48.73; H, 
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 In summary, I have studied the stereoselective synthesis of (R,S)-CMA from its 
corresponding ketone, (S)-CMK, through three reduction methods: (1) MPV reduction, 
(2) ATH reaction, and (3) boron reducing agents.  The highest DR (9.5:1) was achieved 
when a chiral catalyst was used either in the ATH reaction or with a borohydride 
reducing agent.  I also discovered that switching the Boc protecting group of (S)-CMK 
with a phthalimide group, which replaces the acidic hydrogen on the amine, reverses the 
selectivity of the MPV reduction to give a DR as high as 1.1:1.  While investigating the 
MPV reduction, I also observed a significant rate enhancement when the classic MPV 
catalyst, aluminum isopropoxide, was replaced with aluminum tert-butoxide. 
 The use of aluminum tert-butoxide to improve the rate of the MPV reduction is 
new intellectual property.  Increasing the rate of the reaction can save both time and 
money since the reaction mixture does not need to be heated for a long period of time.  
Another way to reduce the cost of the MPV reduction is to decrease the amount of 
catalyst used.  Not only does this lower the cost of the reagents and their subsequent 
disposal, but it would also improve the product purity by reducing the amount of catalyst 
that could leach into the final product.  I recommend investigating the kinetics of the 
MPV reduction with smaller amounts of aluminum tert-butoxide catalyst.  The current 
process, using about 0.5 molar equivalents of aluminum isopropoxide, requires two 
hours of reaction time at 50°C to go to completion.  A smaller amount of aluminum tert-
butoxide can be used to complete the MPV reduction in the same amount of time and 
the economics of either running the reaction for a shorter duration or using a smaller 




 Another aspect of the stereoselective MPV reduction that I recommend pursuing 
is the exploration of different protecting groups on (S)-CMK.  I ran the MPV reduction on 
Phth-CMK and TFA-CMK, in addition to the original Boc-protected (S)-CMK.  Although 
the Phth-CMK results were in agreement with the hypothesis that hydrogen bonding 
plays a key role in the diastereoselectivity of the classic MPV reduction, no other tertiary 
amine protecting groups were investigated.  Steric bulkiness of the protecting groups 
may also play a big role in the selectivity and could be used to increase the DR further.  I 
propose the use of multiple alkyl or aryl protecting groups on the amine to improve the 
stereoselectivity (Figure 7.1).  Comparing the DR of the MPV reduction of (S)-CMK with 
different protecting groups would give more insight into the effect of the protecting group 
on the reduction. 
 
 
Figure 7.1: (S)-CMK with different protecting groups on the tertiary amine. 
 
 
 Although the ATH reaction has been shown to give good diastereoselectivity in 
the reduction of (S)-CMK, the chiral catalyst complex is expensive for industrial 
processes.  Using the ruthenium catalyst precursor, I was able to achieve a DR as high 
as about 0.45:1.  Other researchers have shown that modifications of (1R,2R)-TsDPEN 
have led to increases in the selectivity of the reaction.1  I recommend pursuing similar 
ligands, as shown in Figure 7.2, which have a substituted amine group on TsEN.  This 






Figure 7.2: N-Alkyl-N'-tosyl-1,2-ethanediamine ligand. 
 
 
 The use of boron reagents is the most promising reduction method investigated.  
However, the research presented is only a preliminary screening of reducing agents.  I 
recommend the optimization of the reduction of (S)-CMK using BH3•THF in conjunction 
with the chiral oxazaborolidine (R)-(+)-CBS.  Throughout the reactions explored, the 
reaction conditions changed, making it difficult to accurately compare the results.  
Further investigation of the effects of the reaction conditions, such as temperature, 
reaction time, and reagent concentrations, should be pursued to optimize the reaction. 
 Although the use of chiral oxazaborolidines results in high diastereoselectivity, 
these catalysts are expensive and are difficult to recycle after the reaction.  Once the 
reaction has been optimized, I recommend attaching the chiral oxazaborolidines to a 
solid support for their use in a continuous flow process.  A few methods for preparing 
supported oxazaborolidines have been reported in the literature.2-6  Utilizing a solid 
support would increase the recyclability of the chiral catalysts, make the reduction 
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 APPENDIX A MANGANESE(SALEN) CATALYST SYNTHESIS FOR 






Homogeneously catalyzed reactions generally run faster, give greater product 
selectivity, and result in higher yields than their heterogeneously catalyzed analogs.  
However, isolating the product and/or recovering the catalyst after the reaction is often 
difficult and can lead to product contamination.  On the other hand, heterogeneous 
catalysts readily separate from the reaction mixture but the reaction is often slower than 
homogeneously catalyzed reactions due to mass transfer limitations. 
To address these concerns, the OATS (Organic Aqueous Tunable Solvent) 
system was designed.  OATS couples the benefits of efficient homogeneous catalysis 
with the ease of heterogeneous separation.1   OATS consists of a mixed organic-
aqueous solvent system (e.g., THF and water), which is fully miscible under ambient 
conditions.  Upon addition of modest pressure (<30 bar) of carbon dioxide, a phase split 
occurs between the organic solvent and water.  The hydrophobic products preferentially 
partition into the organic phase and easily separate from the hydrophilic catalyst, which 
remains in the aqueous phase.  Furthermore, the water-soluble catalyst can be easily 
recycled.  OATS has been proposed as a sustainable alternative to current 
pharmaceutical processes, reducing solvent waste and improving product quality by 
minimizing catalyst contamination. 
This work explored the potential of OATS for the asymmetric oxidation of alkenes 




peroxide as an environmentally benign oxidant.  In this case, carbon dioxide acts as both 
a hydrogen peroxide activator2 and a miscibility switch for product separation and 
catalyst recovery.  In order for the catalyst and products to properly partition in the OATS 
system, the catalyst must remain in the aqueous phase while the product preferentially 
dissolves into the organic phase.  Most salen catalysts used for asymmetric epoxidation 
of alkenes are hydrophobic, so a custom water-soluble catalyst was designed and 
synthesized.  My work focused on the synthesis of this hydrophilic Mn(salen) catalyst.  
Although the Mn(salen) catalyst was successfully synthesized and characterized, I found 
that it was unstable in hydrogen peroxide.  However, I propose many other future uses 





 Solvent choice can greatly influence chemical processing.  Solvents can affect 
reaction rates, dictate separation processes, and impact human health and the 
surrounding environment, in addition to playing a major role in process economics.3  
Different processes, and often separate steps of the same process, may require different 
solvents.  For instance, a solvent that enhances the solubility of reactants may be 
difficult to remove in subsequent purification steps.  Unfortunately, no perfect solvents 
exist that work well in all processes. 
One approach would be to use a solvent that can be changed as needed.  For 
example, tunable solvents are solvents whose properties vary by changing an external 
stimulus (e.g., temperature or pressure).  One of the most well-known categories of 
tunable solvents is supercritical fluids (SCFs).4  These solvents exist at a pressure and 




densities merge and the liquid phase ceases to exist).  The properties of SCFs, such as 
solvent strength and transportability, lie between those of gases and liquids and vary 
greatly by simply tuning the pressure.  In addition to their tunability, SCFs like 
supercritical carbon dioxide are easily removed upon venting of the system.  However, 
they require relatively high operating temperatures and pressures, which increases the 
operating costs.  SCFs also have weaker solvent strength than organic solvents, which 
can limit their use in industrial applications. 
Gas-expanded liquids (GXLs) make up the next generation of tunable solvents 
that combine the tunability of SCFs with the solvent power of traditional organic 
solvents.5  GXLs are formed by the dissolution of a gas (usually carbon dioxide) into an 
organic solvent (e.g. methanol or acetonitrile) to create a volume-expanded solvent 
phase with pressure-tunable properties.6  GXLs readily achieve a large range of solvent 
properties, from those of pure carbon dioxide to those of the pure organic solvent.  
Figure A.1 shows the relative transport properties and solvent power of GXLs compared 
to traditional organic solvents, SCFs, and gases.  Some advantages of using GXLs as a 
solvent include improved chemical processing and reduced environmental impact.  
GXLs have enhanced gas solubility of gases such as hydrogen, oxygen, and carbon 
monoxide, which are important for hydrogenation, oxidation, and hydroformylation 
reactions.  The use of GXLs also reduces the total volume of volatile organic solvents as 






Figure A.1: Relative properties of GXLs compared to other solvent classes. 
 
 
 As a result of their advantageous properties, GXLs have been used in a variety 
of applications.  The most common application of GXLs, gas-antisolvent crystallization, 
uses the poor solvent strength of the dissolved gas to precipitate solute molecules.7  
This technique has been applied to the synthesis of nanoparticles to produce particles 
with small size distributions.8,9  The use of GXLs also improves catalytic 
hydroformylation, oxidation,10,11 and hydrogenation reactions12 by improving the gas 
solubility.13  Carbon dioxide-expanded alcohols can also form reversible alkylcarbonic 
acids, which can catalyze reactions without the need for subsequent acid neutralization 
steps.14  The versatility and tunability of GXLs allows for a multitude of additional 
applications, beyond the examples above. 
 
OATS System 
 GXLs have been applied to the development of OATS, a reaction process that 
combines homogeneous catalysis with heterogeneous separations.  The reaction runs 
homogeneously in a miscible mixed organic/aqueous solvent (e.g., THF and water).  
Upon completion of the reaction, carbon dioxide is added to the reaction mixture to 




The hydrophilic catalyst remains in the aqueous phase while the hydrophobic products 
partition into the organic phase, allowing for simple isolation of the products while 
recycling the catalyst for further use (Figure A.2).1  The OATS process results in highly 




Figure A.2: OATS process schematic. 
 
 
 By utilizing carbon dioxide as a miscibility switch, OATS allows facile separation 
since the carbon dioxide-expanded organic phase becomes a poorer solvent for 
hydrophilic substances.  As a proof of concept, a water-soluble dye was dissolved in a 
mixed water/acetonitrile solvent system.  Upon the addition of 30 bar of carbon dioxide, 
a gas-expanded acetonitrile phase was formed, inducing a phase split. The water-
soluble dye preferentially partitioned into the aqueous phase.6  The benefits of the OATS 
system are summarized in Figure A.3, which shows OATS combining the properties of 
homogeneous catalysis (increased yields and product selectivity) with those of 






Figure A.3: Summary of OATS benefits. 
 
 
The OATS system was applied to a number of pharmaceutically relevant 
reactions with promising results.  OATS improved the substrate and catalyst solubility in 
the hydroformylation of hydrophobic olefins and allowed the catalyst to be recycled three 
times with no loss of activity.15  The hydroformylation reaction was applied to long chain 
olefins that cannot be processed industrially in the commercial biphasic (water/organic) 
solvent, due to solubility issues.  Although the system is biphasic, the reaction takes 
place in the aqueous phase, thereby relying on the olefin’s solubility in water.  By 
combining aqueous and organic solvents, OATS improved the reaction between the 
substrate and the catalyst by reducing mass transfer limitations.  OATS has also been 
applied to biocatalysis, where the enzyme was successfully recycled in the aqueous 
phase after completion of the reaction.16 
 
Salen Catalysts 
 In the past few decades, homogeneous chiral salen catalysts have emerged as a 




chiral salen catalysts result in high enantiomeric excesses, but they also function well in 
a wide variety of reactions, including polymer formation,18 kinetic resolution of 
epoxides,19 sulfoxidation,20 and alkene epoxidation.21  The term “salen” refers to 
compounds with structures derived from N,N’-bis(salicylidine)ethylenediamine.  These 
molecules arise from the simple condensation of a salicylaldehyde with a 1,2-diamine 
(Figure A.4).  The salen ligand then complexes with a transition metal (e.g., Mn, Cr, Co, 
Cu, Ti, Ru) to form the salen catalyst.  Researchers have obtained a large number of 
salen ligand variations through the addition of functional groups to either the aldehyde or 
diamine starting materials.22  Most notably, the use of a chiral diamine results in chiral 
salen ligands for use in asymmetric reactions. 
 
 




 One of the most common uses of chiral salen catalysts is the stereoselective 
epoxidation of alkenes.  The production of pharmaceuticals often involves these chiral 
epoxide intermediates.  As an example, Figure A.5 shows the epoxidation of indene to 
indene oxide, a crucial step in the synthesis of the AIDS treatment drug Crixivan®.23  
Epoxidations using salen catalysts traditionally run in an organic phase with an organic 
oxidant like peroxides, or a biphasic system with a hydrophilic oxidant such as sodium 
hypochlorite.  The products subsequently get purified using column chromatography to 




OATS would allow for facile recovery and reuse of the expensive chiral catalyst while 
removing the need for additional product purification steps. 
 
 
Figure A.5: Preparation of Crixivan® from indene. 
 
 
 In addition to catalyst recovery, the use of expensive organic oxidants or 
environmentally unfriendly halogenated oxidant systems represents a major challenge to 
epoxidation reactions.  Hydrogen peroxide-based epoxidation provides an ideal 
alternative synthetic route.  Besides its low cost, hydrogen peroxide is preferred because 
the only byproduct formed from its reaction is water.  Researchers have successfully 
used hydrogen peroxide, in combination with chiral salen catalysts, to synthesize a 
variety of chiral epoxides.24,25  Although hydrogen peroxide epoxidation slows the 
reaction compared to more active oxidants, it has previously been shown that 
supercritical carbon dioxide can enhance the rate of reaction by forming peroxycarbonic 
acid in situ.2  I proposed to use carbon dioxide both to activate the hydrogen peroxide 








RESULTS AND DISCUSSION 
 
Synthesis of Mn(salen) Catalyst 
 First, a chiral salen catalyst that would preferentially partition into the aqueous 
phase of our OATS system was designed.  Researchers previously investigated the 
application of the chiral phosphino catalyst shown in Figure A.6, whose synthesis exists 
in the literature.26  However, preliminary investigations revealed that this catalyst only 
partitioned about 1:1 between water and acetonitrile in OATS, which would result in poor 
catalyst recovery and recycle.  Instead of the phosphino groups, I proposed to use 
sulfonate groups to further increase the water solubility of the catalyst. 
 
 
Figure A.6: Water-soluble Mn(salen) catalyst. 
 
 
 Figure A.7 shows the reaction scheme for the synthesis of the sulfonated 
Mn(salen) catalyst.  I first sulfonated 3-(tert-butyl)-2-hydroxybenzaldehyde to improve 
the water solubility of the catalyst.  Then this sulfonated intermediate was added to 
(1R,2R)-1,2-diaminocyclohexane in a condensation reaction.  Finally, the Mn(salen) 






Figure A.7: Synthesis of Mn(salen) catalyst. 
 
 
Synthesis of 3-tert-Butyl-5-formyl-4-hydroxybenzenesulfonate 
 Figure A.8 shows the first step towards synthesis of the desired Mn(salen) 
catalyst was sulfonation of 3-tert-butyl-2-hydroxybenzaldehyde.  I followed a literature 
procedure using a similar starting compound (chlorobenzaldehyde).27  The aldehyde was 
added dropwise to fuming sulfuric acid in an ice bath.  After all of the aldehyde was 
added, the reaction mixture was heated to 85°C and reacted for an additional hour.  The 
excess acid was neutralized with calcium carbonate and the resulting product was 
recrystallized in methanol.  3-tert-Butyl-5-formyl-4-hydroxybenzenesulfonate precipitated 












 Next, 3-tert-butyl-5-formyl-4-hydroxybenzenesulfonate was condensed with 
(1R,2R)-1,2-diaminocyclohexane (Figure A.9).  In a literature procedure on a similar 
starting material [(3-tert-butyl-5-formyl-4-hydroxybenzyl)triphenylphosphonium chloride], 
the condensation reaction ran in ethanol.28  However, the sulfonate salt did not dissolve 
well in ethanol, even at high temperatures, so acetonitrile was used as the reaction 
solvent instead.  (1R,2R)-1,2-Diaminocyclohexane was added to 3-tert-butyl-5-formyl-4-
hydroxybenzenesulfonate in acetonitrile and the reaction was run at 80°C.  Filtering off 
the solid product and recrystallizing in methanol yielded yellow crystals of 5,5’-(1E,1’E)-
(Cyclohexane-1,2-diylbis(azan-1-yl-1-ylidene))bis(methan-1-yl-1-ylidene)bis(3-tert-butyl-











Synthesis of Mn(salen) Catalyst Complex 
 The last step in the Mn(salen) catalyst synthesis involved mixing the salen ligand 
with the manganese metal center, as shown in Figure A.10.  I stirred 5,5’-(1E,1’E)-
(cyclohexane-1,2-diylbis(azan-1-yl-1-ylidene))bis(methan-1-yl-1-ylidene)bis(3-tert-butyl-
4-hydroxybenzenesulfonate) together with manganese acetate tetrahydrate in ethanol.  
The reaction mixture refluxed at 80°C and ran for three hours.  The product residue was 
recrystallized in methanol to give a dark brown powder.  The Mn(salen) catalyst was 
characterized by MS, IR, and elemental analysis. 
 
 
Figure A.10: Synthesis of Mn(salen) catalyst. 
 
 
Mn(salen) Catalyst Stability 
 I first noticed the instability of the Mn(salen) catalyst in hydrogen peroxide when I 




added a 30% hydrogen peroxide solution and the mixture immediately started to release 
gas and a large exotherm was observed.  The catalyst decomposed during this reaction.  
To test the stability of my salen ligand and catalyst to hydrogen peroxide, the UV 
absorbance was measured over time.  The salen ligand showed the same absorbance 
over the course of 24 hours in a 30% hydrogen peroxide solution.  However, as Figure 
A.11 shows, the absorbance at a wavelength of 400 nm corresponding to the Mn(salen) 
catalyst in hydrogen peroxide decreased drastically in just a few minutes.  Because of 
the catalyst’s instability to the chosen oxidant, I stopped further work on this project. 
 
 









CONCLUSIONS AND RECOMMENDATIONS 
 
 In conclusion, I successfully synthesized and characterized a water-soluble 
Mn(salen) catalyst.  The synthetic approach to prepare the catalyst was not previously 
described in the literature.  Unfortunately, the custom-made catalyst decomposed in the 
presence of the chosen oxidant, hydrogen peroxide.  When the UV-vis absorbance of 
the catalyst in hydrogen peroxide was measured over time, it was found that the catalyst 
decomposed in less than ten minutes, much shorter than the reaction time for our 
proposed epoxidation reaction.  I stopped any further research on this project at this 
point. 
 Although I did not quantify the partitioning coefficient of the catalyst between 
water and organic solvents, I observed good solubility of both the salen ligand and the 
Mn(salen) catalyst in water and minimal solubility of both in organic solvents used in 
OATS (acetonitrile, THF).  Therefore, this catalyst has good potential for improved 
recovery in the OATS system, compared to the previously investigated phosphino 
Mn(salen) catalyst.   
Chiral salen catalysts have found a wide range of applications in the chemical 
industry.  The combination of my chiral salen catalyst and the OATS system could easily 
be applied to another reaction that does not utilize hydrogen peroxide, such as the 
kinetic resolution of epoxides.  This system would still have the benefits of facile product 
purification and catalyst recycling, decreasing the operating costs of the process as well 
as the environmental impact. 
I also propose a strategy to increase the stability of the Mn(salen) catalyst.  Salen 
catalysts readily degrade through hydrolysis of the imine bond, yielding the diamine and 
aldehyde starting materials.  Figure A.12 shows my proposed reduction and methylation 














Materials and Equipment 
 All chemicals were ordered from Sigma-Aldrich or VWR and used as received, 
unless otherwise noted. 
1H and 13C NMR spectra were obtained from a Varian-Mercury VX400 MHz 
spectrometer using d6-DMSO or D2O as an internal reference.  Infrared spectra were 
recorded on a Bruker infrared spectrometer.  Mass spectrum analysis was obtained from 
an ESI-MS by the Georgia Tech Bioanalytic Mass Spectrometry Facility (Atlanta, GA).  
Elemental analysis was performed by Atlantic Microlab, Inc. (Norcross, GA).  UV-visible 
spectra were obtained on a Hewlett-Packard 8453 spectrometer. 
 
Synthesis of Mn(salen) Catalyst 
Synthesis of 3-tert-Butyl-5-formyl-4-hydroxybenzenesulfonate 
 Sulfonation of 3-tert-butyl-2-hydroxybenzaldehyde was done following a literature 
procedure used on a similar compound.27  The glassware was dried in an oven 
overnight.  A three-neck, round-bottom flask was set up with a thermocouple, a 
condenser with an argon gas line, and an addition funnel.  The flask was placed in an ice 
bath, charged with fuming sulfuric acid (20 mL), and purged with argon for a few 
minutes.  The addition funnel was loaded with 3-tert-butyl-2-hydroxybenzaldehyde (3.8 
mL, 22 mmol).  The aldehyde was added dropwise to the sulfuric acid over an hour, 
keeping the temperature in the flask below 10°C.  The reaction was left to stir for an 
additional 15 minutes after all the aldehyde was added.  The flask was removed from the 
ice and heated gradually to 85°C.  The reaction was run at 85°C for one hour and then 
the flask was removed from the heat and cooled to room temperature.  The reaction 




mixture to neutralize the excess acid.  Once the mixture stopped bubbling, the white 
solid (calcium sulfonate) was filtered off.  The filtrate was dried under vacuum and the 
residue was recrystallized in methanol.  The final product was an off-white powder. 
 1H NMR (D2O): 1.26 (s, 9H), 7.80 (s, 1H), 7.83 (s, 1H), 9.76 (s, 1H).  13C NMR 
(D2O): 28.44, 34.61, 119.78, 130.25, 131.17, 133.84, 139.48, 162.49, 199.00.  
Calculated for Ca[C11H13SO5]2·2H2O: C, 44.73; H, 5.12; S, 10.86.  Found: C, 44.04; H, 
5.04; S, 10.97.  ν (cm-1): 3400 (H2O or OH), 1650 (C=O), 1440 and 1200 (S=O).  ESI- 




 The condensation of 3-tert-butyl-5-formyl-4-hydroxybenzenesulfonate with 
(1R,2R)-1,2-diaminocyclohexane was done following a similar literature procedure.28  
The sulfonated aldehyde (0.50 g, 0.80 mmol) was stirred in acetonitrile (10 mL).  The 
aldehyde was not completely soluble and formed a suspension.  The mixture was 
heated to 80°C.  (1R,2R)-1,2-diaminocyclohexane (0.092 g, 0.80 mmol) was added and 
the reaction was run at 80°C for four hours.  The solid yellow product was filtered off and 
washed with DCM.  The product was recrystallized in methanol to give yellow crystals. 
 1H NMR (d6-DMSO): 1.31 (s, 18H), 1.43 – 1.92 (br, 8H), 3.51 (m, 2H), 7.43 (s, 
2H), 7.48 (s, 2H), 8.55 (s, 2H).  13C NMR (d6-DMSO): 24.38, 29.76, 33.12, 35.10, 70.88, 
117.39, 127.48, 127.91, 136.41, 137.90, 161.53, 166.65.  Calculated for 
CaC28H36N2S2O8·5H2O: C, 46.54; H, 6.37; S, 8.86; N, 3.89.  Found: C, 45.92; H, 6.25; S, 
9.03; N, 4.17.  ν (cm-1): 3394 (H2O or OH), 1628 (C=N), 1438 and 1184 (S=O).  ESI- MS 
m/z593 [C28H26S2O10]2-. 
 




 Using the previously synthesized 5,5’-(1E,1’E)-(cyclohexane-1,2-diylbis(azan-1-
yl-1-ylidene))bis(methan-1-yl-1-ylidene)bis(3-tert-butyl-4-hydroxybenzenesulfonate), I 
made the Mn(salen) catalyst following a known procedure.28  The salen ligand (0.15 g, 
0.20 mmol) was stirred together with manganese acetate tetrahydrate (0.049 g, 0.20 
mmol) in ethanol (4 mL).  The mixture was refluxed at 80°C for three hours.  The 
reaction mixture was removed from heat and cooled to room temperature.  The solvent 
was removed under vacuum to give a brown solid residue.  The residue was 
recrystallized in methanol to give dark brown crystals. 
 Calculated for Ca[Mn(CO2CH3)C28H34N2S2O8]·6H2O: C, 42.25; H, 5.75; S, 7.51; 
N, 3.29.  Found: C, 42.26; H, 5.33; S, 7.63; N, 3.18.  ν (cm-1): 3425 (H2O or OH), 1620 
(C=N), 1433 and 1181 (S=O).  ESI- MS m/z 645 [MnC28H34N2S2O8]2-. 
 
Catalyst Stability 
 A solution of the salen ligand (1x10-6 M) was made in 30% hydrogen peroxide.  
The UV-vis spectrum of this solution was taken periodically over the course of 24 hours.  
No change in absorbance was seen over this time period.  The Mn(salen) catalyst was 
dissolved in both water and 30% hydrogen peroxide at concentrations of 2x10-6 M.  The 
UV-vis spectrum of the catalyst in water was taken as a reference.  An initial spectrum of 
the hydrogen peroxide solution was taken and subsequent spectra were recorded after 
10, 20, and 30 minutes. The catalyst UV-vis spectra were normalized by subtracting the 
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 Paclitaxel, commonly known by the trade name Taxol®, is a chemotherapy drug 
that is currently used to treat lung, breast, and ovarian cancers.  The history of paclitaxel 
begins with a 1958 National Cancer Institute study that commissioned Department of 
Agriculture botanists to collect samples of over 30,000 plants to test for anticancer 
properties.  In 1963, Wall discovered that the bark of the Pacific yew tree possessed 
antitumor qualities and the active ingredient was isolated and identified as paclitaxel four 
years later.1  Prior to 1993, almost all paclitaxel produced was extracted from yew trees, 
a process which requires six 100-year old yew trees to be cut down for every patient 
treated.  This led to a drive to produce paclitaxel synthetically, which was first published 
in 1994.2-4  The total synthesis pathways published around this time all had very low 
yields (<1%), making them highly inefficient for manufacturing processes.  Later, a 
shorter and more efficient synthetic route was developed from the natural product 10-
deacetylbaccatin, isolated from the needles of Pacific yew trees.  This shorter route 







Figure B.13: Structure of paclitaxel with side chain highlighted. 
 
 
 Largely due to an enormous research and development effort, starting in 
government facilities and later in commercial labs, paclitaxel quickly became an all-time 
best-selling pharmaceutical.  Paclitaxel was brought to the market by Bristol-Myers 
Squibb in 1993 as Taxol®.  Annual sales peaked in 2000, reaching $1.6 billion.  
Unfortunately, the Pacific yew tree is one of the slowest growing trees in the world.  
Although other paclitaxel-like compounds may be extracted from various parts of yew 
trees, these are not as potent as paclitaxel itself. 
 Since the current synthetic method for the production of the paclitaxel side chain 
is complex and expensive, I investigated cheaper alternative routes to the paclitaxel side 
chain.  Simplifying the synthetic pathway would make paclitaxel a cheaper and more 
readily available anti-cancer drug. 
 The aim of my research was to develop a proprietary synthetic pathway to the 
synthesis of the side chain.  This appendix reports three approaches: (1) Jacobi 







RESULTS AND DISCUSSION 
 
Jacobi Synthesis 
 A synthetic route for the paclitaxel side chain starting from N-benzoyl-2-
phenylglycinaldehyde was investigated.  Jacobi and Herradura reported the synthesis of 
(+)- and (-)-nephrosteranic acid from dodecyl aldehyde using potassium cyanide to form 
the cyanohydrin intermediate.5  Upon ethanolysis, the cyanohydrin intermediate yielded 
the racemic mixture of the corresponding α-hydroxy ethyl ester products.  The pure 
enantiomers were isolated upon resolution with quinine.  The reaction scheme outlined 
in Figure B.14, using N-benzoyl-2-phenylglycinaldehyde as the starting material was 
investigated.  The “Jacobi synthesis” would result in a simple and cheap method to 
produce the paclitaxel side chain molecule. 
 
 
Figure B.14: Proposed synthetic pathway to paclitaxel side chain using Jacobi method.5 
 
 
 The starting material for the proposed synthesis of the paclitaxel side chain, N-
benzoyl-2-phenylglycinaldehyde, is not commercially available.  However, the 
unprotected carboxylic acid and alcohol derivatives are widely available.  First, the 2-
phenylglycinol was selected as the starting material.  Upon oxidation, 2-phenylglycinol 
will yield the desired aldehyde, N-benzoyl-2-phenylglycinaldehyde.  Several strategies 




Commonly, a protecting group was first introduced on the amine, followed by the 
controlled oxidation of the alcohol to the aldehyde (Figure B.15). 
 
 
Figure B.15: Benzoyl protection and subsequent oxidation of 2-phenylglycinol. 
 
 
Protection of 2-phenylglycinol 
 Following a literature procedure,6 the amino group of 2-phenylglycinol was 
successfully and selectively protected with a benzoyl group ( 
Figure B.16).  Equimolar amounts of 2-phenylglycinol and benzoyl cyanide were mixed 
together at -10°C and the product precipitated in less than twenty minutes.  After 
completion of the reaction, the N-benzoyl-2-phenylglycinol was purified via trituration in 
DCM.  N-benzoyl-2-phenylglycinol was isolated as a white powder in 66% yield and was 
characterized by 1H and 13C NMR.  This N-benzoyl-2-phenylglycinol was used in 










The Swern oxidation of N-benzoyl-2-phenylglycinol was originally chosen for its 
mild reaction conditions and high reported yields.7    I first mixed cyanuric chloride and 
DMSO in THF at -30°C to form the activated sulfonium salt intermediate.  Then N-
benzoyl-2-phenylglycinol was added.  After 30 minutes, the reaction was quenched with 
triethylamine (Figure B.17). The original workup procedure resulted in poor mass 
balance and impure product.  The workup procedure was improved by changing the 
extraction solvent from diethylether to DCM.  Thus, the mass balance was achieved.  
However, no aldehyde peaks were visible by 1H NMR. 
 
 









 The next strategy involved the Dess-Martin oxidation.8  Dess-Martin periodinane 
was added to a solution of N-benzoyl-2-phenylglycinol in DCM at room temperature 
(Figure B.18).  The starting material was completely consumed after two hours of 
reaction. Although peaks corresponding to the desired aldehyde product were visible by 
1H NMR, a large number of byproducts also present made isolation of the aldehyde very 
difficult.  Column chromatography failed to yield the aldehyde in pure form.  Because of 
the difficulty of product purification, this strategy was not pursued further. 
 
 
Figure B.18: Attempted Dess-Martin oxidation of N-benzoyl-2-phenylglycinol. 
 
 
Pyridinium Dichromate Oxidation 
 The selective and mild oxidation of alcohols utilizing pyridinium dichromate as the 
oxidative agent was next investigated (Figure B.19).  Pyridinium dichromate was added 
to a solution of N-Benzoyl-2-phenylglycinol in DCM and the reaction was run overnight at 
room temperature.   As seen with the Dess-Martin oxidation, over-oxidation and partial 
reaction yielded a complex crude material (unreacted alcohol, desired aldehyde product, 







Figure B.19: Attempted pyridinium dichromate oxidation of N-benzoyl-2-phenylglycinol. 
 
 
Manganese Dioxide Oxidation 
 Manganese dioxide was used to oxidize N-benzoyl-2-phenylglycinol (Figure 
B.20).  Following a general oxidation procedure in the literature,9 manganese dioxide 
was added to a solution of N-benzoyl-2-phenylglycinol in DCM at room temperature.  
The product mixture was analyzed by 1H and 13C NMR.  For the first time, the desired 
aldehyde was the major product with about 50% of the overall products.  The reaction 
time was optimized based on the maximum production of the aldehyde product with 
minimal oxidation to the carboxylic acid.  Based on the 1H NMR analysis, a reaction time 
of two days was deemed optimal. 
 
 






 Due to the fine powdery nature of the manganese dioxide, the workup and 
isolation of the aldehyde product was strenuous and difficult.  The product mixture was 
filtered on multiple Celite pads to remove all traces of the manganese dioxide.  After 
purification on a silica column, only about 1% of the aldehyde product was isolated.  I 
also tried centrifuging the crude product mixture before filtration on Celite but the 
manganese dioxide was not successfully centrifuged out of the solution.  In addition, I 
ran a continuous extraction from the manganese dioxide remaining on the Celite to 
recover all of the aldehyde product, but I was still unable to close the mass balance.  
Although this method gave the best yield of the aldehyde in the crude product mixture 
and a small amount of the aldehyde was isolated for the first time, the overall yield was 
not viable. 
 
Acylsilane Benzoin Condensation 
 Since the starting material for the Jacobi synthesis (N-benzoyl-2-
phenylglycinaldehyde) was difficult to isolate, I investigated alternative methods to 
synthesize the paclitaxel side chain.  One method was acylsilane benzoin condensation 
(Figure B.21).  When a silyl intermediate is used, the benzoin condensation directs the 
ketone placement to be adjacent to the phenyl ring, which is desired for the paclitaxel 
side chain.  So I first investigated two methods to synthesize the trimethylsilyl ketone: 1) 
Capperucci’s (trimethylsilyl)cuprate method, and 2) Katritzky’s benzotriazole synthesis. 
 
 





Capperucci (Trimethylsilyl)cuprate Synthesis 
 The method used by Capperucci to synthesize the trimethylsilyl phenyl ketone is 
a relatively simple one-pot synthesis with a published yield of 87% (Figure B.22).10  A 
solution of hexamethylphosphoramide (HMPA) and hexamethyldisilane was mixed with 
methyl lithium in anhydrous THF at -78°C.  The solution was warmed to 0°C and reacted 
for fifteen minutes.  The solution was cooled to -23°C and copper cyanide and benzoyl 
chloride were added to the reaction mixture.  The reaction was quenched with 
ammonium chloride and the organics were extracted into diethylether.  However, 
although my experimental observations were identical to the literature procedure, I was 
unable to reproduce their product yields.  The 1H and 13C NMR showed many 
overlapping peaks and the GC-MS showed only starting material. 
 
 
Figure B.22: Capperucci (trimethylsilyl)cuprate reaction scheme. 
 
 
Katritzky Benzotriazole Synthesis 
 Katritzky and coworkers established an alternative procedure for synthesizing 
trimethylsilyl ketones using a benzotriazole intermediate (Figure B.23).11,12  This reaction 
method reportedly provided 80% yield of the desired product.  The first step is to 
synthesize the benzotriazole ether from benzaldehyde, benzotriazole, and 




products were extracted into diethylether, dried, and analyzed by 1H and 13C NMR.  The 
NMR spectra were very complex, showing many overlapping peaks, which prevent the 
identification of the product peaks.  The product mixture was analyzed by GC-MS, which 
did not show a peak for the desired product (based on the mass).  Purification was 
unsuccessful.  This pathway was stopped. 
 
 
Figure B.23: Katritzky benzotriazole reaction scheme. 
 
 
Tungstophosphoric Acid Reaction 
 Another method I investigated was the tungstophosphoric acid catalyzed 
oxidation of aromatic alkenes to α-hydroxyketones.  Zhang and coworkers used this 
technique successfully on styrene.13  They showed that the reaction proceeds 
regioselectively with the ketone group adjacent to the aromatic ring.  Starting from trans-
cinnamic acid, I proposed to synthesize the desired α-hydroxyketone shown in Figure 
B.24.  I chose to pursue this reaction because it follows a relatively simple one step 
procedure with mild reaction conditions and reagents that are not sensitive to air or 
water.  In addition, the tungstophosphoric acid catalyst is much cheaper than most 
transition metal catalysts.  As an initial investigation, I repeated the literature reaction 




tungstophosphoric acid, cetylpyridinium chloride, and hydrogen peroxide in chloroform.  
The reaction was run overnight at reflux.  Analysis of the crude reaction mixture by 1H 
NMR and GC-MS showed the disappearance of the starting material.  However, it was 
difficult to isolate the desired product from the crude mixture, even after the workup 
procedure was optimized. 
 
 
Figure B.24: Tungstophosphoric acid catalyzed oxidation of trans-cinnamic acid. 
 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
 In conclusion, I investigated multiple means to synthesize the paclitaxel side 
chain through cost-effective and simple reaction procedures.  The methodologies 
investigated include the Jacobi synthesis from N-benzoyl-2-phenylglycinaldehyde, 
acylsilane benzoin condensation, and the tungstophosphoric acid catalyzed oxidation of 
trans-cinnamic acid.  In all the cases investigated, product purification was a significant 
road block to achieving our goal of identifying a potential industrial process. 
 The Jacobi reaction reacting an aldehyde with potassium cyanide in the 
presence of sodium metabisulfite allows for the formation of the corresponding 
cyanohydrins.  This later can undergo ethanolysis in acidic conditions to yield the α-
hydroxyethyl ester.  The starting alcohol, N-benzoyl-2-phenylglycinol, was prepared and 
its synthesis was optimized and scaled up.  Unfortunately, after trying many methods to 




dichromate oxidation, and manganese dioxide oxidation), the aldehyde was not 
successfully isolated on a usable scale. 
 The Capperucci synthetic method used water sensitive and highly reactive 
reagents that led to synthesis of many side products that made isolation of our desired 
product difficult.  The Katritzky benzotriazole method seemed more promising but still led 
to many side products. 
 The most promising reaction was the simple synthesis of the side chain via 
oxidation of trans-cinnamic acid.  Although the 12-tungstophosphoric acid catalyzed 
oxidation was reported successfully in the literature, I was unable to reproduce their 
results on styrene.  However, this method would be a relatively cheap and simple means 
to obtain the paclitaxel side chain. 
 Although I attempted a few different methods to synthesize the paclitaxel side 
chain, the lack of chemoselectivity was a major roadblock for industrial applications.  In 
the future, I would recommend focusing on the tungstophosphoric acid reaction, as it 






Materials and Equipment 
 All chemicals were ordered from Sigma-Aldrich or VWR and used as received, 
unless otherwise noted.  1H and 13C NMR spectra were obtained from a Varian-Mercury 
VX400 MHz spectrometer using CDCl3 or d6-DMSO as an internal reference. 
 
Jacobi Synthesis 
Synthesis of N-Benzoyl-2-phenylglycinol 
 The amino protection of 2-phenylglycinol was done following a literature 
procedure using benzoyl cyanide to selectively protect the amino group.6  2-
phenylglycinol (0.69 g, 5.0 mmol) was dissolved in DCM (15 mL) in a sodium 
chloride/ice/water bath.  Benzoyl cyanide (0.66 g, 5.0 mmol) was dissolved in DCM (4 
mL) and this solution was added dropwise to the starting material.  The hydrogen 
cyanide generated in this reaction was subsequently treated with a sodium hydroxide 
solution for further disposal.  A white precipitate formed almost immediately but the 
reaction was allowed to run for an additional 20 minutes.  The solvent was removed 
under vacuum to give the crude product.  Trituration in DCM was used to remove any 
remaining starting material and the product was filtered off and dried.  This reaction was 
also successfully scaled up by a factor of ten.  This procedure resulted in a white 
powdery product in a yield of 66%. 
 1H NMR (d6-DMSO): 3.64 (m, 2H), 4.93 (t, 1H), 5.06 (q, 1H), 7.23 – 7.89 (m, 
10H), 8.68 (d, 1H).  13C NMR (d6-DMSO): 40.60, 49.10, 111.18, 111.35, 111.77, 112.46, 







 The reaction procedure for the Swern oxidation was adapted from literature with 
changes to the workup procedure.7  Cyanuric chloride (0.66 g, 3.6 mmol) was dissolved 
in THF (20 mL) in a calcium chloride/ice/water bath.  DMSO (1.25 mL, 17.6 mmol) was 
added and left to react for 30 minutes.  Then N-benzoyl-2-phenylglycinol (0.72 g, 3.0 
mmol) in THF (10 mL) was added slowly.  After an additional 30 minutes, triethylamine 
(2.0 mL, 14 mmol) was added.  The reaction mixture was removed from the ice bath and 
warmed to room temperature 15 minutes after addition of the triethylamine.  The solvent 
was removed under vacuum and the residue was dissolved in DCM and the organic 
phase was washed with 1 N HCl, saturated sodium bicarbonate, then brine.  The 
combined organic phase was dried over magnesium sulfate and the solvent removed 
under vacuum.  This afforded an off-white product which did not have the desired 
product by 1H NMR and was not further analyzed. 
 
Dess-Martin Oxidation 
 The Dess-Martin oxidation of N-benzoyl-2-phenylglycinol was done according to 
a literature procedure.8  Dess-Martin periodinane (1.0 g, 2.4 mmol) was added to a 
solution of N-benzoyl-2-phenylglycinol (0.49 g, 2.0 mmol) in DCM (7.5 mL) at room 
temperature.  DCM (2 x 3 mL) was added to the solution every 15 minutes.  The reaction 
was monitored by thin layer chromatography, which showed the disappearance of the 
starting material after two hours.  Diethylether (7 mL) was added to the reaction and the 
solution was washed with a solution of sodium thiosulfate (5.65 g) in an 80% saturated 
sodium bicarbonate solution.  The aqueous layer was extracted with diethylether then 
the combined organics were washed with saturated sodium bicarbonate, water, and 
brine.  The organic solution was dried over magnesium sulfate and the solvent was 




impurities and left at -15°C for one hour.  The solvent was removed under vacuum.  The 
product was washed with a 4:1 hexane/ether solution and dried to give a light yellow 
powder in 69% yield. 
 
Pyridinium Dichromate Oxidation 
 N-Benzoyl-2-phenylglycinol (0.50 g, 2.0 mmol) and pyridinium dichromate (0.78 
g, 2.0 mmol) were stirred in DCM (10 mL), forming a dark brown suspension.  The 
reaction was run overnight at room temperature.  The reaction mixture was diluted with 
diethylether and filtered.  The organic solution was run through a silica plug before the 
solvent was removed under vacuum. 
 
Manganese Dioxide Oxidation 
 N-Benzoyl-2-phenylglycinol (1.5 g, 6.0 mmol) and manganese dioxide (20 g, 0.23 
mol) were stirred in DCM (50 mL) for 48 hours at room temperature.  The reaction slurry 
was filtered on Celite until the filtrate was colorless.  The solvent was removed under 
vacuum to give an off-white solid (0.43 g, 44% yield of crude product). 
 
Acylsilane Benzoin Condensation 
Capperucci (Trimethylsilyl)cuprate Synthesis 
 The method published by Capperucci and coworkers was followed to synthesize 
phenyl(trimethylsilyl)methanone.10  HMPA (1 mL, 5.7 mmol) and hexamethyldisilane (0.5 
mL, 2.4 mmol) were cooled in a dry ice/acetone bath (the mixture froze).  Methyl lithium 
(1.25 mL of a 1.6 M solution in hexane, 2 mmol) and anhydrous THF (3 mL) were added.  
The dry ice/acetone bath was replaced with an ice bath (0°C).  The reaction mixture was 
a homogeneous solution.  After about 15 minutes, the solution turned bright red.  At this 




(90 mg, 1 mmol) was added and this solution was stirred for 30 minutes.  Benzoyl 
chloride (0.23 mL, 2 mmol) was dissolved in THF (1.5 mL) and added to the reaction 
mixture dropwise.  The reaction was stirred on the ice/calcium chloride bath for five 
minutes and then warmed to room temperature over one hour.  The reaction was 
quenched with a saturated aqueous ammonium chloride solution.  The organics were 
extracted into diethylether and washed with water.  The solvent was removed under 
vacuum to give a dark yellow oil. 
 
Katritzky Benzotriazole Synthesis 
 Following Katritzky’s published procedure, benzaldehyde (2.0 mL, 20 mmol), 
ethanol (2.3 mL, 40 mmol), benzotriazole (3.0 g, 25 mmol), triethyl orthoformate (10 mL, 
60 mmol), and sulfuric acid (6 drops) were stirred in THF (30 mL) at room temperature 
for three hours.  The mixture was then heated to reflux for an additional three hours.  
The organics were extracted into diethylether (200 mL), washed with saturated sodium 
carbonate (2 x 100 mL) and water (100 mL).  The solvent was removed under vacuum 
and purified on a silica column with 1:3 ethyl acetate/hexane. 
 
Tungstophosphoric Acid Reaction 
 The oxidation of styrene to an α-hydroxyketone was run according to a literature 
procedure.13  12-tungstophosphoric acid (0.59 g, 0.21 mmol), cetylpyridinium chloride 
(0.22 g, 0.62 mmol), and hydrogen peroxide (2.0 mL of a 35% solution, 20 mmol) were 
mixed together in chloroform (15 mL).  Styrene (0.23 mL, 2 mmol) was added to start the 
reaction.  The reaction was run at reflux (60°C) overnight.  The reaction was removed 
from heat and quenched with 10% sodium bisulfite and 10% sodium hydroxide.  The 
organics were extracted in chloroform, washed with brine, and dried over magnesium 
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